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Abbrevations: 
 
abs absolute Me methyl 
AD asymmetric dihydroxylation MeCN acetonitrile 
Ar aryl MeOH methanol 
atm. atmosphere MeOPEG polyethylene glycol 
monomethyl ether AzaBOX azabis(oxazoline) 
BINOL 1,1´-bi-2-naphthol min minute 
Bn benzyl MS mass spectrometry 
Boc tert-butyloxycarbonyl nBu n-butyl 
BOX bis(oxazoline) n-BuLi n-butyl lithium 
Bz benzoyl nd not determined 
Cbz carboxybenzyloxy NLE non linear effect 
CI chemical ionization (MS) NMR nuclear magnetic resonance 
COD 1,5-cyclooctadiene nPr n-propyl 
d days OAc acetate 
DCM dichloromethane TBS tert-butyl silyl 
Diglyme bis(2-methoxyethyl) ether OTf triflate 
DIPEA N,N-diisopropylethylamine PE hexanes 
DMSO dimethylsulfoxide Ph phenyl 
ee enantiomeric excess PMMH phenoxy-methyl(methyl-
hydrazono) EE ethyl acetate 
EI electron impact (MS) ppm part per million 
ent enantiomer p-TSA para-toluene sulfonic acid 
eq. equivalent quant. quantitative 
ESI electrospray ionization 
(MS) 
R arbitrary rest 
r.t. room temperature 
Et ethyl rac racemic 
EtOH ethanol tBu tert-butyl 
GC gas chromatography tBuOH tert-butanol 
h hour TfOH trifluoromethanesulfonic acid 
HPLC high performance liquid  THF tetrahydrofurane 
 chromatography TLC thin layer chromatography 
iPr iso-propyl TMS tetramethylsilyl 
IR infrared spectroscopy   
LDA lithium diisopropylamide   
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A. Introduction 
Already in the beginning of the 19th century the French physicist Biot discovered, that 
certain inorganic and organic compounds are able to rotate the plane of polarized 
light.1,2 Later Pasteur revealed that the sodium ammonium salt of tartaric acid 
precipitates into enantiomorphic crystals. He was able to mechanically separate the 
two types of crystals and made the discovery that the solutions of the crystals rotate 
plane polarized light by the same value but in opposite directions. His explanation for 
these observations was that the crystals consist of molecules which are 
nonsuperimposable mirror images of one another. He established that the 
phenomenon of optical activity is correlated to an asymmetric grouping of atoms 
within a molecule. 
 
 
Figure 1: Louis Pasteur (1822-1895). 
 
All this took place even before it was known that carbon is tetravalent, a finding which 
was established by Kekulé about 40 years later.3 After the postulates of van’t Hoff 
and Le Bel, which independently reported that tetravalent carbon has a tetrahedral 
structure, the stage was set for the fundamental feature of organic molecules, their 
ability to exist in two mirror image configurations. This architecture can result when 
the central carbon is connected to four different substituents and this stereogenic 
carbon atom is said to be “chiral” (Figure 2). The expression “chirality” was 
introduced already more than one century ago by Lord Kelvin, but it took several 
decades until it became a key word in chemical text books.4 
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Figure 2: The two mirror image forms of a stereogenic tetrahedral carbon atom. 
 
Ever since the seminal discoveries of Pasteur, van’t Hoff and Le Bel it 
biggest goals of organic chemists to be able to synthesize only one of the possible 
stereoisomeric forms, so to produce enantiomerically pure products. Especially in the 
last few decades, more and more efforts 
synthesis of molecules. Particularly for
single enantiomers of chiral compounds
thalidomide tragedies. This fact is reflected in Figure 3, showing that in 1989 the 
amounts of racemates an
whereas in 2000 there were almost ten times more single enantiomers applied.
 
Figure 3: Annual distribution of worldwide approved drugs according to chirality 
character (1989–2000). * Including diastereomeric mixtures.
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Up to date the access to enantiomerically pure compounds relies largely on biologic 
and biochemical transformations. However, these methods often suffer from 
drawbacks such as limited substrate scope or instability of the biocatalyst (enzyme, 
microorganism) in the reaction media. In order to produce new stereogenic centers 
several chemical methodologies are known: (a) substrate control, (b) auxiliary control 
and (c) reagent control. The first asymmetric reactions that were conducted used 
substrate control. This means, that an existing chiral center of the substrate 
influences the stereochemical outcome of the formation of a new stereocenter during 
the reaction with an achiral reagent. The first observations in this field were made by 
E. Fischer in the reaction of hydrogen cyanide with D-arabinose (1). The resulting 
nitriles 2 and 3 were formed in a diastereoselective manner (2:3 = 66:34) (Scheme1). 
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Scheme 1: Diastereoselective addition of HCN to D-arabinose.6 
 
After these first results it took more than 50 years until a deeper insight into 
asymmetric induction in substrate controlled reactions was gained. In 1952 Cram 
published ‘The rule of “Steric Control of Asymmetric Induction” in the Syntheses of 
Acyclic Systems’7 which was the basis for a rational interpretation and control of the 
stereochemical outcome of substrate controlled reactions. 
Another approach to the synthesis of chiral compounds was the use of chiral 
auxiliaries. For this purpose, a chiral, nonracemic molecule (the chiral auxiliary) is 
covalently attached to the substrate. In the second step, the substrate reacts with an 
achiral reactant and the stereochemical outcome is controlled by the auxiliary. After 
the transformation the auxiliary is cleaved to obtain the enantiomerically enriched 
product. Chiral auxiliaries were introduced by Corey, who used (1S,2R,5S)-2-(1-
methyl-1-phenylethyl)-5-methyl-cyclohexanol (4) as directing group in 1978.8 Up to 
date, the most prominent auxiliaries are the Evans-auxiliaries (5), so molecules 
derived from oxazolidinones, which were used, for example, for enantioselective 
Aldol-reactions.9 
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Figure 4: Different types of chiral auxiliaries. 
 
But also other molecules can serve as chirality transmitting groups. Myers et al. 
reported the use of both enantiomers of pseudoephedrine (7) as auxiliaries.10 For the 
enantioselective reaction pseudoephedrine 7 first was attached to the substrate to 
form the amide 8. After enolization of the amide, a subsequent substitution with 
benzyl bromide afforded very good diastereoselectivity. The intermediate 9 could be 
converted into different products with high enantioselectivities (Scheme 2). 
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Scheme 2: Use of pseudoephedrine as chiral auxiliary according to Myers et al.9 
 
The major disadvantages of this methodology were the introduction of two additional 
synthetic steps into the reaction sequence and the need for stoichiometric amounts of 
the auxiliary, which usually cannot be recycled. 
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The third possibility to implement enantioselectivity in a reaction was the application 
of reagent control. These asymmetric transformations can be divided into two 
methodologies: (a) the chiral reagent is used in stoichiometric amounts; and (b) the 
chiral compound is used in sub-stoichiometric quantities (chiral catalysis). In these 
types of asymmetric reactions, the stereochemical outcome of the reaction is coined 
by the chirality of the reagent. A very elegant example for asymmetric reactions with 
reagent control was published by Masamune et al.11 They used the chiral dialkyl 
borane 11 for the hydroboration of different alkenes. Applying this methodology also 
tri-substituted alkenes could be transformed to the corresponding alcohols with 
almost perfect control of the two new stereocenters (Scheme 3).   
 
 
Scheme 3: Hydroboration of a tri-substituted alkene by Masamune et al.10 
 
Although the deployment of chiral reagents is an elegant way to obtain 
enantioselective products, it would be more desirable to use the reagent in a sub-
stoichiometric amount, as a catalyst that is not consumed during the reaction. 
Asymmetric catalysis can again be divided into two main fields: the organocatalysis 
and catalysis employing metal complexes. Since the introduction of the term 
“organocatalysis” by MacMillan in 2000 it has become a great field of interest for 
organic chemists and the number of publications concerning this type of chemistry is 
increasing each year (Figure 5). This is mainly due to the facts that no (possibly) toxic 
metal has to be used and many catalysts are derived from readily available 
substances of the chiral pool (amino acids, sugars, terpenes, etc.).  
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Figure 5: Number of publications using the keyword “organocatalysis” in title or 
abstract since the year 2000 (from SciFinder, 23.11.2009). 
 
Organocatalysts, which are usually small organic molecules, can increase the 
reaction rate by different interactions with the substrate, i.e. covalent bonding or non-
covalent interactions like hydrogen bonding. The most important mode of action is 
the covalent bonding of the catalyst to the substrate. Herein, the enamine and the 
iminium catalysis play the most prominent role. The enamine-type is prevalent in the 
majority of proline or proline-derived catalysis (Scheme 4). Under these 
circumstances, the catalyst and the carbonyl compound form an enamin, which is 
amenable to a nucleophilic attack. 
 
 
Scheme 4: Highly enantioselective anti-Mannich reaction.12 
 
In the second case, the iminium ion catalysis, the secondary amine catalyst and the 
carbonyl compound will form an iminium ion. The active species then is able to 
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accomplish a number of reactions, like Diels-Alder-reactions, Michael-additions, 
Friedel-Crafts-alkylations, to mention only few. 
Although the impact of organocatalysis was expanding in the last years, a number of 
reactions cannot be performed without the use of metal ions so far. For that reason, a 
lot of research is dedicated to the field of organo-metallic catalysis and great efforts 
and improvements have been made to enable synthesis of more active and selective 
catalytic systems. However, enantioselective catalysis is not just a tool in academic 
research but suitable for large scale synthesis, since there are already a lot of 
processes catalyzed by metal-organic compounds which are conducted on industrial 
scale.13 
 
1. Historical remarks on organo-metallic, asymmetric catalysis  
The first example of homogeneous enantioselective catalysis in literature dates back 
to 1966.14 In this reaction, the cyclopropanation of styrene with ethyl diazoacetate, an 
enantiomeric ratio of 53:47 (regarding the trans isomer) was achieved. Two years 
later, in 1968, Knowles et al.15 and Horner et al.16 independently reported on the 
hydrogenation of prochiral olefins using Rh complexes of the Wilkinson type, 
containing optically active phosphines. However, only poor enantioselectivities were 
achieved using these monodentate ligands, which were chiral on the phosphorus 
atom. One of the milestones in asymmetric catalysis was the synthesis of DIOP (19), 
a diphosphine ligand derived from tartaric acid that was synthesized by Kagan and 
coworkers.17 This represented the first C2-symmetric ligand, which was able to 
reduce the number of possible conformations due to bidentate coordination. 
 
Scheme 5: Asymmetric hydrogenation using DIOP.16 
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Under these conditions it was possible to hydrogenate dehydro N-acetyl-tyrosine 17 
to afford the corresponding N-protected (R)-amino acid 18 in good yields and with 
good enantioselectivities (Scheme 5). These promising results stimulated the 
research worldwide and as a result many new chiral diphosphines were developed 
(Figure 6).18 
 
O
O PPh2
PPh2
H
H
DIOP 19
H3C CH3
PPh2Ph2P
Chiraphos 20
PP
OO
DIPAMP 22
H3C
PPh2Ph2P
Prophos 21
N
Boc
Ph2P
PPh2
BPPM 23
 
Figure 6: Prominent optically active diphosphines.19 
 
A special role plays the DIPAMP ligand 22, because this compound was used for the 
first catalytic asymmetric process on industrial scale, namely the synthesis of  
L-DOPA. In a rhodium(I)-catalyzed reaction, unsaturated amino acid 24 was reduced 
to the intermediate 25, which furnished the desired product after hydrolysis of the 
protecting groups (Scheme 6). 
 
 
Scheme 6: The asymmetric synthesis of L-DOPA using a C2-symmetric ligand.20 
 
A. Introduction 
 
9 
 
Another benchmark for asymmetric hydrogenations was set by Noyori in 1980, when 
he introduced the axially chiral C2-symmetric ligand BINAP 29, whose rhodium(I) and 
ruthenium(II) complexes were also used for hydrogenation reactions. Currently 
several chiral drugs are produced using these catalytic systems. For instance, the 
anti-inflammatory drug naproxen 28 is prepared from α-arylacrylic acid 27 in a highly 
enantioselective process (Scheme 7). 
 
CO2H
OMe
CO2HMe
OMe
PPh2
PPh2
27 Naproxen 28
(R)-BINAP 29
0.5 mol% Ru(29)(OAc)2
H2, MeOH, r.t.
92%, 97% ee
 
Scheme 7: Asymmetric synthesis of naproxen 28.21 
 
But not only hydrogenations were successfully applied in asymmetric catalysis, as 
shown for example by Sharpless and Katsuki, who were able to selectively epoxidize 
allylic alcohols (Scheme 8). 
 
 
Scheme 8: Sharpless-Katsuki asymmetric epoxidation of allylic alcohols.22 
 
In this reaction several allylic alcohols could be epoxidized by the Ti-complex of 
tartrate 32. For their great contributions to asymmetric catalysis, Noyori and Knowles 
were awarded the Nobel Prize in 2001, for their achievements in asymmetric 
hydrogenation reactions, next to Sharpless for his work on the asymmetric oxidation 
of alkenes.23  
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A new class of ligands was developed by Pfaltz et al. in 1986, with the pseudo  
C2-symmetric semicorrin ligand 33a, which was inspired by naturally occuring 
structural motifs of corrinoid and porphinoid metal complexes.24 The ligand is derived 
from pyroglutamic acid 34, a compound which is commercially available in both 
enantiomeric forms (Scheme 9). 
 
 
Scheme 9: Retrosynthetic analysis of semicorrin ligand 33a.24 
 
The structural motif of nitrogen containing bidentate ligands found a wide range of 
applications and a plethora of new catalysts were developed on the basis of this 
concept. Some of them are shown in Figure 7. The most prominent representatives 
of bidentate N-containing ligands were established almost simultaneously by 
Masamune et al.25 and Evans et al.26, when they published the synthesis of 
bis(oxazoline) (BOX) ligands 35. They represent the consequent enhancement of 
ligands based on the structural element of oxazolines, which was implemented by 
Brunner et al.27 The bis(oxazolines) are among the most useful ligands for 
asymmetric catalysis due to their ability to coordinate a large number of metals.28 
These ligands were successfully applied in a manifold of reactions, such as 
cyclopropanations, Diels-Alder reactions, allylic substitutions or 1,3-dipolar 
cycloadditions.29 
 
 
Figure 7: Bidentate nitrogen containing ligands. 
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Another class of N-containing ligands are the azabis(oxazoline) (AzaBOX) ligands 
36, which were developed in our group.30 They combine the relatively simple 
synthesis, like the bis(oxazolines), starting from the corresponding amino alcohols, 
and the possibility of a functionalization on the central nitrogen, like the aza-
semicorrins. Furthermore, due to the different electronic properties, they are less 
prone to metal-leaching compared to bis(oxazolines).31 These attributes qualify 
azabis(oxazolines) for anchoring to different solid supports, in order to recycle the 
catalyst. Several approaches have been accomplished successfully, where the 
ligands were bound to supports like MeOPEG,29a,32 Merrifield-resin, fluorous tags,33 
dendrimers34 or nanoparticles.35 The metal complexes showed their usefulness in a 
variety of reactions like cyclopropanations,29a benzoylation of 1,2-diols,32 conjugate 
reductions36 or Michael-additions.37 
The goal of this research project was to synthesize new azabis(oxazoline) ligands 
and extend the scope of their usability in different transformations.  
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B. Main Part 
1. Ligand Synthesis 
For the synthesis of azabis(oxazoline) (AzaBOX) ligands two main routes are 
established. Both start from β-amino alcohols, which are readily available from the 
chiral pool by simple reduction of the corresponding amino acid. For the conversion 
of these amino alcohols into 2-aminooxazolines (38) several strategies are known, for 
example the reaction of the amino alcohol with in situ formed BrCN, following the 
protocol of Poos et al. (Scheme 10).1 
 
 
Scheme 10: Synthesis of aminooxazolines following Poos et al.1 
 
The likewise formed aminooxazolines originally should be converted to imines in the 
presence of benzaldehyde and p-toluenesulfonic acid, to produce new chiral building 
blocks for asymmetric catalysis. But instead, a condensation of two molecules of 38 
took place, under the formal elimination of ammonia, and as a main product 
azabis(oxazolines) 36 were obtained (Scheme 11).2  
 
 
Scheme 11: Synthesis of azabis(oxazolines) by M. Glos.2 
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But this short and elegant synthesis turned out to be useful only in the case of iPr and 
tBu substituted azabis(oxazolines). Even in these cases the purification was often 
tedious and only moderate yields could be achieved. For that reasons a new 
synthetic route was developed by H. Werner3 which gave access to new AzaBOX-
ligands. The new methodology was based on the results of Gawley et al.,4 who 
examined the reactivity of ethoxyoxazolines 39 towards sec. amines (Scheme 12). 
 
 
Scheme 12: Reaction of ethoxyoxazoline 39a with sec. amine.4 
 
The synthesis of the ethoxyoxazoline starts from the easy accessible oxazolidinone, 
which can be formed from the amino alcohol by a multitude of possible ways. One of 
them is the reaction of amino alcohol 37 with diethyl carbonate in the presence of 
sodium ethanolate. Subsequently, the oxazolidinones 42 can be alkylated on the 
carbonyl oxygen by use of Meerwein salt (Scheme 13). 
 
 
Scheme 13: Synthesis of ethoxyoxazolines 39.5 
 
The hereof obtained ethoxyoxazolines 39 usually are quite unstable, therefore they 
are directly reacted with the aminooxazoline 38 to form the azabis(oxazolines)  
(Table 1). 
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Table 1: Azabis(oxazolines) synthesized by H. Werner[a] and A. Gissibl[b].3,6  
 
Entry Product R1 R2 Temperature (°C) Yield (%) 
1[a] 36a iPropyl- iPropyl- 110 50 
2[a] 36b tButyl- tButyl- 110 92 
3[a] ent-36c Phenyl- Phenyl- 50 35 
4[a] 36e tButyl- Phenyl- 50 64 
5[b] 36d Benzyl- Benzyl- 110 35 
 
Following this procedure it was even possible to synthesize unsymmetrical 
substituted ligands (Table 1, entry 4).  
One goal of this work was to create new azabis(oxazoline) ligands and apply them in 
asymmetric catalysis. For that reason the commercially available amino alcohol 
(1R,2S)-1-amino-2-indanol 37e was chosen as starting point, because the analog 
bis(oxazoline) ligand has already found application in different catalytic reactions like 
Henry reactions,7 Diels-Alder reactions,8 Nazarov reactions9 or conjugate additions.10 
In the beginning the route of Werner was attempted, exhibiting usually high 
compatibility towards different substitution patterns on the oxazoline ring and giving 
often superior yields (Scheme 14).  
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Scheme 14: Synthesis of the indanyl-substituted AzaBOX 45 following the procedure 
of H. Werner. 
 
Therefore the aminooxazoline 43 was formed under standard conditions in moderate 
yield after recrystallisation. In a second reaction the amino alcohol 37e was 
converted to the oxazolidinon 42e in very good yield. Subsequently, the oxazolidinon 
was transformed into the ethoxyoxazoline 44 in good yield. Unfortunately, the 
coupling of the two fragments 43 and 44 turned out to be problematic. The desired 
product 45 could only be isolated in 26% yield. One explanation could be the 
surprisingly high stability of the ethoxyoxazoline, which could be reisolated as a 
crystalline product even after column chromatography. Usually these kinds of 
compounds decompose within some days at room temperature. Due to this result the 
strategy was changed and the protocol of Glos was applied using only the 
aminooxazoline 43 (Scheme 15).  
 
 
Scheme 15: Synthesis of indanyl-substituted AzaBOX following the protocol of Glos. 
 
Under these conditions the yield could be considerably increased to 68% and the 
product was obtained in pure form after recrystallisation. This result led to the 
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suggestion, that already in the first case (Scheme 14) the achieved product can be 
ascribed only to the coupling of the aminooxazoline fragments.  
The structure of ligand 45 could be confirmed by X-ray analysis as shown in Figure 8.  
 
 
 
 
 
Figure 8: X-ray structures of the indanyl-AzaBOX 45 (protons are omitted for clarity). 
 
According to the already known structures the two oxazoline rings form an almost 
planar system. This fact can be ascribed to a possible amine-imine-tautomerism of 
the central bridging nitrogen and one of the oxazoline nitrogens (Scheme 16). 
 
 
Scheme 16: Possible tautomeric forms of azabis(oxazoline) 45. 
 
The obtained ligand 45 furthermore was methylated on the central nitrogen bridge, 
using standard conditions, to give compound 46 (Scheme 17). 
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 Scheme 17: Methylation of ligand 45. 
 
For the methylated ligand it was not possible to grow a single crystal for X-ray 
analysis, but after the complexation with Cu(ClO4)2 utilizable crystals could be 
obtained (Figure 9).  
 
       
Figure 9: X-ray structure of complex 47 (counter ions and protons are omitted for 
clarity). 
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In analogy to other complexes of azabis(oxazolines)2,6 the ligand 46 and the copper-
salt form a 2:1 complex in the solid state, although the compounds were mixed in a 
1:1 ratio. 
It was also envisaged to propargylate the ligand 45 on the central nitrogen, to be able 
to immobilize it via ‘click’-reaction on different solid supports (Scheme 18). But during 
the addition of propargyl bromide the substrate precipitated from the reaction mixture 
and couldn’t be redissolved even at higher temperatures. The same problem 
occurred when the reaction was reiterated under more diluted conditions. 
 
 
Scheme 18: Attempt to propargylate the ligand 45.  
 
In order to validate the catalytic activity of the new ligands, the Henry reaction was 
chosen as test reaction, being known to give very good enantioselectivities with the 
indanyl-substituted BOX-ligand 52. The results are summarized in Table 2. 
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Table 2: Asymmetric Henry reaction.[a] 
 
 
Entry Ligand Solvent Substrate Yield (%)[b] ee (%)[c] 
1 45 EtOH 49b 9 0 
2 45 THF 49a – – 
3 46 EtOH 49b 94 75 
4[d] 52 EtOH 49b 85 78 
5[d] 52 EtOH 49a 76 94 
[a] Reagents and conditions: aldehyde (0.5 mmol), nitro methane (5 mmol), r.t., 1 mL 
solvent. [b] Isolated yield of 51. [c] Determined by chiral HPLC. [d] Taken from ref. 7. 
 
The results show, that the unmethylated ligand 45 is catalytic inactive under the 
given conditions (Table 2, entries 1 and 2). This can be ascribed to the poor 
solubility of this compound in the most common organic solvents. In contrast, the 
methylated ligand 46 is soluble and therefore is able to perform the reaction in high 
yield and with an enantioselctivity which is comparable to the literature value (Table 
2, entries 3 and 4). Because of this promising result the new ligands were tested in 
several transformations, which will be shown later. 
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2. Immobilization on water-soluble dendrons 
For the application of catalytic systems on industrial scale one prerequisite is often 
the ability of catalyst recycling. Especially organo-metallic compounds frequently 
suffer from the drawback of being cost-intensive. Therefore, many approaches have 
been made to graft the catalytically active species to different supports in order to 
facilitate their recovery. The attachment can be done by a multitude of methods, i.e. 
covalent bonding, electrostatic interactions1 or encapsulation.2 One general 
possibility is to connect the catalyst to an insoluble support, like nanoparticles, 
clays, alumina, zeolithes or highly branched organic polymers (polystyrene, 
polyacrylate). In these cases the recuperation can be achieved by a simple filtration 
or magnetic decantation (nanoparticles). The major disadvantage of the 
heterogeneous catalysts is their often reduced activity and selectivity compared to 
the unbound counterpart. To circumvent these drawbacks soluble, linear polymers 
(polyethylenglycol, polystyrene) and organic macromolecules (dendrimers) have 
been developed, which give rise to homogeneous reaction conditions. The catalyst 
recovery can be done after precipitation of the polymer using unpolar solvents. As 
already mentioned, both types of solid supports have been applied successfully for 
azabis-(oxazolines) (Figure 10). 
 
Figure 10: Examples of immobilized azabis(oxazolines) (left: on dendrimer, right: 
on magnetic nanoparticles).3,4 
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Dendrimers, as depicted in Figure 10 (left), are repeatedly branched, monodisperse 
and usually highly symmetric macromolecules. For the synthesis of dendrimers two 
major routes are known, the divergent synthesis and the convergent synthesis.5 In 
the divergent synthesis the molecule is assembled from the core by stepwise 
addition of monomers (Scheme 19).  
 
Scheme 19: Divergent synthesis of dendrimers. 
 
In contrast, the convergent route starts from the surface and proceeds inwards. In 
the end the synthesized dendrons are attached to the core (Scheme 20). The 
advantage of this approach is the relatively easy separation of defective 
dendrimers, but especially for dendrimers of higher generation this synthesis 
becomes challenging, due to the increasing steric bulk of the dendrons. 
 
G0
G1
G2
G3
Dendron Core
 
Scheme 20: Last step of the convergent dendrimer synthesis. 
 
If dendrimers are used for transition metal catalysis the catalyst can be attached at 
different positions on the dendrimer, for example on the surface or in the core of the 
molecule. But also catalysts immobilized on dendrons have already found 
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application.6 For that reason and on the basis of the results of F. Jaroschik3 and A. 
Gissibl, 6,3 who attached azabis(oxazolines) to the surface of the PMMH-dendrimer, 
investigations were made to connect AzaBOX-ligands to water soluble dendrons. 
This project was carried out under the supervision of J.-P. Majoral at the LCC in 
Toulouse. 
The AzaBOX bearing dendron was planned to be built up in analogy to the 
synthesis of the PMMH (PhenoxyMethyl(MethylHydrazono)) dendrimer, which is 
depicted briefly in Scheme 21. 
 
Scheme 21: Synthesis of the PMMH-dendrimer.7 
 
The intended synthesis started from propargylated azabis(oxazolines) 63, which 
would undergo a click reaction with the aldehyde fragment 62, that was derived 
from p-hydroxybenzaldehyde 54 (Scheme 22). 
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Scheme 22: Intended synthesis of water soluble dendrons (part 1). 
 
With the compound 64 in hands the synthesis of higher generations should be 
accomplished as shown in Scheme 23. To make the dendrons water soluble two 
different strategies were suggested as depicted in Scheme 23. 
 
Scheme 23: Intended synthesis of water soluble dendrons (part 2). 
 
Depending on the functional group on the surface either ethylendiamine (65) or the 
Girard’s reagent T (66) were planned to be used for establishing a quaternary 
ammonium ion function on the surface.  
Unfortunately, during the synthesis it turned out that the oxazoline moieties of the 
ligand are unstable against the hydrazide 56. To circumvent this problem the ligand 
was complexed with CuCl2 in order to stabilize the oxazoline rings. Indeed the 31P-
NMR spectrum of the obtained product 68 showed only one peak, but during the 
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next coupling step with the p-hydroxybenzaldehyde decomposition was observed 
(Scheme 24). 
 
H2N N
Me
PCl2
S
CHCl3+
N
N N
OO
Bn Bn
N
N
N
Cu
ClCl
O
O
N
N N
OO
Bn Bn
N
N
N
Cu
ClCl
O
N N
PCl2
Me
S
THF, Cs2CO3
HO
O
decomposition
67 56 68
Scheme 24: Synthesis with AzaBOX-CuCl2 complex. 
 
As a consequence of these results the synthetic strategy was changed. The idea 
was to construct the dendron first and connect the ligand to it right before the 
introduction of the ammonium groups. But now a new problem arose, the click 
reaction didn’t proceed even with dendrons of first generation (69). This fact was 
ascribed to the reactive PSCl2 unit, therefore it was tried to react this group with  
p-hydroxybenzaldehyde 54. Unfortunatelly, the attempted reaction resulted in a 
decomposition of the material. 
Scheme 25: Attempted new strategy for the dendron synthesis. 
 
Due to the instability of the ligand against the conditions of the dendron synthesis 
and a lack of time no further investigations could be made to achieve the goal of 
having water soluble ligands for asymmetric catalysis. 
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3. Catalysis 
3.1 Asymmetric Kharasch-Sosnovsky-reaction 
The Kharasch-Sosnovsky-reaction, also known as allylic oxidation, is a reaction of  
tbutyl perbenzoate with olefins under transition metal catalysis.1 The obtained 
products are of special interest because they can be easily transformed into allylic 
alcohols by a simple saponification of the ester. These allylic alcohols represent 
versatile building blocks for the synthesis of biological active compounds, for 
instance the (S)-enantiomer of cyclohex-2-enyl benzoate (82) represents a key 
intermediate in the leukotriene B4 synthesis.2 The transformation is usually 
catalyzed by Cu(I) or Cu(II) species. The global mechanism for the Cu(I)-
bis(oxazoline) catalyzed reaction between cyclohexene and tbutyl perbenzoate is 
depicted in Scheme 26. 
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Scheme 26: Global mechanism of the Cu(I)-BOX catalyzed allylic oxidation.3 
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In the catalytic cycle a variation of the oxidation state of the copper is involved. The 
cycle starts from the copper(I)-alkene complex A,4 since a large excess of olefin is 
present under the standard reaction conditions. After ligand exchange the oxidant is 
bound to the metal to form complex C, which subsequently reacts with cyclohexene 
to the species D through a mechanism involving several steps. After reductive 
elimination of the copper(III)-complex and decomplexation of the product the 
catalyst is regenerated for the next cycle. Three different mechanisms are 
postulated for the reaction of species C to complex D, as depicted in Scheme 27.  
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Scheme 27: Mechanism proposed by Beckwith-Zavitsas (left), Slough (middle) and 
Salvatella (right) for the generation of the allyl-copper(III) key intermediate.3 
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In the proposed mechanism of Beckwith and Zavitsas from 1986,5 an allylic 
hydrogen from a cyclohexene molecule is abstracted by a t-butoxyl radical, leading 
to the cyclohexenyl radical and t-BuOH. In a subsequent step, the allylic radical 
binds to the copper atom of the benzoate-copper(II) species to generate the 
corresponding allyl-copper(III) key intermediate D. In the Slough mechanism6 the 
hydrogen is abstracted by the t-butoxyl radical from the ligand bound cyclohexene 
in complex H, a process that incorporates a formal pi-bond migration in the organo-
metallic species. In contrast, the Salvatella mechanism comprises an oxidative 
addition of the oxidant to give species I, which subsequently coordinates the 
cyclohexene (complex J). After hydrogen transfer from the cyclohexene to the  
t-butoxy-group, resulting in the benzoate-η1-cyclohex-2-enyl-copper(III) complex K, 
and release of t-BuOH from the latter complex the key intermediate D is formed. 
During the course of the Kharasch-Sosnovsky-reaction mainly one allylic benzoate 
is formed, in contrast to normal radical reactions of unsymmetrical substituted 
olefins, due to a favored addition of the Cu(II)-benzoate at the less hindered 
position.7 The mechanism of the Cu(II) catalyzed reaction is not clarified completely 
up to now. 
 
The first attempts of doing an asymmetric allylic oxidation gave only low 
enantioselectivities of 15-30%.8 A significant improve was made by Andrus et al. 
and Pfaltz et al. with the use of BOX-ligands.7,9 Some of the results are summarized 
in Table 3. 
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Table 3: Selected results of allylic oxidations using BOX-ligands. 
 
 
Entry Substrate Ligand Time Temperature Yield (%) ee (%) 
1[a] n=1 72 5d -20°C 49 81 
2[a] n=2 35b 5d -20°C 43 80 
3[a] n=4 35b 5d -20°C 44 13 
4[b] n=1 35b 22d -20°C 61 84 
5[b] n=2 35b 15d 7°C 64 77 
6[b] n=3 35a 14d 7°C 44 82 
[a] Taken from ref. 7. [b] Taken from ref. 9. 
 
Besides the problem of moderate enantioselectivities long reaction times were 
needed because of low reaction rates. This problem was solved by the introduction of 
different additives like phenyl hydrazine or molecular sieves.10 Numerous ligands 
have been designed and found application in the Kharasch-Sosnovsky reaction. 
Some of them are depicted in Figure 11. The best enantioselectivity obtained so far 
for the title reaction using cyclohexene was published by Wilson et al.11 applying the 
bipyridyl-ligand 73. 
 
 
Figure 11: Ligands used for the allylic oxidation.9,10,11 
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With small variations of the reactants and reaction conditions even selectivities of up 
to 99% could be obtained.12  
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Scheme 28: Allylic oxidation of cyclopentene according to Andrus et al.12 
 
Because of the promising results of bis(oxazoline) ligands and the close structural 
relationship of azabis(oxazolines) investigations were undertaken to see the viability 
of these ligands. On the basis of the results obtained by A. Gissibl13 the reactions 
were carried out using acetone as solvent. A series of different azabis(oxazoline) 
ligands was applied in order to find the best catalytic system. For all experiments 
copper(II)-triflate was chosen as metal source. Some of the results were already 
gained during the diploma thesis, they are summarized in Table 4. 
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Table 4: Results of the allylic oxidation[a]. 
 
 
Entry Ligand Time Temp. PhNHNH2 Yield (%)[b] [α]D20 ee (%)[c] 
1[d] 36a 1 h r.t. yes 67 -128.3 55 
2[d] 36a 16 h 0°C yes 64 -117.9 66 
3[d] ent-36c 20 h r.t. no 33 +126.8 56 
4[d] ent-36c 20 h r.t. yes 43 +146.0 61 
5[d] 36d 20 h r.t. no 51 -119.5 51 
6[d] 36d 2 h r.t. yes 74 -168.0 75 
7[d] 36d 16 h 0°C yes 68 -161.1 74 
8[d] 79 16 h 0°C yes 74 -173.0 78 
9 80d 16 h r.t. yes 54 -174.0 78 
[a] Reagents and conditions: 10 mmol cyclohexene, 1 mmol t-butyl perbenzoate, 1 drop of 
phenyl hydrazine, 5 mL solvent. [b] Isolated yield. [c] Determined by chiral HPLC. [d] Results 
of the diploma thesis.14 
 
The results indicate that the AzaBOX ligands provide selectivities that are 
comparable to those obtained with the BOX analogues. Remarkable are the relative 
short reactions times, especially when phenyl hydrazine was used, compared to the 
literature values. Besides the drastic increase in reaction rate a small improve of 
selectivity can be accomplished by the addition of phenyl hydrazine. The best ees are 
obtained with the benzyl-substituted ligands 36d, 80d and the ligand 79 which is 
bearing an additional triazole moiety (Table 4, entries 6, 8 and 9). To explore the 
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importance of the metal source experiments were carried out using different copper 
(I) and (II) species. The results are summarized in Table 5. 
 
Table 5: Influence of the metal source.[a] 
O
O
Ph
Ligand (5 mol%)
Metal (5 mol%)
O
O
O+
Acetone
81 82 83
 
Entry Metal source Time (h) Yield (%)[b] [α]D20 ee (%)[c] 
1 Cu(OTf)2 20 51 -119.5 51 
2 CuI 20 --- --- --- 
3 (CuOTf)2•C6H6 20 55 -78.1 34 
4 Cu(OTf)2+PhNHNH2 2 66 -167.5 72 
[a] Reagents and conditions: 10 mmol cyclohexene, 1 mmol t-butyl perbenzoate, 5 mL 
solvent. [b] Isolated yield. [c] Determined by chiral HPLC. 
 
These results clearly demonstrate that the in situ reduced copper (II) triflate gives the 
best enantioselectivity (Table 5, entry 4). The use of copper(I)-triflate benzene 
complex (entry 3) gave the product with a considerable diminished enantioselectivity 
of 34% after 20h. Another observation is the substantial higher reaction rate when 
phenyl hydrazine is used, in this case the product was obtained with higher yield in a 
much shorter reaction time. 
Furthermore, it could be shown that the ligand to metal ratio doesn’t play a crucial 
role in the Kharasch-Sosnovsky reaction, as demonstrated for the Michael-Addition of 
malonate and indole.15 For these investigations the optimized conditions were 
applied (ligand 36d, Cu(OTf)2, PhNHNH2).  
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Table 6: Influence of ligand to metal ratio.[a]14 
 
Entry Cu/Ligand Yield (%)[b] [α]D20 ee (%)[c] 
1 1/1.1 71 -177.6 76 
2 1/1.3 74 -174.1 76 
3 1/1.5 71 -175.2 78 
[a] Reagents and conditions: 10 mmol cyclohexene, 1 mmol t-butylperbenzoate, 1 drop of 
phenyl hydrazine, 5 mL acetone. [b] Isolated yield. [c] Determined by chiral HPLC. 
 
To explore the synthetic usefulness and to further improve the obtained 
enantioselectivities different substrates were screened. As a first modification only 
the ring size of the olefin was varied. Therefore cyclopentene and cycloheptene were 
chosen as substrates.  
 
Scheme 29: Allylic oxidation using different substrates.16 
 
Both substrates gave only low yields 34% for cyclopentene and 33% for 
cycloheptene respectively. Moreover, the obtained selectivities were only moderate 
(55% ee for cylopentene, 75% ee for cycloheptene). To further investigate the scope 
of substrates different olefins (Figure 12) were tested under the standard conditions. 
 
Figure 12: Substrates for allylic oxidation. 
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The investigations began with ethyl benzene 86, to see if the oxidation can also take 
place in benzylic position, but no reaction was observable. In the next step the Diels-
Alder-adducts 87-89 were tested, again without any success. Unfortunately, there 
was no apparent reaction even after elongated reaction times. The suggestion was 
that this could be ascribed to the strong electron withdrawing effect of the anhydride 
or ester groups. Therefore the ester was reduced to the corresponding alcohol (90), 
which additionally was protected as acetate (91). In these two cases at least some 
conversion was observable, but the wanted product couldn’t be isolated in pure form. 
As a last substrate (-)-β-pinene was used, since the application of bridged bicyclic 
alkenes in the asymmetric Kharasch-Sosnovsky-reaction was already reported in 
literature.17 
 
 
Scheme 30: Allylic Oxidation of (-)-β-pinene. 
 
In this case the procuct could be obtained in moderate yield as a single diastereomer, 
as confirmed by NOE-NMR. 
The results illustrate that azabis(oxazolines) are able to perform the Kharasch-
Sosnovsky reaction with moderate to good enantioselectivities, comparable to those 
in literature. One peculiarity is their high activity which is represented in the short 
reaction times compared to reported values. Regrettably, the scope of substrates is 
limited to olefins bearing no electron withdrawing groups, therefore the applicability of 
the transformation is constricted. 
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3.2 Asymmetric cobalt(II)-azabis(oxazoline) catalyzed reduction of carbonyl 
compounds 
Reductions are among the most fundamental transformations in organic chemistry. 
Therefore, a plethora of catalytic, asymmetric ways is known for reducing prochiral 
carbonyl compounds, starting from hydrogenations, transfer-hydrogenations or 
reductions using boranes. Another approach that is frequently used is the application 
of hydride containing reducing agents like NaBH4, LiAlH4, NaH and so on. It is known 
in literature that cobalt can serve as a reduction catalyst in combination with sodium 
borohydride.1 On the basis of this several reports have been published concerning 
the reductive potential of the latter system. Already in 1989 Pfaltz et al. published the 
use of semicorrin ligands (33a) in combination with CoCl2 to effect the conjugate 
reduction of α,β-unsaturated esters and amides by sodium borohydride in high 
chemical yield and with high enantioselectivities.2 Intrigued by these results C. Geiger 
of our group was able to accomplish the same reactions using azabis(oxazoline) 
ligands (Scheme 31).3 
 
 
Scheme 31: Selected results of the conjugate reduction of α,β-unsaturated esters 
according to C. Geiger.3 
 
Motivated by these results we were interested to further broaden the scope of 
substrates, therefore carbonyl compounds were subjected to the given reaction 
conditions.  
The first asymmetric reduction of ketones using sodium borohydride was published in 
1995 by Mukaiyama et al.4 In this paper the application of different cobalt-salen 
complexes was delineated, giving the products in high yields and in selectivities of up 
to 94% ee (Scheme 32). 
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Scheme 32: Asymmetric reduction of ketones according to Mukaiyama et al.4 
 
On the basis of these results a lot of investigations were conducted using different 
salen-cobalt complexes,5 including macrocyclic6 or unsymmetric salen7 ligands as 
depicted in Figure 13. 
 
 
Figure 13: Different salen ligands used in Co-catalyzed reductions.5,6,7 
 
Apart from the use of salen ligands chiral cobalt(II)-diamine complexes were applied 
as promoters for the asymmetric reduction of carbonyl compounds using hydride 
donors. The chiral diamine was derived from tartaric acid, but in most cases only low 
yields and enantioselectivities were achieved for the reduction of acetophenone 
(Scheme 33). 
 
 
Scheme 33: Reduction of acetophenone using chiral diamine 104. 
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In the beginning of our investigations the optimized conditions for the conjugate 
reduction utilized by C. Geiger were adopted. In first experiments different ligands 
were tested at varying temperatures. The results are shown in Table 7. 
 
Table 7: Results of the asymmetric Co(II)-AzaBOX catalyzed reduction of 
acetophenone.[a] 
 
Entry Ligand Temp. (°C) Yield (%)[b] ee (%)[c] Conformation 
1 80d 30 13 48 (R) 
2 80d 0 79 48 (R) 
3 80d -45 18 18 (R) 
4[d] 80d -45 66 0 (R) 
5 36d 0 58 4 (R) 
6 ent-80c 0 51 24 (S) 
7 80a 0 66 44 (R) 
[a] Reagents and conditions: 0.5 mmol acetophenone, 1.0 mmol NaBH4, 5 mol% ligand,  
5 mol% CoCl2•6H2O, 1 mL EtOH, 1 mL diglyme. [b] Isolated yield. [c] Determined by chiral 
GC. [d] No diglyme was used. 
 
The first experiment was carried out at 30°C, givin g the product with 48%ee but in a 
low yield of only 13% (entry 1). Lowering the temperature to 0°C didn’t affect the 
resulting ee, but the yield was enhanced (entry 2). If the temperature was decreased 
even further (-45°C, entry 3) both, selectivity and  yield were diminished. Entry 4 
displays the situation if diglyme is omitted, in comparison to entry 3 the chemical yield 
is improved, but the product was obtained as a racemate.  
Furthermore, several ligands were tested, to evaluate the influence of the steric and 
electronic properties of the chiral promoter on the transformation. Ligand 36d, 
bearing a proton on the central nitrogen bridge, paled in comparison to its methylated 
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counterpart 80d, giving an almost racemic product (entry 5), which is in agreement 
with the results gained by C. Geiger.3 Under the given reaction conditions this ligand 
most probably is deprotonated on the central nitrogen, forming an anionic species. 
The phenyl-substituted ligand ent-80c and the isopropyl-substituted 80a gave results 
that were little inferior to those of 80d (entries 6 and 7). 
In subsequent investigations a variety of different ketones was tested under the 
optimized conditions.  
 
Table 8: Asymmetric reduction of ketones using AzaBOX 80d.[a] 
 
Entry Ketone Temp. (°C) Yield (%) [b] ee (%)[c] Conformation[d] 
1 
 
105a 0 15 30 (R) 
2 
 
106a[e] 0 20 48 (R) 
3 
 
107a 0 66 52 (R) 
4 
 
108a 0 62 0 – 
5 
 
109a 0 40 56 (R) 
6 
 
110a rt 73 45 (R) 
7 
 
111a 0 56 8 (S) 
8 
N Ph
O
 
112a 0 70 10 (R) 
[a] Reagents and conditions: 0.5 mmol substrate, 1.0 mmol NaBH4, 5 mol% ligand, 5 mol% 
CoCl2•6H2O, 1 mL EtOH, 1 mL diglyme. [b] Isolated yield. [c] Determined by chiral GC or 
chiral HPLC. [d] The configuration was deduced by comparison of the optical rotation with 
literature values. [e] A partial dehalogenation occurred. 
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Different acetophenones 105-107 were tested, because in these cases the 
substituent in ortho position can represent an additional coordination point for the 
metal, giving rise to a better enantio-discrimination in the reaction intermediate. 
Unfortunately, no positive effect of the substituents could be observed (entries 1-3). 
In contrast, substrate 105, bearing a hydroxyl group in ortho position, showed even 
diminished reactivity and selectivity (entry 1). The benzophenone derivative 108 was 
obtained in moderate yield without any ee, probably due to the low steric influence 
exhibited by the methyl group in para position (entry 4). The ketones 109 and 110 
were reduced to the corresponding alcohol in low to moderate yield and with 
moderate enantioselectivity (entries 5 and 6), whereas the substrates 111 and 112 
gave hardly any ee (entries 7 and 8). In further experiments more substrates like α-
hydroxy esters, imines or oximes were screened (Table 9). 
 
Table 9: Attempted asymmetric reduction of different ketones and imines. 
 
Entry Substrate Temp. (°C) Yield (%) ee  (%) 
1 
 
113a 0 40 0 
2 
 
114a 0 84 0 
3 
 
115a 50 no reaction – 
4 
 
116a 60 no reaction – 
[a] Reagents and conditions: 0.5 mmol substrate, 1.0 mmol NaBH4, 5 mol% ligand, 5 mol% 
CoCl2•6H2O, 1 mL EtOH, 1 mL diglyme. [b] Isolated yield. [c] Determined by chiral GC or 
chiral HPLC. 
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Regrettably, only for the substrates 113 and 114 the wanted product was observed, 
albeit no enantioselectivity was induced (entries 1-2). However, no reaction was 
visible for the oxime 115 and the imine 116 even at elevated temperatures. 
 
In conclusion, Co(II)-azabis(oxazoline) complexes are able to perform the 
asymmetric reduction of ketones using sodium borohydride with low to moderate 
yields and enantioselectivities. Nevertheless, the obtained ees are not capable of 
competing with the best values known in literature. Therefore, no further explorations 
regarding this transformation were undertaken. 
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3.3 Asymmetric aza-Michael addition 
The so-called Michael addition represents one of the most important and best studied 
transformations in organic chemistry.1 Even before the discovery of the actual 
Michael addition in 18872 conjugate additions using heteroatom nucleophiles were 
reported. In 1878 the oxa-Michael addition was published by Loydl3 and even earlier, 
in 1874, the aza-Michael addition was dicovered by Heintz, Sokoloff and Latschinoff.4 
This transformation constitutes an especially important variant, since the thereof 
derived products, including β-amino acids5 and β-lactams6, are of great synthetical 
and pharmaceutical value. The first asymmetric aza-Michael additions mainly 
focused on the use of chiral amines,7 chiral substrates8 or chiral auxiliaries.9 Since 
the first catalytic asymmetric aza-Michael addition reported by Jørgensen et al.10 a 
manifold of new catalytic systems has been developed.11 Especially in the field of 
organocatalysis great improvements have been achieved in conducting 
enantioselective aza-Michael additions. Therefore mainly proline-derivatives or 
cinchona alkaloids were used as catalysts. One example represents the aza-Michael 
addition of carbamates 118 to α,β-unsaturated aldehydes reported by Córdova et al. 
(Scheme 34).12 
 
 
Scheme 34: Aza-Michael addition of carbamates 118 to enals.12 
 
Nevertheless, great effort has been undertaken in the field of organo-metallic 
catalysis as well, starting with the already mentioned report of Jørgensen in 1996, in 
which he published the application of titanium-BINOL catalyst 124 in the addition of 
BnONH2 to N-acyloxazolidinones 122.10 The resulting product was obtained in high 
yield, albeit accompanied by moderate enantioselectivity (Scheme 35). 
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Scheme 35: The first asymmetric organo-metallic aza-Michael addition as reported 
by Jørgensen.10 
 
Besides the use of BINOL as chiral catalyst for the asymmetric aza-Michael addition, 
several reports focused on the application of different bis(oxazoline) ligands. One 
interesting example represented the contribution of Sibi et al.,13 in which 
bis(oxazoline) 127 was used in combination with MgBr2•OEt2 as Lewis acid. Good 
chemical yields and selectivities up to 97% were achieved in the addition of  
O-benzylhydroxylamine to a 3,5-dimethylpyrazole-derived enoate 125 (Scheme 36). 
 
 
Scheme 36: Aza-Michael addition according to Sibi et al.13 
 
It is noteworthy, that in the latter case the opposite enantiomer of product 126 was 
obtained when a lanthanide salt was employed as Lewis acid instead of magnesium, 
although the reversed sense of stereoinduction could not be explained by the 
authors. 
The first stereoselective addition of secondary amines to acylpyrrolidinones 128 was 
investigated by Jørgensen et al.,14 showing that DBFOX ligand 131 is capable of 
performing the reaction with selectivities up to 96% (Scheme 37). 
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Scheme 37: Addition of secondary aromatic amine 129 to acylpyrrolidinones 128 
according to Jørgensen et al.14 
 
In all the studies comprising bis(oxazoline) ligands the α,β-unsaturated carbonyl 
compound contained two groups which could coordinate to the metal center. In the 
approach made during the course of this work the use of the simple chalcones 132 
was intended, as these substrates are easily accessible via common aldol 
condensation reactions. Shibasaki et al. could accomplish the asymmetric aza-
Michael addition of O-alkylhydroxylamine 135 to chalcones using the heterobimetallic 
multifunctional catalyst 134.15 
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Scheme 38: Asymmetric aza-Michael addition of O-alkylhydroxylamine 135 to 
chalcone according to Shibasaki et al.15 
 
For the investigations simple anilines served as nitrogen nucleophile, since the use of 
aromatic amines has not been thoroughly studied up to now.16 The combined use of 
these simple starting materials, chalcones and anilines, is rather unexplored so far. 
To the best of the author’s knowledge, only one report dealing with these substrates 
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was published yet by Scettri et al.17 In this approach cinchona alkaloids were used as 
catalysts under solvent free conditions. Cinchonine 138 was identified as the catalyst 
giving superior enantioselectivities, although only values up to 58% ee were 
obtained. Some of the results are depicted in Table 10. 
 
Table 10: Selected results from the addition of aniline to chalcones catalyzed by 
cinchonine. [a]17 
 
Entry R R′ Substrate Time (h) Yield (%)[b] ee (%)[c] 
1 Ph Ph 132a 24 >99 58 
2 Ph p-Cl-Ph 132b 24 >99 31 
3 Ph p-Me-Ph 132c 24 50 52 
4 p-MeO-Ph Ph 132d 48 44 49 
5 p-Cl-Ph Ph 132e 24 72 27 
[a] Reagents and conditions: 0.25 mmol chalcone, 0.5 mmol aniline, 0.05 mmol catalyst,  
24h-48h, r.t. [b] Isolated yield. [c] Determined by chiral HPLC. 
 
The best result was achieved for the unsubstituted substrates 132a and 136 (entry 
1), giving excellent yields but only moderate enantioselectivity. Furthermore, an 
electron withdrawing group on either of the two aromatic rings of the chalcone lead to 
a diminished selectivity (entries 2 and 5). 
The investigations started with the search for an appropriate metal salt. Therefore, 
different copper salts were screened without any ligand. The Lewis-acids that have 
been chosen were CuCl2, Cu(OTf)2, Cu(OAc)2•H2O and Cu(ClO4)2•6H2O. 
Unfortunately, only in the case of Cu(OAc)2•H2O some conversion was observed 
after 24h. For that reason the experiment was repeated in different solvents and in 
B. Main Part 
 
50 
 
the presence of azabis(oxazoline) ligand, to examine if the process was ligand 
accelerated. The results are shown in Table 11. 
 
Table 11: Results of the aza-Michael addition between chalcone 132a and aniline 
136 in different solvents and with different metal salts.[a]  
 
Entry Metal salt Solvent Yield (%)[b] ee (%)[c] 
1 CuCl2 CH2Cl2 – – 
2 CuCl2 CHCl3 – – 
3 CuCl2 EtOH – – 
4 CuCl2 Toluene 5 nd 
5 Cu(OAc)2•H2O CH2Cl2 19 73 
6 Cu(OAc)2•H2O EtOH 22 68 
7 Cu(OAc)2•H2O Toluene 52 70 
8 Cu(OAc)2•H2O MeCN 19 66 
9 Zn(OTf)2 Toluene 5 nd 
10 Co(OAc)2•4H2O Toluene 6 nd 
11 SnCl2 Toluene 5 nd 
[a] Reagents and conditions: 0.5 mmol chalcone, 1.0 mmol aniline, 5 mol% ligand 36d,  
5 mol% metal salt, 1 mL solvent, r.t. [b] Isolated yield. [c] Determined by chiral HPLC, nd = 
not determined. 
 
The results indicated that only copper acetate was able to catalyze the reaction in 
moderate yields (entries 5-8). In all the other cases no conversion was observed or 
only poor yields of ca. 5% were obtained, which is only insignificantly more than the 
uncatalyzed background reaction.17 The best results for the given substrates were 
gained in toluene (entry 7). Although DCM as solvent gave slightly superior selectivity 
(73%, entry 5) the yield paled in respect to toluene (19% vs. 52%). As a 
consequence of these results, the subsequent experiments were performed using 
Cu(OAc)2•H2O as metal source and toluene as solvent. 
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In order to evaluate the scope of the catalytic system, different ligands were tested in 
the asymmetric aza-Michael addition (Table 12). 
 
Table 12: Ligand screening for the asymmetric aza-Michael addition of aniline 136 to 
chalcone 132a.[a] 
 
Entry Ligand Solvent Yield (%)[b] ee (%)[c] 
1 36a Toluene 39 18 
2 80a Toluene 58 9 
3 36d Toluene 52 70 
4 80d Toluene 19 39 
5 ent-36c Toluene 60 31 
6 ent-80c Toluene 47 21 
7 36b Toluene 29 10 
8 45 EtOH 20 7 
9 46 Toluene 29 22 
[a] Reagents and conditions: 0.5 mmol chalcone, 1.0 mmol aniline, 5 mol% ligand,  
5 mol% Cu(OAc)2•H2O, 1 mL solvent, r.t. [b] Isolated yield. [c] Determined by chiral HPLC. 
 
The results clearly indicated the supremacy of the benzyl substituted ligand 36d. 
Although only a moderate yield of 52% was obtained entry 3 represented the best 
enantiomeric excess known so far for these substrates. All other ligands paled in 
comparison to 36d regarding selectivity. In entry 8, ethanol was used as solvent due 
to the poor solubility of ligand 45 in toluene. An explanation for the preponderance of 
ligand 36d might be found in pi−pi-interactions between the aromatic rings of the 
catalyst and the substrate. Such effects have been noted in literature.18 However, the 
main problem remained the poor reactivity of the system, which can be ascribed to a 
possible deactivation of the Lewis acid by the excess of amine.19 To circumvent this 
problem, Sodeoka et al. used the amine as a salt of trifluoromethanesulfonic acid 
(TfOH) and were able to increase both, yield and selectivity (Table 13).19 
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Table 13: Representative results of the conjugate addition according to Sodeoka et 
al.19 
 
 
Entry Catalyst TfOH (equiv.) Time (h) Yield (%) ee (%) 
1 142-1 – 24 35 2 
2 – – 24 41 – 
3[a] 142-1 1.0 24 25 88 
4 142-1 0.5 24 98 4 
5[a] 142-2 1.0 12 92 98 
[a] TfOH was added as a salt of p-OMe-aniline. 
 
Entries 3 and 5 unambiguously showed the effect of the utilization of an anilinium 
salt. Especially catalyst 142-2 exhibited high enantioselectivity combined with high 
chemical yield. 
On the basis of these results it was investigated if the application of the 
corresponding anilinium salt lead to higher reactivity. Unfortunately, no conversion 
was observed neither for the use of the p-TSA-salt nor for the TfOH-salt  
(Scheme 39). 
 
Scheme 39: Attempts to use the amine as a salt of different acids. 
 
An explanation for these results could be the exchange of the counter ion of the 
metal salt, leading to a less active species, since an excess of anions resulting from 
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the added acid was present. At least Cu(OTf)2 was known to be unable to catalyze 
the given process. 
Furthermore, the comparability of the two catalytic systems (Pd-BINAP vs. Cu-
AzaBOX) is limited. 
In additional experiments different substrates were tested, to see how different 
electronic and steric properties would influence the reaction (Table 14). 
 
Table 14: Aza-Michael addition using different substituted chalcones and anilines.[a] 
 
Entry R Ar-NH2 Product Solvent Yield (%)[b] ee (%)[c] 
1 CF3 (132f) Ph (136) 137f Toluene 49 55 
2 Cl (132e) Ph (136) 137e Toluene 38 5 
3 OMe (132d) Ph (136) 137d Toluene 33 13 
4 H (132a) 3,5-OMe-aniline (145a) 146a Toluene 41 0 
5 H (132a) 2,6-
iPr-aniline 
(145b) 146b Toluene – – 
6 H (132a) 2-OH-aniline (145c) 146c EtOH – – 
7 H (132a) 3-NO2-aniline (145d) 146d EtOH – – 
[a] Reagents and conditions: 0.5 mmol chalcone, 1.0 mmol aniline, 5 mol% ligand,  
5 mol% Cu(OAc)2•H2O, 1 mL solvent, r.t. [b] Isolated yield. [c] Determined by chiral HPLC. 
 
Again, these results illustrate the problem of poor reactivity of the substrates. Only  
33-49% yield were obtained. Furthermore, only low to moderate ees were gained. 
The best result was obtained with the p-CF3-substituted chalcone 132f (entry 1), 
giving 55% ee. For the different substituted anilines in entry 5-7 no reaction was 
observable, probably due to steric hindrance (entry 5) or electronic properties (entries 
6 and 7). In the case of the 2-OH-substituted and the 3-NO2-substituted aniline 
ethanol was used as solvent again, because these substrates were insoluble in 
toluene. 
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In conclusion, the asymmetric aza-Michael addition between chalcones and anilines 
was accomplished with the highest enantioselectivity known so far in literature using 
azabis(oxazolines). Nevertheless, the process suffered from low yields and the 
dependence on the right catalytic system. Only ligand 36d was able to produce good 
selectivity in combination with Cu(OAc)2•H2O. Further studies are required in order to 
prove the value of the given process.  
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3.4 Kinetic resolution 
Among the different possibilities of producing optically active compounds the kinetic 
resolution has the distinction of being the oldest. According to the 1996 IUPAC 
recommendation the definition of kinetic resolution follows: “The achievement of 
partial or complete resolution by virtue of unequal rates of reaction of the 
enantiomers in a racemate with a chiral agent (reagent, catalyst, solvent, etc.)”.1 The 
kinetic resolution can be divided onto two major fields, the enzyme catalyzed 
techniques and non-enzymatic processes. The enzyme catalyzed methods have 
gained tremendous importance due to their often very high selectivities and activities, 
but they also lack of the drawback that the enzyme selectivity cannot be predicted for 
a certain substrate. The first example of non-enzymatic kinetic resolution was 
published already in 1899 by Marckwald and McKenzie when they reported the 
enantioselective esterification of racemic mandelic acid 147 by (-)-menthol.2  
 
OH
O
OH
OH
O
O
OH
+ +
HO
O
OH
147 148 149 (S)-147
 
Scheme 40: First non-enzymatic kinetic resolution according to Marckwald and 
McKenzie.2 
 
In this reaction the (R)-enantiomer of the mandelic acid showed the higher reaction 
rate and the recovered (S)-enantiomer could be isolated in pure form after several 
recrystallization steps. An important fact regarding kinetic resolution is that the 
enantiomeric excess of the product is dependent on the conversion of the reaction, 
as shown for the first time by Dakin.3 For obtaining high ees the maximum yield that 
can be obtained is 50%, if no racemisation process of the starting material is included 
(dynamic kinetic resolution). Kinetic resolutions can be applied to virtually every class 
of chiral substrates and can be used in combination with all methods of 
enantioselective synthesis.4  
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3.4.1 Kinetic resolution of alcohols 
In the context of kinetic resolution alcohols are the functional groups that have 
received the most attention due to their broad applicability. One of the big 
advantages exhibited by alcohols is the possibility of a simple inversion of 
stereocenters, e.g. under Mitsunobu conditions. This might, in principle, lead to a 
higher efficiency, but stoichiometric amounts of chiral phosphines are needed for 
these processes.5 Another method that has gained considerable interest in the field 
of kinetic resolution of alcohols is the oxidation of sec. alcohols to the corresponding 
ketones, as these can be easily recycled to the racemic starting material by simple 
reduction. The first broadly applicable approach was published by Noyori et al., as 
shown in Scheme 41. 
 
OH OH O
rac-150 (R)-150
N
H
RuAr
N
Ph
Ph
Ts
O
+
151
152
 
Scheme 41: Kinetic resolution of sec. alcohol by oxidation to the prochiral ketone.6 
 
This reaction actually represents the reverse of the asymmetric hydrogenation of 
ketones, a method that employs the same catalyst together with isopropanol as a 
stoichiometric hydride donor. In the present case, which works best with benzylic 
alcohols, the chiral ruthenium catalyst abstracts a hydride form rac-150 which is 
subsequently transferred to acetone as hydride acceptor. 
The most prominent way for the kinetic resolution of alcohols is the transfer of acyl 
groups through activation of anhydrides or acid chlorides. The first experiments in 
this field can be traced back to the 1930s, when Wegler accomplished the 
enantioselective acylation with acetyl chloride and acetic anhydride under alkaloid 
catalysis.7 The first non-enzymatic kinetic resolution of alcohols with eligible 
selectivity factors was published by Diver et al. in 1996.8 Herein, the chiral phosphine 
155 was employed to activate m-chlorobenzoic anhydride (Scheme 42). 
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Scheme 42: Enantioselective acylation catalyzed by chiral phosphine 155.8 
 
The product was obtained with 81% ee at a conversion of 25%, this corresponds to a 
selectivity factor >10. 
In order to acylate alcohols with high enantiomeric excesses a multitude of enzymatic 
methods are known,9 but organometallic or organocatalytic processes exist as well. 
One of the most prominent transition-metal catalyzed kinetic resolutions of 1,2-diols 
was published by Matsumura et al., using bis(oxazoline) ligands for the 
monobenzoylation of the latter alcohols.10 The product was obtained with 49% yield 
(theoretical maximum: 50%) and >99% ee. 
 
 
Scheme 43: Asymmetric monobenzoylation of diol 156 with bis(oxazoline) ligands.10 
 
To give an explanation for the high selectivities achieved, the authors postulated a 
transition state that is depicted in Figure 14. In the intermediate B the benzoyl 
chloride can access the alkoxide, which is generated from (S,S)-156 with (R,R)-Ph-
BOX-CuCl2, more easily compared to the complex A, where more steric hindrance is 
present.   
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Figure 14: Schematic representation of the unfavored (left) and favored (right) 
transition state of the asymmetric benzoylation. 
 
Besides the excellent results for hydrobenzoin several other substances were used 
successfully as substrates. Some of the results are shown in Table 15. 
 
Table 15: Selected results of the benzoylation according to Matsumura et al. 
HO
R R
OH HO
R R
OBz HO
R R
OH
PhCOCl (0.5 eq.)
DIPEA (1.0 eq.)
DCM, 0°C
+
ent-35c-CuCl2
(5 mol%)
O
N N
O
Ph Ph
Cu
Cl Cl
ent-35c-CuCl2158-161 162-165
 
Entry Substrate Product Yield (%) ee (%) 
1 p-Cl-hydrobenzoin (158) 162 48 >99 
2 p-MeO-hydrobenzoin (159) 163 49 98 
3 trans-1,2-cyclohexane diol (160) 164 37 80 
4 trans-1,2-cycloheptane diol (161) 165 49 84 
 
Due to the close structural relationship between bis(oxazolines) and azabis-
(oxazolines) investigations were carried out to prove the viability of the latter ligands 
for these kind of processes. In a series of elegant experiments A. Gissibl could show 
that AzaBOX ligands are capable of performing the benzoylation of 1,2-diols with 
very high yields and enantioselectivities.11 The scope of substrates was also 
examined and good results could be obtained as illustrated in Table 16. 
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Table 16: Selected results of the benzoylation carried out by A. Gissibl.[a]11 
 
Entry Substrate Ligand Yield (%) ee (%) Configuration 
of the product s
[b]
 
1 
 
36d 45 97 R,R 160 
2 
 
80d 49 99 R,R 751 
3 
 
ent-36c 46 83 S,S 22 
4 
 
36a 46 82 R,R 21 
5 
 
36a 43 79 R 16 
6 Ph
OH
OEt
O
 
36a 45 75 R 13 
[a] Reagents and conditions: substrate (1 mmol), benzoylchloride (0.5 mmol), DIPEA (1 
mmol), 0°C, CH 2Cl2. [b] Ref. 12 
 
In additional experiments it was shown that azabis(oxazolines) can be attached to a 
manifold of solid supports in order to be able to recycle and reuse the catalyst. For 
homogeneous reaction conditions the soluble supports MeOPEG 5000 and 
dendrimers were used, which could be recycled by precipitation and subsequent 
filtration. Especially the dendrimers could prove their usefulness, as they were able to 
perform the benzoylation with high selectivity in several cycles (Figure 15). Also 
heterogeneous catalytic processes were possible with the use of Merrifield-resin or 
magnetic nanoparticles as backbone for the ligands. The nanoparticles represent a 
very elegant possibility for catalyst recovery, as they are separated from the reaction 
mixture by simple magnetic decantation. They could be used in up to four cycles 
without any evident drop in yield or selectivity (Figure 15). 
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Figure 15: Selected supported ligands that were used in the asymmetric 
benzoylation of hydrobenzoin (left: Gc1 bound AzaBOX, right: AzaBOX on magnetic 
nano-particle).13,14 
 
3.4.2 Kinetic resolution of β-hydroxy amides 
Inspired by the promising results obtained in the asymmetric benzoylation of 1,2-diols 
and α-hydroxy carbonyl compounds using azabis(oxazolines), investigations were 
carried out to further broaden the scope of substrates. β-Hydroxy carboxylic acid 
derivatives represent a class of high synthetic relevance, especially in 
enantiomerically pure form, as they are versatile precursors for pharmaceuticals and 
natural products.15 Applying these substrates the intermediary built chelate would be 
a six membered ring instead of the five membered one in the case of 1,2-diols or α-
hydroxy carbonyl compounds. 
 
Fe3O4
N
NN
N
N
OO
N
Bn Bn
OTMS
TMSO
TMSO
TMSO
TMSO
OTMS
OTMS
4 cycles
43-49%
95-98% ee
167
3 cycles 
35-43% 
99% ee 
166 
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Figure 16: Suggested chelates built during the benzoylation reaction. 
 
The first experiments were carried out using β-hydroxy ketones and β-hydroxy esters. 
However, attempts to employ these classes of compounds were unsuccessful as 
depicted in Table 17. 
 
Table 17: Results of the benzoylation using β-hydroxy ketones and β-hydroxy 
esters.[a] 
 
Entry Ligand R Yield (%)[b] ee (%)[c] 
1 36a
 
Me 
– – 
2 36a
 
OEt 28 38 
3 36a
 
OtBu 27 46 
4 ent-36c
 
OtBu 20 36 
5 36d
 
OtBu 25 33 
6[d] 36d
 
OtBu 18 35 
7 80a
 
OtBu 15 56 
[a] Reaction conditions: Substrate (0.5 mmol), ligand-Cu-complex (5 mol%), base (0.5 mmol), 
benzoylchloride (0.25 mmol) in 3 mL of solvent. [b] Isolated yield. [c] Determined by chiral 
HPLC. [d] Cu-complex was prepared in situ. 
 
Not only low enantioselectivities were obtained, but an even more severe problem 
was represented by the low reactivity of these compounds. No reaction was 
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observable for the ketone 168 and only low to moderate yields were obtained utilizing 
different esters and catalysts. Intrigued by the reports of Onomura et al.,16 that α-
hydroxy amides represent superior substrates compared to α-hydroxy esters in the 
asymmetric tosylation with bis(oxazoline) ligands, investigations were started to apply 
β-hydroxy amides in asymmetric benzoylation reactions. The explorations were 
commenced using the protocol established for the benzoylation of α-hydroxy esters. 
Nevertheless, optimization studies were carried out using different solvents, bases 
and ligands.  
 
Table 18: Optimization studies for the benzoylation of β-hydroxy amides.[a] 
 
 
Entry Ligand Base Solvent Configuration[b] Time  Yield (%) ee (%)[c] 
1 36a K2CO3 MeCN S 12 h 22 83 
2 36a DIPEA MeCN S 12 h 42 75 
3 36a K2CO3 CH2Cl2 S 12 h 49 82 
4 36a DIPEA THF S 24 h – – 
5 36a DIPEA EtOAc S 24 h 24 76 
6 36a DIPEA EtOH S 4 h 32 74 
7 36a DIPEA CH2Cl2 S 12 h 48 83 
8 80b[d] DIPEA CH2Cl2 S 12 h 39 69 
9 36d DIPEA CH2Cl2 S 12 h 39 65 
10 ent-36c DIPEA CH2Cl2 R 12 h 38 43 
11 35a[d] DIPEA CH2Cl2 S 12 h 20 7 
[a] Reaction conditions: Substrate (0.5 mmol), ligand-Cu-complex (5 mol%), base (0.5 mmol), 
benzoylchloride (0.25 mmol), 3 mL of solvent at r.t. [b] The absolute stereo configuration was 
deduced by comparing the optical rotation of the product with literature values.17  
[c] Determined by chiral HPLC. [d] Cu-complex was prepared in situ. 
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Although a high selectivity was obtained using K2CO3 in MeCN only a moderate yield 
of 22%, based on the substrate 174, was achieved. The other tested solvents paled 
compared to DCM in both, enantioselectivity and yield. It is noteworthy, that in THF 
no reaction was observable even after elongated reaction times (entry 4). The 
influence of the employed base was found to be of minor importance, at least for 
DCM as solvent (entries 3 and 7). Nevertheless, DIPEA was chosen for the further 
investigations, due to an easier work-up procedure where no extraction was required. 
Among the different ligands used, the isopropyl substituted ligand 36a gave the best 
results (entry 7). The difference of the results between the N-methylated ligand 80a 
and its counterpart 35a can be explained by the possible deprotonation of 35a on the 
central nitrogen bridge, leading to different catalytic active species. An interesting fact 
is that the bis(oxazoline) ligand 35a (entry 11) gave hardly any enantioselectivity and 
only a low yield of 20%. 
Utilizing the optimized conditions several substrates were screened having different 
substituents in β-position or on the amide nitrogen. 
 
Table 19: Benzoylation of different substituted β-hydroxy amides.[a] 
R1 NR2
OOH
R1 NR2
OOBz
PhCOCl (0.5 eq.)
DIPEA (1.0 eq.), DCM, r.t.
35a-CuCl2
(5 mol%)
R1 NR2
OOH
+
176a-h 177a-h 176a-h
 
[a] Reaction conditions: Substrate (0.5 mmol), ligand-Cu-complex (5 mol%), base (0.5 mmol), 
benzoylchloride (0.25 mmol) in 3 mL of solvent at r.t. [b] Isolated yield. [c] Determined by 
chiral HPLC. [d] Determined by chiral GC after cleavage of the Bz-group. 
 
Entry Substrate R1 R2 Product Yield (%)[b] ee (%)[c] 
1 176a Ph iPr 177a 49 78 
2 176b Ph Ph 177b 44 44 
3 176c Ph -(CH2)5- 177c 42 70 
4 176d p-OMe-Ph Me 177d 39 73 
5 176e p-Cl-Ph Me 177e 40 75 
6 176f p-NO2-Ph Me 177f 46 38 
7 176g cyclohexyl Me 177g 38 72[d] 
8 176h nPr Me 177h 47 73[d] 
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All the products could be received in acceptable to high yields. The influence of the 
substituent on the amide nitrogen can be seen in the entries 1-3. If an alkyl 
substituent is present no drastic changes in enantioselectivity are visible compared to 
the model substrate 174. In contrast, an amide function bearing aromatic groups 
gives rise to inferior ees (entry 2), which can probably be ascribed to the electron 
withdrawing effect of these groups leading to a weaker coordination of the substrate 
to the catalyst. The influence of the substituents in β-position is only of subsidiary 
relevance as shown in the entries 4-8. Only the p-nitro substituted starting material 
176f gave a dimished ee compared to the others. This finding can be explained by 
the possible coordination of the nitro group to the copper center giving rise to an 
unselective reaction. 
In conclusion, it could be demonstrated, that the copper catalyzed asymmetric 
benzoylation of β-hydroxy amides can be fulfilled using azabis(oxazoline) ligands. In 
this process high yields and good enantioselectivities up to 83% ee were obtained. 
During the course of the investigations comparable results were published by 
Onomura et al., demonstrating that bis(oxazoline) ent-35c is also capable of 
performing the kinetic resolution of β-hydroxy amides.17 Some of the results are 
shown in Scheme 44. 
 
N
H
OOH
BzCl (0.5 eq.)
K2CO3 (1 eq.)
EtOAc, r.t., 2 h
Cu(OTf)2
ent-35c
N
H
OOBz
Ph Ph N
H
OOH
Ph+
41%, 85% ee
N
H
OOH
BzCl (0.5 eq.)
K2CO3 (1 eq.)
EtOAc, r.t., 1.5 h
Cu(OTf)2
ent-35c
N
H
OOBz
N
H
OOH
+
37%, 89% ee
O
N N
O
Ph Ph
ent-35c
178 179 178
180 181 180
 
Scheme 44: Kinetic resolution of β-hydroxy amides according to Onomura et al.17 
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3.4.3 Kinetic resolution of β-lactams 
Intrigued by the results of the kinetic resolution using β-hydroxy amides another class 
of substrates should be examined. For that reason it was focused on β-lactams, 
cyclic amides which are additionally bearing a hydroxyl moiety in α-position to the 
carbonyl function. The structural motif of β-lactams can be found in a manifold of 
natural products and since the seminal discovery of Fleming, who introduces the β-
lactam antibiotic penicillin in 1928,18 many efforts have been made to synthesize this 
kind of compounds.  
 
Figure 17: Selected antibiotics containing a β-lactam unit.19,20 
 
The synthesis of the β-lactam started from the readily available glycolic acid 185, 
which was acetyl protected on the hydroxyl function to give 186 and afterwards 
converted to the acid chloride 187, using standard techniques, in good yields. The 
obtained acid chloride was subsequently reacted with the imine 188 applying the 
protocol of Kingston et al.21  
 
OH
O
HO
OH
O
AcO
Cl
O
AcO
Cl
O
AcO
N N
OAcO
+
DIPEA, DCM
-78°C
quant.
SOCl2AcOCl
Dioxane
80°C
74%
Pyridine
80°C
68%
185 186 187
187 188 189
 
Scheme 45: Synthesis of the β-lactam. 
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The selectivity of this reaction strongly depends on the reaction conditions and the 
used starting materials. Furthermore, a decisive criterion is that the reaction can 
proceed in different pathways. For instance, a concerted [2+2] cycloaddition or a two 
step process with the zwitterionic intermediate 192 are reasonable.22  
 
 
Scheme 46: β-lactam formation with a zwitterionic intermediate.22 
 
The product 189 was obtained as a single diastereomer. In the present case only the 
cis configured product was built in the [2+2] cycloaddition of ketene and imine. In the 
final step the acetyl protecting group was cleaved to give the α-hydroxy substituted  
β-lactam 194 in acceptable yield. 
 
 
Scheme 47: Deprotection of the OH-group. 
 
The likewise obtained substrate was tested in the kinetic resolution using different 
azabis(oxazoline)-metal complexes. The results are summarized in Table 20. 
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Table 20: Attempted benzoylation of β-lactam 194.[a] 
 
Entry Ligand Metal-salt Temp. Time Yield (%)[b] ee (%)[c] 
1 36d CuCl2 r.t. 4 h 41 – 
2 45 CuCl2 r.t. 2.5 h 40 – 
3 ent-36c Mg(OTf)2 r.t. 1 h 48 – 
4 ent-36c Mg(OTf)2 -15°C 16 h 47 – 
[a] Reaction conditions: Substrate (0.5 mmol), ligand (5.0 mol%), metal salt (4.8 mol%), base 
(0.5 mmol), benzoylchloride (0.25 mmol) in 5 mL of solvent. [b] Isolated yield. [c] Determined 
by chiral HPLC. 
 
In the first experiments the standard conditions of the benzoylation were used 
(entries 1 and 2). In these cases good yields were obtained, but no selectivity was 
observed at all. In further reactions Mg(OTf)2 was used as metal source, because in 
that case the metal complex has a different geometry compared to the copper 
complex. Nevertheless, in none of the cases any enantioselectivity was obtained. An 
explanation for these results might be the weak coordination of the substrate to the 
catalyst, due to steric bulk or an unfavorable complex geometry. Therefore, it would 
be suggestive that in further experiments other substrates or metal sources should be 
tested. Maybe substrates bearing less hindered substituents could be used in 
additional studies. Another useful approach could be the employment of calcium as 
metal source, due to the higher ion radius a better chelatisation could be possible. 
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4. Assessment of Catalyst Activities 
4.1 Asymmetric catalytic Michael-Addition 
Michael-additions are among the most prominent processes for the formation of new 
C-C bonds and still a lot of research in done to improve existing methods or to find 
new ways for the enantioselective accomplishment of these reactions. In the case 
that an aromatic or heteroaromatic substance is added to the α,β-unsaturated 
carbonyl compound the reaction can also be regarded as Friedel-Crafts-alkylation. In 
the present case indole is used as substrate due to the high relevance of indole 
derivatives in pharmacological drugs.1 The copper-bis(oxazoline) catalyzed process 
has been a great field of research starting with the pioneering work of Jørgensen et 
al., who was able to fulfill the addition of indole to α,β-unsaturated keto esters with 
perfect enantioselectivies of >99% ee.2 In contrast, the 1,4-addition of indole to 
benzylidene malonate (Scheme 48) could only be accomplished with moderate 
selectivities (up to 69% ee) under the same reaction conditions.3  
 
 
Scheme 48: Enantioselective Michael-addition of indole to benzylidene malonate.  
 
In subsequent studies Tang et al. could improve the selectivity of the latter reaction4 
and could also show that tris(oxazolines) 199 are superior ligands for this process.5 
With the optimized conditions selectivities of up to 93% ee were achieved and a 
penta-coordinated Cu(II)-species was postulated as the decisive intermediate for high 
enantioselectivities. The mechanism of the reaction is depicted in Scheme 49. It 
starts with the coordination of the malonate B to the copper source A to form the 
complex C. After addition of the indole, intermediate D is formed which then 
undergoes a proton transfer to give E. After decomplexation the product F is released 
and the catalyst is recovered for the next cycle. 
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Scheme 49: Mechanism of the enantioselective Friedel-Crafts alkylation.5 
 
In studies that were conducted together with R. Rasappan it could be shown, that the 
addition of indole to benzylidene malonate can be done with simple bis(oxazolines) 
and azabis(oxazolines) with very high selectivities, if the metal/ligand ratio is adjusted 
meticulously. Some of the results are summarized in Table 21. 
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Table 21: Dependence of enantioselectivity on copper(II)/ligand ratios in the 
asymmetric 1,4-addition to benzylidene malonates.6 
 
Entry Cu-salt Ligand Cu/Ligand 
ratio 
Cu/Ligand 
mol% Solvent 
Yield 
(%) ee (%)
[a]
 
1[b] Cu(OTf)2 35a 1/1.2 10/12 iBuOH 85 79 
2[c] Cu(OTf)2 35b 1/1.1 10/11 iBuOH 99 82[d] 
3[c] Cu(OTf)2 35b 1/1.1 10/11 EtOH 94 76 
4[b] Cu(OTf)2 199 1/1.2 10/12 iBuOH 90 93 
5 Cu(ClO4)2 201 1/1.1 4.5/5.0 EtOH 93 95 
6 Cu(ClO4)2 80a 1/1.1 4.5/5.0 EtOH 88 70 
7 Cu(ClO4)2 36a 1/1.1 4.5/5.0 EtOH 85 66 
8[e] Cu(ClO4)2 36a 1/1.1 4.5/5.0 EtOH 92 81 
9 Cu(ClO4)2 36d 1/1.3 3.8/5.0 EtOH 90 87 
10 Cu(ClO4)2 36d 1/1.04 4.8/5.0 EtOH 96 95 
11 Cu(OTf)2 36a 1/1.3 3.8/5.0 EtOH 98 81 
12 Cu(OTf)2 36a 1/1.1 4.5/5.0 EtOH 93 85 
13[f] Cu(OTf)2 36a 1/1.04 4.8/5.0 EtOH 97 >99 
14 Cu(OTf)2 36a 1/1 5.0/5.0 EtOH 90 98 
15 Cu(OTf)2 36a 1.1/1 5.5/5.0 EtOH 96 98 
16 Cu(OTf)2 36a 1.3/1 6.5/5.0 EtOH 95 91 
17 Cu(OTf)2   7.5/0 EtOH 90 0 
18 Cu(OTf)2 35a 1/1.04 4.8/5.0 EtOH 89 99 
[a] Determined by chiral HPLC. [b] Taken from ref. 5d. [c] Taken from ref. 5c. [d] 75% yield, 
93% ee at -25°C. [e] 5.5 mol% of triazole 200 were added. [f] Obtained in three runs. 
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The investigations began with the finding, that ligand 201 is able to catalyze the 
reaction with better enantioselectivity than the bis(oxazolines) (35) and the 
tris(oxazoline) 199 (Table 21, entry 5).7 This was surprising, because a tridentate 
coordination, according to the tris(oxazolines), is not possible due to the rigidity of the 
triazole framework. Nevertheless, an intermolecular coordination of the triazole unit to 
a second metal center can take place as confirmed by X-ray analysis (Figure 18). 
 
 
Figure 18: X-ray structures of CuCl2•XY (left) and [Cu(ClO4)2(CH3CN)2•XY]n (right);  
iPr, Ph, and ClO4 groups are omitted for clarity.6 
 
The X-ray structure shows a polymeric ligand structure (Figure 18, right picture) 
which is bridged by copper atoms. Consequently we suggested, that an external 
additive that is able to coordinate to the metal, should be sufficient to obtain high 
selectivities. However, a slight improve was visible (Table 21, entries 7 and 8) but the 
result could not equalize the performance of ligand 201. With these observations a 
new mechanism for the title reaction was proposed: The coordination of three 
nitrogens to the copper might represent a resting state of the catalyst. In order to 
form the active species one of the ligands has to dissociate off. In the case of 
bis(oxazoline) ligands, the excess of ligand used might provide a third oxazoline 
(Scheme 50, complex A). If then one of the chelating oxazoline moieties dissociates 
off a species like B (Scheme 50) is created, which would give rise to low 
enantioselectivity. If now an additive is present that coordinates weaker, a species 
like C would be favored, resulting in high enantioselectivity. 
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Scheme 50: Mechanistic model for the asymmetric 1,4-addition to benzylidene 
malonates. 
 
The superior results using the tris(oxazoline) ligands can also be understood, 
following this line of argument, since the dissociation of any oxazoline moiety would 
result in a species of type C.  
The rational consequence of this finding would be that the copper/ligand ratio plays a 
fundamental role for obtaining high selectivities and an excess of ligand can be 
detrimental therefore. This is quite in contrast to the usually applied ligand excess, 
which is utilized to avoid any background reaction by uncomplexed metal. Indeed, a 
variation of the ligand/metal ratio exhibited a strong effect on the resulting ee (Table 
21, entries 11-13). Applying this protocol enantioselectivities of 99% could be 
achieved for both, azabis(oxazolines) and bis(oxazolines). Using these standard 
conditions also different substrates were screened and good results were obtained 
as shown in Table 22.  
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Table 22: Asymmetric Michael-addition using different indoles and benzylidene 
malonates. [a] 6 
 
Entry Ar R1 Product Yield (%)[b] ee (%)[c] 
1 Ph (197) H 198 97 99 
2 p-Me-Ph (203) H 207 80 93 
3 p-Cl-Ph (204) H 208 91 98 
4 o-Br-Ph (205) H 209 89 85 
5 p-NO2-Ph (206) H 210 94 80 
6 Ph (197) OMe 211 80 90 
[a] Reagents and conditions: benzylidene malonate 1.0 mmol, indole 1.2 mmol, 4 mL EtOH. 
[b] Isolated yield. [c] Determined by chiral HPLC. 
 
All the products were obtained in high yields and with good to excellent selectivities. 
Only the p-NO2-sustituted benzylidene malonate paled in regard of enantioselectivity. 
This finding at first was explained by a possible coordination of the nitro group to the 
metal center, which would lead to an unselective reaction. 
In further experiments A. Schätz could show, that the influence of the ligand/metal 
ratio strongly depends on the substrate nature.8 It was found out that only for electron 
rich benzylidene malonates a ligand surplus is detrimental for the optical yield of the 
reaction. In contrast if electron withdrawing groups are present even a ligand excess 
is required to get the optimal ee.  
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Figure 19: Semi-logarithmic correlation of optical yield ratio versus σI values of para 
substituents in the reaction of indole with substituted benzylidene malonates.8 
 
Furthermore, it could be shown that the influence of the ligand/metal ratio vanishes if 
an excess of triflate is used. The explanation therefore is that the triflate ion 
coordinates to the copper in apical position9 and impedes the coordination of a third 
oxazoline moiety. Some of the results are summarized in Table 23. 
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Table 23: Dependence of enantioselectivity on the ligand/metal ratio in the 1,4-
addition of indole to benzylidene malonates; influence of triflate as an additive.[a] 
Entry Ligand/metal ratio R Li(OTf)2/36a Yield (%) ee (%)[b] 
1 1.04/1.0 H - 97 >99[c] 
2 1.05/1.0 H 5 90 93 
3 1.3/1.0 H - 98 81[c] 
4 1.3/1.0 H 5 97 96 
5 1.05/1.0 NO2 - 92 82[c] 
6 1.05/1.0 NO2 5 89 96 
7 1.3/1.0 NO2 - 83 94[c] 
8 1.3/1.0 NO2 5 73 93 
[a] Reaction conditions: 1.2 mmol indole, 1.0 mmol malonate, 5 mol % 36a, 20°C, 8 h; 4 mL 
EtOH. [b] Determined by chrial HPLC. [c] Obtained by at least two independent runs. 
 
In conclusion, simple copper(II)-bis(oxazoline) complexes are excellent catalysts for 
the asymmetric Michael-addition of indoles to benzylidene malonates, under the 
precondition of a precise adjustment of the ligand/metal ratio depending on the 
electronic properties of the substrates.    
 
 
4.2 Determination of catalyst activities 
As Noyori has pointed out, asymmetric catalysis is actually four-dimensional 
chemistry.10 This means, that a high efficiency of a catalyst can only be achieved 
through a combination of an ideal three dimensional structure and suitable kinetics. 
Especially for applications on industrial scale it is important that the catalytic active 
species shows not only high selectivity but also high activity. Generally the activities 
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are determined by comparison of the reaction kinetics. The problem herein is the 
evaluation of the kinetic data; usually this comprises the meticulous measurement of 
increments over a potentially long period of time. This means that after defined 
intervals aliquots have to be taken from the reaction mixture, often followed by a work 
up procedure, before the actual measurement (i.e. HPLC, GC, NMR) can take place. 
The ideal way would be a real-time monitoring, without affecting the system in any 
way, but this often requires complicated and cost intensive reaction setups (Figure 
20). 
 
 
Figure 20: Polymerization reactor with real-time monitoring.11 
 
In our approach, which is rather unexplored so far, the goal was to deduce 
information about relative catalyst activities only from the level of enantioselectivity 
obtained. Therefore a simple experimental setup is sufficient, which does not call for 
a continuous recording. Nevertheless, it allows a precise assessment of relative 
reaction rates. 
Our investigations mainly concentrated on the well explored Michael-addition of 
indole to benzylidene malonate, which was summarized in the previous paragraph, 
due to the fact that high yields and selectivities are obtained for both bis(oxazolines) 
and azabis(oxazolines). Hence, both ligands appear equally suited for the reaction 
under these conditions. The idea of the new approach was to have two chiral ligands 
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inside the reaction mixture which are producing the opposite enantiomers during the 
reaction. From the resulting ee and the known selectivities of the normal reactions 
(using only one ligand) the relative activities of the catalysts can be derived. For the 
calculation of the relative reaction rates the following formula was developed by S. 
Wittmann and F. Pein: 
 
 
  
	 
 
 
 
νrel = relative reaction rate 
ee1 = enantioselectivity of ligand 1 
ee2 = enantioselectivity of ligand 2 
eer = resulting enantioselectivity using both ligands 
 
As a first step the reactions were carried out using only one ligand because the 
preliminary results of the Friedel-Crafts alkylation were obtained with an optimal 
ligand/metal ratio of 1.04/1.0. For the intended experiments, however, a small excess 
of ligand is not suggestive, because this may lead to unequal amounts of the different 
complexes in the reaction mixture. For that reason a thoroughly preserved ratio of 1/1 
was employed. The results are summarized in Table 24. 
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Table 24: Asymmetric 1,4-addition of indole to benzylidene malonates catalyzed by 
different bis(oxazoline)- and azabis(oxazoline)-copper(II) complexes respectively.[a] 
 
 
Entry Ligand R Product Yield (%) ee (%)[b] 
1[c] 35a H (197) 198 89 - 99 
2[c] 36a H (197) 198 97 + 99 
3 ent-35a H (197) 198 93 - 90 
4 36a H (197) 198 90 + 98 
5 80a H (197) 198 84 + 77 
6 36d H (197) 198 90 + 81 
7 ent-36c H (197) 198 63 - 57 
8 ent-35a Cl (204) 208 84 - 80 
9 36a Cl (204) 208 87 + 76 
10 ent-35a Me (203) 207 79 - 84 
11 36a Me (203) 207 66 + 78 
12 ent-35a OMe (212) 213 80 - 83 
13 36a OMe (212) 213 47 + 71 
14 214 H (197) 198 81 + 87 
[a] Reagents and conditions: 1.2 mmol indole, 1.0 mmol benzylidene malonate, 5 mol% 
ligand, 5 mol% Cu(OTf)2, 20°C, 16h, solvent: 4 mL EtOH. [b] Determined by chiral HPLC. [c] 
4.8 mol% Cu(OTf)2, Taken from ref. 6. 
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The results indicate that the selectivities are inferior to those obtained under 
optimized conditions (entries 1 and 2). Nevertheless, good to excellent ee’s were 
achieved, with the exception of the phenyl-substituted AzaBOX ligand ent-36c (entry 
7), for all ligands and substrates tested. The entries 3 and 4 clearly show a 
prevalence of the iPr-substituted ligands ent-35a and 36a, regarding 
enantioselectivity, for the unsubstituted benzylidene malonate. Therefore, only these 
ligands were used for the substrate screening experiments. The MeOPEG 
immobilized ligand 214 also showed results that are comparable with the unbound 
counterpart in regards of selectivity (Table 24, entry 14). For all these experiments 
elongated reaction times were applied to ensure a complete conversion. 
Having these results, the next step was the utilization of two ligands in the reaction 
mixture. All the experiments were carried out twice to assure the reproducibility of the 
applied method.  
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Table 25: Asymmetric 1,4-addition of indole to benzylidene malonates: Comparison 
between different bis(oxazolines) and azabis(oxazolines).[a] 
 
Entry Ligand 1 Ligand 2 R Yield (%)[b] ee (%)[c] νrel. 
1 ent-35a 36a H 90 - 53 4.1 
2 ent-35a 80a H 89 - 63 5.2 
3 ent-35a 36d H 90 - 58 4.4 
4 35a ent-36c H 92 - 80 13.7 
5 36d ent-36c H 84 + 48 3.2 
6 ent-35a 36a Cl 87 - 41 3.0 
7 ent-35a 36a Me 65 - 49 3.7 
8 ent-35a 36a OMe 44 - 55 4.6 
9[d] ent-35a 214 H 71 - 52 3.6 
[a] Reagents and conditions: 1.2 mmol indole, 1.0 mmol malonate, 2.5 mol% ligand 1, 2.5 
mol% ligand 2, 5 mol% Cu(OTf)2, 20°C, 16h, solvent: 4 mL EtOH. [b] Average of two  runs. [c] 
Determined by chiral HPLC; average of two runs. [d] Results from S. Wittmann. 
 
Within the two independent runs only negligible aberrance in isolated yield and 
selectivity was obtained. The conglomerated ee-values and the thereof derived 
reaction rates show a clear tendency. In all competitive experiments between BOX 
and AzaBOX ligands the resulting enantioselectivity is coined by the chirality of the 
BOX ligand. The ee-values vary from 53-80%, giving rise to relative reaction rates 
between 3.6 and 13.7. Interestingly the N-methylated iPr-substituted AzaBOX ligand 
80a is a little slower than the unmethylated counterpart 36a (entries 1 and 2). In 
contrast, the polymer supported ligand 214 shows more or less the same activity as 
the unbound ligand 36a (entry 9). The Bn-substituted azabis(oxazoline) 36d provides 
again activities compareable to 36a. Only ligand ent-36c pales in regard of activity, 
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being 13.7 times slower than BOX 35a. But it was pleasing to find that this results 
could be predicted almost exactly by the multiplication of the values in the entries 3 
and 5 (calculated: 14.1). For a better visualization the results of the unsubstituted 
benzylidene malonates are depicted in Scheme 51. 
 
 
Scheme 51: Schematic representation of the correlation of rate ratios of 
bis(oxazoline)- and different azabis(oxazoline)-ligands derived from Table 25; arrows 
point towards the less active ligand. 
 
An interesting tendency is observed for different substituted benzylidene malonates 
(Table 25, entries 6-8). The electronic nature of the substrate influences the rate ratio 
between the ligands. The rate-supremacy of the BOX ligand is decreased when an 
electron withdrawing substituent is present. This observation can be easily 
rationalized by the fact that these substrates are more active towards the addition of 
indole and therefore the difference in reaction rate is alleviated.  
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Figure 21: Influence of the electronic properties of the substrate on the relative 
reaction rates. 
 
To further extend the scope of the employed method experiments were planned 
where the ligands are used in uneven amounts. Therefore the formula to calculate 
the rate ratios had to be adjusted: 
  
 
  
		 
 
 
 
X1 and X2 represent the amount of catalyst 1 and catalyst 2 respectively. 
 
With this formula the relative reaction rates of two catalysts should be determinable in 
any proportion.  
For these experiments the BOX ligand ent-35a and the AzaBOX ligand 80a were 
employed. The use of ligand 80a instead of 36a is rationalized by the higher solubility 
of the corresponding copper complex because a precipitation of one of the 
complexes would alter the composition of active species. The results are shown in 
Table 26. 
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Table 26: Assessment of relative reaction rates using uneven amounts of catalysts.[a] 
 
Entry Amount 80a (%) Amount ent-35a (%) Yield (%)[b] ee (%)[c] νrel 
1 0 100 93 -90 – 
2 10 90 89 - 89 18,4 
3 20 80 89 - 83 5,7 
4 40 60 87 - 36 1,4 
5 50 50 89 - 63 5,2 
6 60 40 89 - 63 7,8 
7 80 20 89 - 1 3,5 
8 90 10 88 + 31 0,29 
9 100 0 84 + 77 – 
[a] Reagents and conditions: 1.2 mmol indole, 1.0 mmol malonate, 20°C, 16h, solvent: 4 mL 
EtOH. [b] Isolated yield; average of two runs. [c] Determined by chiral HPLC; average of two 
runs. 
 
All experiments gave very good yields but, unfortunately, the obtained 
enantioselectivities and the thereof derived rate ratios did not represent the intended 
values. In principle all reactions should give the same value, the one of the 1/1 
mixture of ligands (entry 5), apart from a certain inaccuracy in the measurements. But 
the ratios fluctuate in a huge range. In order to elucidate the results it was 
investigated if the reactions are influenced by non linear effects of the catalysts, 
because it is known for bis(oxazolines) that NLE’s can occur.12 Thus, the correlation 
between the ee of the product and the ee of the utilized ligand was explored. The 
results are visualized in Figure 22. 
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Figure 22: Correlation of the product ee and the ligand ee. 
 
The diagrams lead to the suggestion that no non linear effect is present under the 
employed reaction conditions. Nevertheless, these experiments only represent the 
situation for the application of only one pair of enantiomers. The actual conditions of 
the ligand comparison experiments are not displayed by these investigations. Non 
linear effects often are ascribed to the so called Reservoir Effect13, this means that 
the formation of heterochiral dimeric complexes is favored due to a higher stability of 
these complexes compared to the homochiral ones, as the steric repulsion is reduced 
in these cases. Several examples of chiral amplifications are known and can be 
ascribed to this effect.14 Probably the most prominent example of a chiral 
amplification was published by Noyori et al. with the diethylzinc addition to 
benzaldehyde using an aminoalcohol as chiral ligand (Scheme 52). 
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Scheme 52: Diethylzinc addition to benzaldehyde by Noyori et al.15 
 
For this reaction a ligand with only 14% ee was used and 98% ee were obtained due 
to the formation of heterochiral dimeric complexes which were catalytic inactive. As 
there are several examples of heterochiral dimeric complexes reported being more 
stable than their homochiral complements16 we also tried to get an idea of the 
composition of complex species formed under the given conditions, therefore ESI-
mass spectra were recorded. The spectra are depicted in Figure 23 and the most 
important peaks are labeled. 
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Figure 23: ESI-spectra of ligand ent-35a and 80a with copper(II)triflate. 
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The spectra indicate that mainly complexes are formed, where the metal is 
coordinated by two ligand molecules. This is quite surprising, at least for the first 
spectra, because here the ligands are added in equimolar amounts referring to the 
metal source and 1/1 complexes would be suggestive, since otherwise free metal 
would be present and this principally should give rise to reduced enantioselectivities. 
The 2/1 species are catalytic inactive because in these cases the coordination of the 
malonate at the metal center is obviated. It can also be estimated, that in the present 
case it comes to the preferential formation of homochiral instead of heterochiral 2/1 
complexes, which would be in contrast to the results by Chen et al. who used 
pseudo-enantiomeric bis(oxazoline) ligands for his investigations.16 Furthermore, an 
interesting observation can be made for the catalytic active species, so the 
monomeric ligand-metal complex. If the quantity of ligands is incrased (Figure 23, 
lower spectra) the peak of the BOX•Cu+ species is reduced but the signal for the 
AzaBOX•Cu+ species vanishes almost completely, because now the equilibrium is 
ever further shifted towards the dimeric homochiral complex. As the latter complex is 
inactive in the catalysis this can be an explanation why the bis(oxazoline) ligand 
dominates the resulting ee even when the amount of azabis(oxazoline) is increased. 
These findings also support the hypothesis that the azabis(oxazolines) stronger bind 
to a metal center due to the different electronic properties compared with 
bis(oxazolines). Of course, these results only represent the situation in the gas 
phase, but together with the well known X-ray structures of 2/1 complexes, they can 
at least give a hint of the conditions in solution. The postulated situation that 
accounts for the results obtained with different ligand amounts is displayed in 
Scheme 53. 
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Scheme 53: Schematic representation of the possible complexes. 
 
If the metal is coordinated only by one ligand, BOX or AzaBOX, the catalytic active 
species A and E are formed because in that case free coordination sites are present 
for the substrate to bind to the metal. These two complexes are able to coordinate 
another ligand molecule, to form the agglomerates B, C and D, whereupon the 
heterochiral complex C is of insignificant importance. The two homochiral species 
can be seen as a resting state of the active catalyst. Probably due to the stronger 
binding of the azabis(oxazoline) to the metal the equilibrium is shifted strongly 
towards the side of the complex B, especially if the amount of AzaBOX is increased. 
This would lead to the suggestion that an increase in the concentration of ligand 80a, 
compared to the metal salt, would not favor the formation of the (S)-enantiomer 
(coined by the azabis(oxazoline)), instead a suppression of the active species A 
would be the result. The conclusion would be that the stereochemical outcome of the 
reaction should be dominated by the BOX ligand with an increase of the ligand 
concentrations. For that reason the reaction was run with elevated amounts of ligand. 
The results are summarized in Table 27. 
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Table 27: Influence of the ligand concentration.[a] 
 
Entry Order of Addition mol% of the ligands 
 80a            ent-35a Yield (%)
[b]
 ee (%)[c] 
1 BOX was added first 5 5 88 - 84 
2 AzaBOX was added first 5 5 88 - 78 
3 ligands added simultaneously 5 5 90 - 84 
4 BOX was added first 10 10 61 - 83 
5 AzaBOX was added first 10 10 68 - 76 
6 ligands added simultaneously 10 10 66 - 84 
[a] Reagents and conditions: 0.6 mmol indole, 0.5 mmol malonate, 20°C, 16h, solvent: 2 mL 
EtOH. [b] Isolated yield; average of two runs. [c] Determined by chiral HPLC; average of two 
runs. 
 
In order to verify if dynamic ligand exchange processes take place the order of ligand 
addition was varied. Therefore either one of the two ligands was stirred with the metal 
salt for a certain amount of time before the other ligand was added, or both ligands 
were added simultaneously as a solution in EtOH. The mixture then was stirred again 
for a while, so that the ligand exchange can take place. The results clearly show that 
the ligand molecules are exchanging because in all experiments the (-)-enantiomer is 
formed mainly, and this can be ascribed to the reaction catalyzed by ligand ent-35a. 
It can also be seen that the catalytic active species of the AzaBOX ligand is 
suppressed almost completely, even at a ligands to metal ratio of 2/1, as the resulting 
ee almost equals the value of the reaction catalyzed only by the BOX ligand (90% 
ee). If the concentration of the ligands is increased further to a ligands/metal ratio of 
4/1 no change in selectivity is observable, but the isolated yields are diminished 
considerably (entries 4-6). Because of the high amounts of ligands these reactions 
were found to proceed sluggish, as the coordination of the benzylidene malonate to 
the copper is oppressed especially in the end, when only low concentrations of 
malonate are present.  
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In a further control experiment it should be investigated if the method is applicable 
when two azabis(oxazolines) are used in uneven molar amounts. Therefore the 
ligands ent-36c and 36d were employed, because the only structural difference is the 
additional CH2-group of the substituents in 36d. Since the electronic properties of 
these two ligands are complementary only the different steric properties of these 
substituents should influence the formation of the distinct complexes. 
 
 
Figure 24: ESI-mass spectrum of the ligands ent-36c and 36d with copper(II)-triflate. 
 
The spectrum shows all three possible dimeric agglomerates, the two homochiral and 
the heterochiral one. Furthermore, a set of peaks appears which can be ascribed to 
the deprotonation of the latter complexes.  
The results of the experiments are shown in Scheme 54 and represent again the 
average of two runs with only negligible variations.  
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Scheme 54: Michael-addition with uneven molar amounts of ligands ent-36c and 
36d. 
 
The product was obtained in good yields and the cumulated enantiomeric excess 
was 5%. This leads to a relative reaction rate of 2.4 (in preference of the Bn-
substituted ligand 36d), which is quite in accordance to the obtained value of the 
experiment using equimolar amounts (3.2). The small aberrance can be explained by 
the relatively high inaccuracy of the method when it comes to very low ees. 
Nevertheless, it could be shown that the approach is applicable not only for the use 
of even catalyst amounts. 
Finally, the reaction kinetics of the Michael addition of indole to benzylidene malonate 
catalyzed by the ligands ent-35a and 36a was verified. Therefore, aliquots were 
taken from the reaction mixture after certain intervals of time and, after a small 
workup, were analyzed by HPLC. The reaction progress of the BOX catalyzed 
reaction is depicted in Figure 25. 
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Figure 25: Waterfall diagram of selected HPLC spectra to show the reaction 
progress; the displayed samples were taken after 15, 60 and 300 min. 
  
The results of the kinetic measurements are shown in Figure 26. The clear tendency 
that was obtained before can also be seen in these data, the bis(oxazoline) ligand is 
able to perform the reaction with higher activity. 
 
 
Figure 26: Results of the kinetic measurements. 
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To further validate the established methodology other transformations were 
investigated. One of the first asymmetric catalytic reactions examined is the 
cyclopropanation of olefins. A plethora of catalytic systems was already applied for 
this type of transformation, including salen-,17 bis(oxazoline)-18 and semicorrin-
ligands.19 Also azabis(oxazolines) were already successfully applied in these 
processes,20 therefore this kind of reaction would also be suitable for the employment 
in ligand comparison experiments. For the investigations the reaction between  
1,1-diphenylethylene 217 and the diazo ester 218 was chosen (Scheme 55).  
 
 
Scheme 55: Cyclopropanation of 1,1-diphenylethylene with methyl diazo ester. 
 
The measurement of kinetics in these kinds of reactions is quite difficult, as one 
reagent (the diazo ester) is added slowly over a long period of time. The rate ratios in 
this process depend on two factors, the decomposition of the diazo ester to form the 
carbene intermediate 220 and the transmission of the carbene to the double bond. 
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Figure 27: Carbene intermediate formed during the cyclopropanation. 
 
It is also known in literature, that the reaction rate of the cyclopropanation depends 
on the ligand/metal ratio.21 A strong deactivation was observed, when two 
equivalents of ligand were used with regard to the metal, because the metal was 
complexed by two ligand molecules and no more free coordination site was present. 
The results of the conducted experiments are summarized in Table 28. 
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Table 28: Results of the cyclopropanation.[a] 
 
Entry Ligand ent-35a (mol%) 
Ligand 80a 
(mol%) Yield (%)
[b]
 ee (%)[c] νrel 
1 5 - 70 + 53 - 
2 - 5 86 - 57 - 
3[d] 2.5 2.5 82 + 7 1.4 
4[d] 2 3 70 + 25 4.4 
5[d] 3 2 72 + 34 3.2 
[a] Reagents and conditions: 1.0 mmol 1,1-diphenylethylene, 2.0 mmol diazo ester, 1 drop 
phenyl hydrazine, 20°C, 16h, solvent: 2 mL DCM. [b]  Isolated yield. [c] Determined by chiral 
HPLC. [d] Average of two runs. 
 
Both ligands, when used alone, give the product in good yields and with moderate 
enantioselectivities, which is known for these substrates. The azabis(oxazoline) is a 
little inferior in both, yield and selectivity, but without significant differences. In this 
case it can be seen that the used ligands show almost the same reaction rate, ligand 
ent-35a is only marginally faster. Furthermore, it was tested again if the amount of 
ligands can be varied. But once more the received values are not in accordance with 
the 1/1 experiment, most probably due to the already discussed reasons. 
 
Another reaction that was examined is the dihydroxylation of olefins using the 
methodology of Sharpless.22 In this process an alkene is reacted with osmium 
tetroxide in the presence of the chiral quinine ligands (DHQ)2-PHAL or (DHQD)2-
PHAL (Figure 28). 
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Figure 28: Ligands for the asymmetric dihydroxylation using AD-mixes. 
 
The investigations took place with styrene and trans-stilbene as substrates; the 
results are listed in Table 29. For all reaction the commercially available AD-mixes 
were used, which contain 0.14% of the osmium source and 0.32% of the chiral 
ligand. The osmium tetroxide is regenerated during the reaction by a 1/1 mixture of 
potassium carbonate and potassium ferricyanide. 
 
Table 29: Results of the Sharpless asymmetric dihydroxylation.[a] 
 
Entry R AD-mix Yield (%)[b] ee (%)[c] νrel 
1 H α 27 + 95 - 
2 H β 43 - 93 - 
3 Ph α 47 > - 99.9 - 
4 Ph β 54 > + 99.9 - 
5[d] H α+β 28 + 9 1.2 
6[d] Ph α+β 52 + 6 1.1 
[a] Reagents and conditions: 1.0 mmol alkene, 3.0 mmol AD-mix (α, β, α+β), 20°C, 48h, 
solvent: 1 mL H2O, 1 mL tBuOH. [b] Isolated yield. [c] Determined by chiral HPLC. [d] 
Average of two runs. 
 
The products were obtained with low to moderate yield after 48h, especially the 
styrene showed only low reactivity (27-43 % yield). The obtained selectivities using 
only one AD-mix are very good for styrene; the reaction of trans-stilbene gave a 
product that was enantiomerically pure. In the ligand comparison the intended results 
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are obtained, the two AD-mixes can be regarded as equally fast, which is not 
surprising, since the chiral ligands are pseudo-enantiomers of one another.  
 
To further explore the generality of the given method organocatalytic methods should 
be applied, the latter reactions were carried out by C. Padié. The reaction between 
propanal 225 and diethyl azodicarboxylate 226 was chosen as model reaction, which 
represents an electrophilic α-amination of carbonyl compounds. After the first direct, 
enantioselective α-amination of 2-keto esters by Jørgensen et al., 23 using copper(II)-
bis(oxazolines), several organocatalytic approaches have been made successfully.24 
Especially proline and proline derived catalysts were able to perform this kind of 
transformation with high yield and selectivity. Hence, (L)-proline 229 and the 
Jørgensen-Hayashi catalyst 230 were used for the studies. 
 
Table 30: Results of the organocatalytic experiments.[a] 
 
 
Entry Catalyst mol% Yield (%)[b] ee (%)[c] νrel 
1 proline 5 43 - 98 - 
2 Jørgensen 5 48 + 79 - 
3[d] proline + Jørgensen 5 + 5 45 + 59 7.9 
4[d] proline + Jørgensen 2.5 + 2.5 67 + 60 8.1 
[a] Reagents and conditions: 1.5 mmol propanal, 1.0 mmol diethyl azodicarboxylate, addition 
of 1.3 mmol NaBH4 after disappearance of the yellow color of the azodicarboxylate, 20°C, 
solvent: 2.5 mL DCM. [b] Isolated yield. [c] Determined by chiral GC. [d] Average of two runs. 
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A problem that occurs when the reaction is performed is that the enantiomeric excess 
of the product formed by the direct α-amination decreases slowly because of the 
acidity of the α-position. To circumvent this problem the compound 227 was in situ 
reduced by sodium borohydride, leading to the oxazolidinone 228 after basic 
treatment. It might be intuitive expectation that ligands within the same enantiomeric 
series coin the chiral information in the target molecule alike. However, the two 
utilized catalysts give rise to different enantiomers although they have the same 
stereochemistry. All reaction suffer from moderate yields, nevertheless, with proline 
very high enantioselectivities were obtained (entry 1). The Jørgensen-Hayashi 
catalyst paled in the comparison of selectivity and gave only 79% ee (entry 2). 
However, the mixture of catalysts 229 and 230 furnished the (S)-configured aminated 
product 228 with a conglomerated enantioselectivity of 59% and 60% respectively 
(entry 3 and 4). Therefore it appears that 230 is an eightfold faster promoter of that 
reaction. The reason for this big discrepancy in activity can be seen in the kinetic 
measurements carried out by UV-spectroscopy (Figure 29). Whereas the Jørgensen-
Hayashi catalyst is active right in the beginning the (L)-proline shows an induction 
period in which only very low conversions are observable.  
 
Figure 29: Kinetic measurements of the α-amination reaction of propanal and diethyl 
azodicarboxylate. 
 
This induction period can probably be ascribed to the relatively slow formation of the 
enamine 231 with the aldehyde, due to the low solubility of the catalyst. 
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Scheme 56: Formation of the enamin intermediate.  
 
After approximately 5 min the activity is increased rapidly, but almost 50% of the 
starting material is already converted by catalyst 230. This case clearly demonstrates 
that the present method only represents the determination of the situation at the end 
point of the reaction, a variation of catalyst activity during the process, caused by 
induction periods or maybe decomposition of a catalyst, cannot be determined. 
 
In conclusion, a new methodology for the simple and rapid assessment of relative 
reaction rates has been established. The determination of enantiomeric excesses is 
sufficient for the evaluation of catalyst activities and no time consuming and tedious 
kinetics have to be measured. Furthermore, no special lab equipment besides normal 
HPLC and GC techniques is needed. Nevertheless, it has to be pointed out clearly, 
that the present method illustrates only the situation at the end point of the reaction 
and effects like induction periods cannot be determined. 
The applicability of the new approach was shown in different reactions, i.e. Michael-
addition, cyclopropanation, dihydroxylation and α-amination. Moreover, the scope of 
catalysts is not constricted to organometallic compounds only; in principle every 
catalyst is applicable, which was shown to some extent by the use of 
organocatalysts.  
Besides the determination of reaction rates deeper insight into the formation and 
arrangement of ligand/metal complexes was gained. This can be of big relevance for 
further investigations and helpful for the design of new catalytic processes. 
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C. Summary 
1. Ligand Synthesis 
Chiral bis(oxazolines) represent one of the most useful ligand classes, due to their 
simple synthesis, starting from amino alcohols, and their ability of coordinating a 
large number of metals. The in our group developed azabis(oxazolines) show a close 
structural relation and could also prove their usefulness in a series of different 
transformations.1 One aim of this work was to synthesize new azabis(oxazoline) 
ligands. Therefore the commercially available amino alcohol 37e was chosen as 
starting point. In a short and straightforward synthesis, applying the protocol of Glos,1 
the new ligands 45 and 46 could be obtained in acceptable yield (Scheme 57). 
 
 
Scheme 57: Synthesis of the new ligands 45 and 46. 
 
The catalytic activity of the new ligands was shown in the asymmetric Henry-reaction, 
but up to now no adequate, new transformation was found. 
 
2. Catalysis 
2.1 Kharasch-Sosnovsky-reaction 
The main focus of this work was pointed towards the evaluation and optimization of 
catalytic processes. Therefore different reactions were investigated, starting with the 
Kharasch-Sosnovsky reaction. The allylic oxidation was fulfilled in acceptable 
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chemical yields and good enantioselectivities comparable to those known in literature 
(Table 31). 
 
Table 31: Selected results of the Kharasch-Sosnovsky-reaction. 
 
 
Entry Ligand Time Temp. PhNHNH2 Yield (%)[b] [α]D20 ee (%)[c] 
1[d] 36d 2 h r.t. yes 74 -168.0 75 
2[d] 36d 16 h 0°C yes 68 -161.1 74 
3[d] 79 16 h 0°C yes 74 -173.0 78 
4 80d 16 h r.t. yes 54 -174.0 78 
[a] Reagents and conditions: 10 mmol cyclohexene, 1 mmol t-butyl perbenzoate, 1 drop of 
phenyl hydrazine, 5 mL solvent. [b] Isolated yield. [c] Determined by chiral HPLC. [d] Results 
of the diploma thesis.2 
 
A remarkable fact is the relative short reaction time compared to literature values, 
indicating a reactive catalytic system. Unfortunately, the scope of substrates is 
restricted to olefins bearing no electron withdrawing groups. For that reason the 
applicability of the process is diminished. 
 
2.2 Co(II)-AzaBOX catalyzed asymmetric reductions 
On the basis of the results of C. Geiger1j,3 investigations were carried out for the 
asymmetric reduction of carbonyl compounds using Co(II)-AzaBOX complexes in 
combination with NaBH4. Nevertheless, these processes suffered from low yields and 
low ees (Table 32). 
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Table 32: Selected results of the asymmetric reduction of carbonyl compounds. 
R R'
O CoCl2/Ligand 80d
NaBH4 (2 eq.)
R R'
OH
EtOH, Diglyme (1:1)
N
N
OO
N
Bn Bn
80d102
105a-112a
103
105b-112b
 
Entry Ketone Temp. (°C) Yield (%) [b] ee (%)[c] Conformation[d] 
1 
 
102 0 79 48 (R) 
2 
 
106a[e] 0 20 48 (R) 
3 
 
107a 0 66 52 (R) 
4 
 
109a 0 40 56 (R) 
5 
 
110a rt 73 45 (R) 
[a] Reagents and conditions: 0.5 mmol substrate, 1.0 mmol NaBH4, 5 mol% ligand, 5 mol% 
CoCl2•6H2O, 1 mL EtOH, 1 mL diglyme. [b] Isolated yield. [c] Determined by chiral GC or 
chiral HPLC. [d] The configuration was deduced by comparison of the optical rotation with 
literature values. [e] A partial dehalogenation occurred. 
 
As the results obtained were not comparable to literature values4 the efforts for this 
project were ceased. 
 
2.3 Asymmetric aza-Michael reaction 
Another process that was investigated during the course of this work was the 
asymmetric aza-Michael reaction between chalcones and anilines. The reaction of 
these simple substrates is, to the best of the author’s knowledge, rather unexplored 
so far.5 Some of the results are depicted in Table 33. 
 
 
 
C. Summary 
 
108 
 
Table 33: Selected results of the asymmetric aza-Michael addition. 
 
Entry R Product Solvent Yield (%)[b] ee (%)[c] 
1 Ph (132a) 137a Toluene 52 70 
2 Ph (132a) 137a CH2Cl2 19 73 
3 CF3 (132f) 137f Toluene 49 55 
[a] Reagents and conditions: 0.5 mmol chalcone, 1.0 mmol aniline, 5 mol% ligand,  
5 mol% Cu(OAc)2•H2O, 1 mL solvent, r.t. [b] Isolated yield. [c] Determined by chiral HPLC. 
 
The results achieved for the product 137a represent the highest enantioselectivities 
reported in literature, although the approach is facing the problem of low reactivity 
and the therefore obtained low to moderate chemical yields. Furthermore, only ligand 
36d was able to induce good selectivities, probably through an optimal  
pi−pi-interaction of substrate and catalyst. 
 
2.4 Kinetic resolution of β-hydroxy amides 
The kinetic resolution of alcohols represents one of the most prominent ways for 
gaining chiral products. Since this methodology was already applied successful using 
azabis(oxazolines),1e,f,i,6 further studies were undertaken to broaden the scope of 
substrates. Therefore β-hydroxy amides were subjected to the asymmetric Cu(II)-
catalyzed benzoylation. 
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Table 34: Selected results of the kinetic resolution of β-hydroxy amides. 
 
[a] Reaction conditions: Substrate (0.5 mmol), ligand-Cu-complex (5 mol%), base (0.5 mmol), 
benzoylchloride (0.25 mmol) in 3 mL of solvent at r.t. [b] Isolated yield. [c] Determined by 
chiral HPLC. [d] Determined by chiral GC after cleavage of the Bz-group. 
 
It was shown for a variety of different substrates that azabis(oxazolines) are able to 
perform the kinetic resolution of β-hydroxy amides in good to excellent yields and 
with good ees. 
 
3. Assessment of relative reaction rates 
Besides the classical catalytic investigations a new approach for the assessment of 
catalyst activities was made. This method mainly focused on the well explored 
Michael-addition of benzylidene malonates to indoles (Scheme 58).1k,7  
 
N
H
COOEt
COOEt
N
H
COOEt
COOEt
+
Ligand
Cu(II) salt
Solvent, r.t.
196 197 198  
Scheme 58: Michael-addition of benzylidene malonate to indole. 
 
Entry Substrate R1 R2 Product Yield (%)[b] ee (%)[c] 
1 174 Ph Me 175 48 83 
2 176a Ph iPr 177a 49 78 
3 176c Ph -(CH2)5- 177c 42 70 
4 176d p-OMe-Ph Me 177d 39 73 
5 176e p-Cl-Ph Me 177e 40 75 
6 176g cyclohexyl Me 177g 38 72[d] 
7 176h nPr Me 177h 47 73[d] 
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In this approach only the enantioselectivity derived from the catalytic experiment was 
used for the deduction of relative reaction rates. For the calculation of the reaction 
rates the following formula was developed: 
 
 
  
	 
 
 
νrel = relative reaction rate 
ee1 = enantioselectivity of ligand 1 
ee2 = enantioselectivity of ligand 2 
eer = resulting enantioselectivity using both ligands 
 
According to this formula the relative reaction rates of different ligands were 
determined in competitive reactions using two different ligands at the same time. The 
results of the ligand comparison experiments are depicted in Scheme 59. 
 
 
Scheme 59: Schematic representation of the rate ratios of bis(oxazoline)- and 
different azabis(oxazoline)-ligands; arrows point towards the less active ligand. 
 
It was shown that the results are reproducible, when a 1/1 mixture of ligands was 
used. Applying unequal amounts of ligands lead to unexpected results, which could 
be rationalized by the formation of different amounts of catalytic active species, due 
to the generation of inactive 2/1 ligand/Cu complexes. 
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Furthermore it was shown, that the method is applicable for different transformations, 
like cyclopropanations or dihydroxylations, and catalytic systems, e.g. organo-
catalysts. 
 
In summary, a novel methodology has been established for the rapid and simple 
determination of relative rate ratios of catalysts. 
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D. Experimental 
1. General comments: 
All reactions were carried out in oven dried glassware under atmospheric conditions 
unless utherwise stated.Commercially available chemicals were used as received, 
without any further purification. 
The following solvents and reagents were purified prior to use:  
Dichloromethane (CH2Cl2) was distilled from calciumhydride. Ethanol (EtOH) and 
methanol (MeOH) were distilled from magnesium and stored over molecular sieves 
(3 Å). Tetrahydrofurane (THF) was distilled from sodium wire. Toluene and Xylene 
were dried with CaH2, distilled and stored over sodium wire. Ethylacetate (EE) and 
hexanes (PE) for chromatographic separations were distilled prior to use.  
Benzaldehyde, benzoylchloride, cyclohexene, styrene, trans-stilbene and N,N-
diisopropylethylamine (DIPEA) were distilled prior to use. 
Analytical thin layer chromatography was performed on Merck TLC aluminium sheets 
silica gel 60 F 254. Visualization was accomplished with UV light (254 nm) and 
vaniline solution followed by heating. Liquid chromatography was performed using 
Merck silica gel 60 (70-230 mesh ASTM). 
 
1H- and 13C-NMR: 
NMR-spectra were recorded on a FT-NMR-spectrometer of the type Bruker Avance 
300 (300 MHz for 1H, 75 MHz for 13C) at ambient temperature. Data are as follows: 
Chemical shift in ppm from internal CHCl3 (7.26 ppm) as standard on the δ scale, 
multiplicity (b = broad, s = singlet, d = doublet, t = triplet, q = quartet, qt = quintet,  
dd = doublet of doublet and m = multiplet), integration and coupling constant (Hz). 
13C chemical shifts are reported in ppm from internal CHCl3 (77 ppm) as standard on 
the δ scale. The 13C signals were assigned with the help of DEPT 90 and DEPT 135 
techniques. 
 
Melting points:  
The melting points were measured on a Büchi SMP-20 apparatus in a silicon oil bath 
or on a SRS MPA 100 OptiMelt. Values thus obtained were not corrected. 
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Mass spectrometry: 
Mass spectrometry was performed using a Varian MAT 311A, Finnigan MAT 95 or 
Thermoquest Finnigan TSQ 7000 at the Central Analytical Laboratory (Universität 
Regensburg). 
 
IR spectroscopy:  
ATR-IR spectroscopy was carried out on a Biorad Excalibur FTS 3000 spectrometer, 
equipped with a Specac Golden Gate Diamond Single Reflection ATR-System. 
 
Optical rotation: 
The optical rotation was determined in a Perkin Elmer 241 polarimeter at 589 nm 
wavelength (sodium-d-line) in a 1.0 dm measuring cell of ca. 2 mL volume. 
 
HPLC: 
High performance liquid chromatography was carried out using a HPLC 335 detector 
on a 325 system by Kontron Instruments or a Varian 920-LC with DAD. 
Chiralcel OD-H, OJ and AS respectively served as chiral stationary phase. 
 
GC:  
Gas chromatography was performed on a Fisons GC 8000. 
CP-Chirasil-Dex CB (25m x 0.25mm Di, 0.25µm Film) was used as chiral stationary 
phase. 
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2. Synthesis of literature-known compounds: 
The following compounds were prepared according to literature synthesis: 
(S)-4-isopropyl-4,5-dihydrooxazol-2-amine (38a),1 (R)-4-phenyl-4,5-dihydrooxazol-2-
amine (ent-38c),1 (S)-4-benzyl-4,5-dihydrooxazol-2-amine (38d),2 (S)-4-
isopropyloxazolidin-2-one (42a),1 (R)-4-phenyloxazolidin-2-one (ent-42c),1 (S)-4-
benzyloxazolidin-2-one (42d),2 (S)-2-ethoxy-4-isopropyl-4,5-dihydrooxazole (39a),1 
(R)-2-ethoxy-4-phenyl-4,5-dihydrooxazole (ent-39c),1 (S)-4-benzyl-2-ethoxy-4,5-
dihydrooxazole (39d),2 (S)-bis((S)-4-isopropyl-4,5-dihydrooxazol-2-yl)amine (36a),1 
(R)-bis((R)-4-phenyl-4,5-dihydrooxazol-2-yl)amine (ent-36c),1 (S)-bis((S)-4-benzyl-
4,5-dihydrooxazol-2-yl)amine (36d),2 (S)-4-isopropyl-N-((S)-4-isopropyl-4,5-
dihydrooxazol-2-yl)-N-methyl-4,5-dihydrooxazol-2-amine (80a),1 (R)-N-methyl-4-
phenyl-N-((R)-4-phenyl-4,5-dihydrooxazol-2-yl)-4,5-dihydrooxazol-2-amine (ent-
80c),1 (S)-4-benzyl-N-((S)-4-benzyl-4,5-dihydrooxazol-2-yl)-N-methyl-4,5-dihydro-
oxazol-2-amine (80d),2 4-(3-bromopropoxy)benzaldehyde (61),3 (E)-4-methoxy-N-(1-
phenylethylidene)aniline (116),4 ethyl 3-hydroxy-3-phenylpropanoate (169),5 2-
acetoxyacetic acid (186),6 2-chloro-2-oxoethyl acetate (187),6 (E)-N-benzylidene-
aniline (188),7 diethyl 2-benzylidenemalonate (197),8 diethyl 2-(4-methyl-
benzylidene)malonate (203),8 diethyl 2-(4-chlorobenzylidene)malonate (204),8 diethyl 
2-(4-methoxybenzylidene)malonate (212),8  
 
 
3. Ligand synthesis: 
NH2N
O
 
(3aR,8aS)-8,8a-dihydro-3aH-indeno[1,2-d]oxazol-2-amine (43): 
10 mL of MeOH were cooled to 0°C, bromine (190 µL, 3.69 mmol, 1.1 eq.) was 
added and NaCN (181 mg, 3.69 mmol, 1.1 eq.) was added in small portions. 
Afterwards the amino indanol 37e (500 mg, 3.35 mmol, 1.0 eq.) was added as a 
solution in 10 mL of MeOH. The mixture was stirred for 30 min at 0°C and 30 min at 
r.t., before an aqueous NH3-solution (25 %) was added under ice cooling. The 
mixture was stirred again for 30 min and subsequently the MeOH was evaporated. 
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The residue was cooled to 0°C and NaOH (20 % in wat er) was added. After 
extraction with DCM the organic layer was dried over MgSO4 and the solvent was 
removed. The crude product was recristallized from DCM/hexanes or toluene to yield 
240 mg (62%) as a white solid. 
1H NMR (300 MHz, CDCl3): δ = 3.23 (dd, J = 1.3, 17.7 Hz, 1H), 3.37 (dd, J = 6.3, 
17.8 Hz, 1H), 4,51 (bs, 2H), 5.27-5.35 (m, 1H), 5.41 (d, J = 7.4 Hz, 1H), 7.18-7.25 (m, 
3H), 7.32-7.40 (m, 1H); 13C NMR (75 MHz, CDCl3):  δ = 160.6, 143.1, 139.4, 128.3, 
127.5, 125.2, 84.0, 74.6, 39.2; IR: 3448, 3015, 1676, 1410, 1312, 1172, 1023, 945, 
750, 716, 686 [cm-1]; MS (EI-MS, 70 eV): m/z (%) = 174 (47), 131 (34), 130 (100), 
104 (22), 103 (24), 77 (24), 44 (26); HRMS (PI-EIMS, m/z) [M+•]: calc.: 174.0793, 
found: 174.0793; mp: 148-153°C (decomposition). 
 
 
 
(3aR,8aS)-3,3a,8,8a-tetrahydro-2H-indeno[1,2-d]oxazol-2-one (42e): 
77 mg sodium (3.35 mmol, 1.0 eq.) were dissolved in EtOH (15 mL), amino indanol 
37e and diethyl carbonate were added and the mixture stirred at r.t. for 1 h and 
refluxed for 3-4 h. After that the solvent was removed, the residue was taken up in 
DCM and sat. NH4Cl-solution and the layers were separated. The aqueous layer was 
extracted 3x with DCM, the combined org. layers were dried over MgSO4 and the 
solvent was evaporated, to obtain 571 mg (97%) as a pale brown solid. 
1H NMR (300 MHz, CDCl3): δ = 3.33 (dd, J = 2.2, 17.8 Hz, 1H), 3.42 (dd, J = 6.2, 
17.8 Hz, 1H), 5.18 (d, J = 7.4 Hz, 1H), 5.38-5.47 (m, 1H), 6.34 (bs, 1H), 7.21-7.36 (m, 
4H); 13C NMR (75 MHz, CDCl3):  δ = 159.7, 140.3, 139.8, 129.4, 127.9, 125.6, 124.8, 
80.6, 61.2, 38.9; IR: 3240, 3142, 2923, 2841, 1744, 1700, 1392, 1233, 1204, 1107, 
1050, 960, 749, 681, 601, 435 [cm-1]; MS (EI-MS, 70 eV): m/z (%) = 175 (M+•, 100), 
147 (17), 146 (25), 132 (35), 131 (93), 130 (79), 118 (19), 104 (87), 103 (45), 89 (17), 
78 (30), 77 (43), 65 (33), 63 (17), 51 (27); HRMS (PI-EIMS, m/z) [M+•]: calc.: 
175.0633, found: 175.0636. 
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(3aR,8aS)-2-ethoxy-8,8a-dihydro-3aH-indeno[1,2-d]oxazole (44): 
The oxazolidinone 42e (434 mg, 2.48 mmol, 1.0 eq.) was dissolved in 30-40 mL of 
DCM, cooled to 0°C and a solution of Et 3OBF4 (566 mg, 2.98 mmol, 1.2 eq.) in 5 mL 
of DCM was added dropwise. The mixture was stirred at r.t. overnight. Afterwards it 
was quenched with sat. Na2CO3-solution, the layers were separated and the aqueous 
layer was extracted twice with DCM. The combined org. layers were dried over 
MgSO4 and the solvent was removed to gain 466 mg (92 %) as a pale brown solid. 
1H NMR (300 MHz, CDCl3): δ = 1.30 (t, J = 7.1 Hz, 3H), 3.30 (dd, J = 1.6, 17.8 Hz, 
1H), 3.41 (dd, J = 6.3, 18.1 Hz, 1H), 4.13-4.31 (m, 2H), 5.37-5.43 (m, 1H), 5.46 (d, J 
= 7.4 Hz, 1H), 7.23-7.34 (m, 3H), 7.43-7.51 (m, 1H); 13C NMR (75 MHz, CDCl3):  δ = 
163.0, 142.7, 139.6, 128.3, 127.5, 125.8, 125.5, 83.8, 73.6, 66.7, 39.2, 14.3; IR: 
3044, 2985, 2948, 2902, 1650, 1381, 1349, 1293, 1242, 1006, 832, 750, 730 [cm-1]; 
MS (EI-MS, 70 eV): m/z (%) = 203 (M+•, 30), 175 (100), 146 (83), 130 (73), 116 (37), 
103 (31), 77 (23); HRMS (PI-EIMS, m/z) [M+•]: calc.: 203.0946, found: 203.0941. 
 
 
 
(3aR,8aS)-bis((3aR,8aS)-8,8a-dihydro-3aH-indeno[1,2-d]oxazol-2-yl)amine (45): 
Aminooxazoline 43 (500 mg, 2.87 mmol, 1.0 eq.), benzaldehyde (305 mg, 290 µL, 
2.87 mmol, 1.0 eq.) and p-TSA (30 mg, 0.15 mmol, 5 mol%) were dissolved in 
toluene (50 mL) and the mixture was refluxed overnight, using a Dean-Stark 
apparatus. After that the mixture was stored for 2 days r.t. upon which the product 
precipitated. The solid was filtered off and dried in vacuum to obtain 222 mg (47 %) 
as a white solid. The filtrate was evaporated and the residue was purified by column 
chromatography (hexanes/EE: 25/75 followed by EE) to obtain 100 mg (21 %) of 
product. 
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1H NMR (300 MHz, CDCl3): δ = 3.28-3.46 (m, 4H), 5.28-5.36 (m, 2H), 5.42 (d, J = 7.7 
Hz, 2H), 7.22-7.33 (m, 6H), 7.41-7.49 (m, 2H); 13C NMR (75 MHz, CDCl3):  δ =165.5, 
141.5, 140.0, 128.9, 127.6, 125.5, 125.0, 81.6, 69.0, 39.2; IR: 2938, 2838, 1632, 
1611, 1579, 1382, 1202, 1098, 1072, 1027, 748, 725, 679 [cm-1]; MS (EI-MS, 70 eV): 
m/z (%) = 331 (M+•, 100), 302 (59), 201 (11), 158 (14), 131 (39), 115 (64), 104 (40), 
44 (17); HRMS (PI-EIMS, m/z) [M+•]: calc.: 331.1321, found: 331.1320; [α]D25 =  
+ 445.5 (20.2 mg/2 mL CHCl3); mp: 190-194°C (decomposition). 
 
 
 
(3aR,8aS)-N-((3aR,8aS)-8,8a-dihydro-3aH-indeno[1,2-d]oxazol-2-yl)-N-methyl-
8,8a-dihydro-3aH-indeno[1,2-d]oxazol-2-amine (46): 
Azabis(oxazoline) 45 (222 mg, 0.67 mmol, 1.0 eq.) was dissolved in THF (60 mL), 
cooled to -78°C and n-BuLi (444 µL of a 1.6 M solution in hexane, 0.74 mmol 1.1 eq.) 
was added dropwise. The mixture was stirred for 5 min at this temperature and then 
MeI (208 µL, 3.35 mmol, 5.0 eq.) was added. Subsequently, the cooling was 
removed and the reaction mixture was stirred overnight at r.t. After that it was 
quenched with sat. NaHCO3-solution and H2O, the THF was removed in vacuum and 
the residue was extracted with DCM (3x). The org. layer was dried over MgSO4 and 
the solvent was removed to obtain 211 mg (91 %) as an off-white solid. 
1H NMR (300 MHz, CDCl3): δ = 3.27 (s, 3H), 3.32 (dd, J = 1.9, 17.8 Hz, 2H), 3.41 
(dd, J = 5.8, 18.1 Hz, 2H), 5.41-5.48 (m, 2H), 5.50 (d, J = 7.4 Hz, 2H), 7.20-7.28 (m, 
6H), 7.44-7.52 (m, 2H); 13C NMR (75 MHz, CDCl3):  δ = 158.1, 142.6, 139.5, 128.4, 
127.5, 125.6, 125.2, 84.6, 74.2, 39.4, 37.1; IR: 3022, 2941, 2899, 1627, 1421, 1386, 
1307, 1247, 1167, 1022, 1004, 970, 840, 753, 734, 695, 582, 441 [cm-1]; MS (EI-MS, 
70 eV): m/z (%) = 345 (M+•, 7), 189 (100), 188 (14), 157 (18), 132 (57), 115 (43), 103 
(17); HRMS (PI-EIMS, m/z) [M+•]: calc.: 345.1477, found: 345.1474; mp: 190-195°C 
(decomposition). 
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4. Dendron Synthesis: 
 
(Z)-N'-(4-(3-azidopropoxy)benzylidene)-N-methylphosphorohydrazidothioic 
dichloride (69): 
Aldehyde 62 (1.79 g, 8.7 mmol, 1.0 eq.) was dissolved in 2 mL of THF, cooled to 0°C 
and a solution of hydrazine derivative 56 in CHCl3 (40 mL, 0.24 mol/L, 9.6 mmol, 1.1 
eq.) was added. 10 mL of THF were added to dissolve the built precipitate and the 
mixture was stirred overnight at r.t. Afterwards the solvent was removed partially  
(~ 7 mL remaining) and the solution was dropped into pentane. The precipitate was 
filtered off, redissolved in CHCl3 and again dropped into pentane. The pentane was 
filtered off over a cannula and the product was dried in vacuum, to obtain 1.70 g  
(56 %) of a yellow solid. 
1H NMR (300 MHz, CDCl3): δ = 2.09 (qt, J = 6.2 Hz, 2H), 3.50 (d, J = 14.5 Hz, 3H), 
3.56 (t, J = 6.6 Hz, 2H), 4.11 (t, J = 5.9 Hz, 2H), 6.96 (d, J = 8.7 Hz, 2H), 7.67-7.73 
(m, 3H); 31P NMR (81 MHz, CDCl3): δ = 63.4; IR: 2941, 2883, 2088, 1598, 1512, 
1465, 1239, 1168, 1055, 950, 926, 833, 766, 695, 600, 490 [cm-1]. 
 
 
 
4-(3-(4-((bis((R)-4-phenyl-4,5-dihydrooxazol-2-yl)amino)methyl)-1H-1,2,3-triazol-
1-yl)propoxy)benzaldehyde (ent-64b): 
Propargylated azabis(oxazoline) ent-63b (484 mg, 1.4 mmol, 1.2 eq.) and azide 62 
(240 mg, 1.2 mmol, 1.0 eq.) were dissolved in THF/TEA (20 mL, 4/1), the solution 
was degassed and CuI (23 mg, 0.12 mmol, 10 mol%) was added under Ar-
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atmosphere. The mixture was stirred at r.t. for 16 h, afterwards the solvent was 
removed in vacuum, the residue was extracted several times with EDTA-solution (1% 
in H2O) and the combined aqueous layers were re-extracted once with DCM. The 
combined org. layers were washed with sat. NH4Cl-solution, dried over Na2SO4 and 
the solvent was removed. The crude product was furthermore dissolved in DCM and 
slowly dropped into hexane, whereupon the product precipitated. The solid was 
filtered and dried to get a pale brown solid. 
1H NMR (300 MHz, CDCl3): δ = 2.42 (qt, J = 6.2 Hz, 2H), 3.98-4.12 (m, 2H), 4.28 (t, J 
= 7.8 Hz, 2H), 4.56 (t, J = 6.8 Hz, 2H), 4.83 (t, J = 9.0 Hz, 2H), 5.13-5.37 (m, 4H), 
6.96 (d, J = 8.7 Hz, 2H), 7.17-7.40 (m, 10 H), 7.70 (bs, 1H), 7.83 (d, J = 8.7 Hz, 2H), 
9.89 (s, 1H). 
 
 
 
4-(3-(4-((bis((S)-4-benzyl-4,5-dihydrooxazol-2-yl)amino)methyl)-1H-1,2,3-triazol-
1-yl)propoxy)benzaldehyde (64a): 
Propargylated azabis(oxazoline) 63a (374 mg, 1.0 mmol, 1.2 eq.) and azide 62 (171 
mg, 0.8 mmol, 1.0 eq.) were dissolved in THF/TEA (20 mL, 4/1), the solution was 
degassed and CuI (15 mg, 0.08 mmol, 10 mol%) was added under Ar-atmosphere. 
The mixture was stirred at r.t. for 16 h, afterwards the solvent was removed in 
vacuum, the residue was extracted several times with EDTA-solution (1% in H2O) 
and the combined aqueous layers were re-extracted once with DCM. The combined 
org. layers were washed with sat. NH4Cl-solution, dried over Na2SO4 and the solvent 
was removed. The crude product was furthermore dissolved in DCM and slowly 
dropped into hexane, whereupon the product precipitated. The solid was filtered and 
dried to get a pale brown solid. 
1H NMR (300 MHz, CDCl3): δ = 2.40 (qt, J = 6.2 Hz, 2H), 2.61 (dd, J = 8.6, 13.7 Hz, 
2H), 3.07 (dd, J = 4.2, 13.4 Hz, 2H), 4.04 (t, J = 5.7 Hz, 2H), 4.13 (t, J = 6.7 Hz, 2H), 
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4.25-4.43, (m, 4H), 4.54 (t, J = 6.7 Hz, 2H), 5.10 (dd, J = 13.0, 15.5 Hz, 2H), 6.95, (d, 
J = 8.4 Hz, 2H), 7.10-7.33 (m, 10H), 7.55 (s, 1H), 7.78 (d, J = 8.5 Hz, 2H), 9.82 (s, 
1H); 13C NMR (75 MHz, CDCl3):  δ = 29.7, 41.9, 44.8, 46.8, 64.5, 65.5, 73.1, 114.7, 
123.5, 126.5, 128.5, 129.2, 132.0, 137.8, 144.1, 157.2, 163.4, 190.7; IR: 3417, 3302, 
3027, 2927, 2245, 1637, 1601, 1476, 1428, 1258, 1161, 911, 733, 703 [cm-1]; MS 
(CI-MS): m/z (%) = 579 (100), 420 (26), 193 (20), 233 (11), 212 (19), 195 (31), 179 
(16), 151 (8). 
 
 
5. Catalysis: 
5.1 Asymmetric Kharasch-Sosnovsky reaction: 
General procedure (GP1) for the asymmetric Kharasch-Sosnovsky reaction: 
Cu(OTf)2 (18.1mg, 0.05mmol, 0.05 eq.) and ligand (0.05 mmol, 0.05 eq.) were 
dissolved in dry acetone (5 mL) and stirred for at least 1 h at r.t. Afterwards one drop 
of phenyl hydrazine was added, stirred again for 10 min and the alkene was added 
(10 mmol, 10 eq.). After 10 min the reaction was started by adding t-butyl 
perbenzoate (187 µL, 1.0 mmol, 1.0 eq.). After consumption of the oxidant 
(determined by TLC) the solvent was removed under reduced pressure and the 
residue was purified by column chromatography. 
 
 
 
Cyclohex-2-enyl benzoate (83): 
Prepared according to general procedure GP1. For the column chromatography 
hexanes/ethyl acetate 95/5 was used. The product was obtained as colorless oil. 
1H NMR (300 MHz, CDCl3): δ = 1.62-2.22 (m, 6H), 5.48-5.55 (m, 1H), 5.80-5.88 (m, 
1H), 7.38-7.46 (m, 2H), 7.50-7.58 (m, 1H), 8.02-8.09 (m, 1H); 13C NMR (75 MHz, 
CDCl3):  δ = 166.3, 132.9, 132.8, 130.8, 129.6, 128.3, 125.7, 68.6, 28.4, 25.0, 19.0; 
IR: 2942, 1712, 1269, 1111, 712, 632, 538, 499 [cm-1]; MS (EI, 70 eV): m/z (%) = 202 
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(M+•, 13), 105 (100), 97 (14), 81 (33), 80 (23), 79 (44), 77 (55), 53 (10), 51 (25), 41 
(16), 39 (15); HPLC analysis (Chiralcel OD-H, 0.1% iPrOH/n-heptane, 1.0 mL/min, 
254 nm): tr (major) = 11.02 min, tr (minor) = 11.93 min. 
 
 
 
(1R,3S,5R)-6,6-dimethyl-2-methylenebicyclo[3.1.1]heptan-3-yl benzoate (93): 
Prepared according to general procedure GP1. For the column chromatography 
hexanes/ethyl acetate 95/5 was used. The product was obtained as colorless oil. 
1H NMR (300 MHz, CDCl3): δ = 0.74 (s, 3H), 1.32 (s, 3H), 1.77 (d, J = 9.9 Hz, 1H), 
1.90-2.10 (m, 2H), 2.42-2.55 (m, 2H), 2.59 (t, J = 5.5 Hz, 1H), 4.92 (bs, 1H), 5.15 (t, J 
= 1.2 Hz, 1H), 5.82 (d, J = 7.7 Hz, 1H), 7.39-7.48 (m, 2H), 7.51-7.59 (m, 1H), 8.01-
8.09 (m, 2H); 13C NMR (75 MHz, CDCl3):  δ = 166.1, 150.1, 132.8, 130.9, 129.6, 
128.3, 114.5, 69.2, 50.8, 40.6, 39.6, 33.4, 28.0, 25.9, 22.0; IR: 2971, 2932, 1713, 
1267, 1109, 711, 632, 537, 496 [cm-1]; HPLC analysis (Chiralcel OJ, 1% iPrOH/n-
heptane, 0.5 mL/min, 254 nm): tr = 8.16 min. 
 
 
5.2 Asymmetric Co-catalyzed reduction: 
General procedure (GP2) for the asymmetric cobalt catalyzed reduction: 
Ligand (5 mol%) and CoCl2•6H2O (5 mol%) were dissolved in EtOH (1 mL) and 
stirred for 30 min at r.t. before diglyme (1 mL) or dioxane (1 mL) and carbonyl 
compound (0.5 mmol, 1.0 eq.) were added. After that the solution was cooled to 0°C 
and NaBH4 (47 mg, 1.25 mmol, 2.5 eq.) was added slowly. The mixture was stirred at 
r.t. until completion (monitored by TLC), quenched with H2O and extracted with DCM 
(3x). The combined org. layers were washed once with H2O, dried over MgSO4 and 
the solvent was removed. The residue was purified by column chromatography. 
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1-phenylethanol (103): 
Prepared according to the general procedure GP1 and purified by column 
chromatography (performed with hexanes/ethyl acetate 80/20) to obtain the pure 
product as a colorless liquid.  
1H NMR (300 MHz, CDCl3): δ = 1.50 (d, J = 6.6 Hz, 3H), 1.88 (bs, 1H), 4.90 (q, J = 
6.6 Hz, 1H), 7.24-7.42 (m, 5H); 13C NMR (75 MHz, CDCl3):  δ = 145.9, 128.5, 127.4, 
125.5, 70.3, 25.2; IR: 3356, 2973, 1451, 1204, 1076, 898, 760, 700, 632, 535, 495, 
422 [cm-1]; GC analysis (CP-Chirasil-Dex CB, 110°C isotherma l): tr = 6.35 min, tr = 
6.96 min. 
 
 
 
2-(1-hydroxyethyl)phenol (105b): 
Prepared according to the general procedure GP1 and purified by column 
chromatography (performed with hexanes/ethyl acetate 75/25) to obtain the pure 
product as a colorless liquid. 
1H NMR (300 MHz, CDCl3): δ = 1.60 (d, J = 6.6 Hz, 3H), 2.59 (bs, 1H); 5.08 (q, J = 
6.6 Hz, 1H), 6.80-6.91 (m, 2H), 6.96-7.02 (m, 1H), 7.13-7.21 (m, 1H), 7.96 (bs, 1H); 
13C NMR (75 MHz, CDCl3):  δ = 155.1, 129.5, 128.2, 126.3, 120.3, 117.2, 75.5, 22.3; 
IR: 3371, 2974, 2929, 1586, 1490, 1450, 1232, 1060, 751, 495 [cm-1]; GC analysis 
(CP-Chirasil-Dex CB, 95°C isothermal, TMS-imidazole  was added): tr = 21.12 min, tr 
= 21.69 min. 
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1-(2-bromophenyl)ethanol (106b): 
Prepared according to the general procedure GP1 and purified by column 
chromatography (performed with hexanes/ethyl acetate 75/25) to obtain the product 
as a colorless liquid (a partial dehalogenation was observed during the reaction). 
1H NMR (300 MHz, CDCl3): δ = 1.47 (d, J = 6.6 Hz, 3H), 2.13 (bs, 1H), 5.24 (q, J = 
6.6 Hz, 1H), 7.08-7.17 (m, 1H), 7.30-7.40 (m, 1H), 7.48-7.54 (m, 1H), 7.56-7.63 (m, 
1H); 13C NMR (75 MHz, CDCl3):  δ = 144.7, 132.7, 128.8, 127.9, 126.7, 69.2, 23.6; IR: 
3404, 2974, 2925, 1441, 1200, 1090, 1024, 894, 756, 632, 541, 497 [cm-1]; GC 
analysis (CP-Chirasil-Dex CB, 100°C (12 min) to 140 °C (15°C/min)): t r = 20.16 min, tr 
= 22.78 min. 
 
 
 
1-(2-methoxyphenyl)ethanol (107b): 
Prepared according to the general procedure GP1 and purified by column 
chromatography (performed with hexanes/ethyl acetate 75/25) to obtain the pure 
product as a colorless liquid. 
1H NMR (300 MHz, CDCl3): δ = 1.51 (d, J = 6.7 Hz, 3H), 2.65 (bs, 1H), 3.87 (s, 3H), 
5.10 (q, J = 6.7 Hz, 1H), 6.86-6.91 (m, 1H), 6.93-7.00 (m, 1H), 7.21-7.29 (m, 1H), 
7.32-7.37 (m, 1H); 13C NMR (75 MHz, CDCl3):  δ = 156.6, 133.4, 128.3, 126.1, 120.8, 
110.4, 66.6, 55.3, 22.8; IR: 3354, 2971, 2836, 1601, 1491, 1237, 1077, 1030, 754, 
632, 540, 497 [cm-1]; GC analysis (CP-Chirasil-Dex CB, 140°C isotherma l): tr = 7.36 
min, tr = 7.86 min. 
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Phenyl(p-tolyl)methanol (108b): 
Prepared according to the general procedure GP1 and purified by column 
chromatography (performed with hexanes/ethyl acetate 80/20) to obtain the pure 
product as a colorless oil. 
1H NMR (300 MHz, CDCl3): δ = 2.18 (bs, 1H), 2.33 (s, 3H), 5.82 (d, J = 3.3Hz, 1H), 
7.12-7.18 (m, 2H), 7.22-7.42 (m, 7H); 13C NMR (75 MHz, CDCl3):  δ = 144.0, 141.0, 
137.3, 129.2, 128.5, 127.5, 126.6, 76.1, 21.1; IR: 1656, 1606, 1447, 1317, 1278, 
1177, 732, 700, 632, 543, 494. 
 
 
 
1,2,3,4-tetrahydronaphthalen-1-ol (109b): 
Prepared according to the general procedure GP1 and purified by column 
chromatography (performed with hexanes/ethyl acetate 75/25) to obtain the pure 
product as a colorless liquid. 
1H NMR (300 MHz, CDCl3): δ = 1.70-2.08 (m, 4H), 2.59-2.90 (m, 2H), 4.78 (t, J = 4.7 
Hz, 1H), 7.07-7.14 (m, 1H), 7.15-7.33 (m, 2H), 7.40-7.47 (m, 1H); 13C NMR (75 MHz, 
CDCl3):  δ = 138.9, 137.1, 129.0, 128.7, 127.6, 126.2, 68.1, 32.3, 29.3, 18.9; IR: 3351, 
2932, 2865, 1743, 1665, 1489, 1454, 1065, 1037, 1001, 962, 773, 737, 615 [cm-1]; 
GC analysis (CP-Chirasil-Dex CB, 120°C isothermal):  tr = 18.24 min, tr = 18.96 min. 
 
 
 
1-(naphthalen-2-yl)ethanol (110b): 
Prepared according to the general procedure GP1 and purified by column 
chromatography (performed with hexanes/ethyl acetate 90/10) to obtain the pure 
product as colorless solid. 
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1H NMR (300 MHz, CDCl3): δ = 1.59 (d, J = 6.6 Hz, 3H), 1.96 (d, J = 2.6 Hz, 1H), 
5.07 (dq, J = 2.5, 6.6 Hz, 1H), 7.42-7.55 (m, 3H), 7.79-7.90 (m, 4H); 13C NMR (75 
MHz, CDCl3):  δ = 143.2, 133.3, 132.9, 128.3, 128.0, 127.7, 126.2, 125.8, 123.8, 70.6, 
25.2; IR: 3256, 2973, 1600, 1507, 1365, 1275, 1124, 1074, 900, 860, 822, 742, 483 
[cm-1]; HPLC analysis (Chiralcel OD-H, 10% iPrOH/n-heptane, 0.5 mL/min, 254 nm): 
tr = 24.02 min, tr = 25.73 min. 
 
 
 
1-phenylpropan-2-ol (111b): 
1H NMR (300 MHz, CDCl3): δ = 1.25 (d, J = 6.0 Hz, 3H), 2.70 (dd, J = 8.0, 13.4 Hz, 
1H), 2.80 (dd, J = 4.9, 13.4 Hz, 1H), 3.95-4.10 (m, 1H), 7.15-7.39 (m, 5H); 13C NMR 
(75 MHz, CDCl3):  δ = 138.5, 129.4, 129.2, 128.6, 126.5, 68.9, 45.8, 22.8; IR: 3404, 
2970, 2925, 1661, 1453, 1079, 940, 742, 699, 503 [cm-1]; GC analysis (CP-Chirasil-
Dex CB, 100°C isothermal): t r = 11.43 min, tr = 11.87 min. 
 
 
 
1-phenyl-2-(pyridin-2-yl)ethanol (112b): 
Prepared according to the general procedure GP1 and purified by column 
chromatography (performed with hexanes/ethyl acetate 80/20) to obtain the pure 
product as a pale brown solid. 
1H NMR (300 MHz, CDCl3): δ = 2.97-3.21 (m, 2H), 5.17 (dd, J = 4.4, 7.7 Hz, 1H), 
5.72 (bs, 1H), 7.08-7.14 (m, 1H), 7.15-7.22 (m, 1H), 7.23-7.30 (m, 1H), 7.31-7.39 (m, 
2H), 7.40-7.47 (m, 2H), 7.58-7.66 (m, 1H), 8.51-8.57 (m, 1H); 13C NMR (75 MHz, 
CDCl3):  δ = 159.8, 148.6, 144.1, 136.9, 128.3, 127.3, 125.9, 123.8, 121.8, 73.4, 45.7; 
IR: 3183, 3063, 2936, 1594, 1568, 1439, 1306, 1048, 756, 694, 540 [cm-1]; HPLC 
analysis (Chiralcel OD-H, 10% iPrOH/n-heptane, 0.5 mL/min, 254 nm): tr (major) = 
21.36 min, tr (minor) = 33.19 min. 
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ethyl 2-hydroxypropanoate (113b): 
Prepared according to the general procedure GP1 and purified by column 
chromatography (performed with hexanes/ethyl acetate 50/50) to obtain the pure 
product as a colorless liquid. 
1H NMR (300 MHz, CDCl3): δ = 1.24 (t, J = 7.1 Hz, 3H), 2.36 (d, J = 6.9 Hz, 3H), 3.10 
(bs, 1H), 4.18 (q, J = 7.1 Hz, 2H), 4.21 (q, J = 6.9 Hz, 1H); 13C NMR (75 MHz, 
CDCl3):  δ = 175.7, 66.7, 61.5, 20.3, 14.1; IR: 3466, 2985, 1732, 1211, 1128, 632, 
536, 498 [cm-1]; GC analysis (CP-Chirasil-Dex CB, 60°C isothermal ): tr = 8.63 min, tr 
= 9.95 min. 
 
 
 
N-benzyl-1-phenylethanamine (114b): 
Prepared according to the general procedure GP1 and purified by column 
chromatography (performed with hexanes/ethyl acetate 90/10 followed by 80/20) to 
obtain the pure product as a pale yellow liquid. 
1H NMR (300 MHz, CDCl3): δ = 1.38 (d, J = 6.6 Hz, 3H), 1.61 (bs, 1H), 3.63 (dd, J = 
13.2, 21.0 Hz, 2H), 3.82 (q, J = 6.6 Hz, 1H), 7.20-7.40 (m, 10H); 13C NMR (75 MHz, 
CDCl3):  δ = 145.6, 140.7, 128.5, 128.4, 128.2, 127.0, 126.9, 126.7, 57.5, 51.7, 24.5; 
IR: 3027, 2962, 1493, 1452, 1128, 700, 632, 535, 501 [cm-1]; HPLC analysis 
(Chiralcel OD-H, n-heptane, 0.5 mL/min, 254 nm): tr = 20.41 min, tr = 24.23 min. 
 
 
5.3 Asymmetric aza-Michael addition: 
General procedure (GP3) for the asymmetric aza-Michael addition: 
Azabis(oxazoline) (5 mol%) and Cu(OAc)2•H2O (5 mol%) were dissolved in toluene 
(2 mL) and stirred for at least 1 h at r.t. After that the chalcone (0.5 mmol, 1.0 eq.) 
and aniline (1.0 mmol, 2.0 eq.) were added and the reaction mixture was stirred at r.t. 
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for 1-3 d. Afterwards the solvent was removed under reduced pressure and the 
residue was purified by column chromatography. 
 
 
 
1,3-diphenyl-3-(phenylamino)propan-1-one (137a): 
According to general procedure GP3 104 mg of chalcone and 91 µL of aniline were 
reacted to obtain the product as a white solid. The column chromatography was 
performed using hexanes/ethyl acetate 95/5 followed by 90/10. 
1H NMR (300 MHz, CDCl3): δ = 3.42 (dd, J = 7.7, 16.2 Hz, 1H), 3.52 (dd, J = 5.5, 
16.0 Hz, 1H), 4.56 (bs, 1H), 5.01 (dd, J = 5.2, 7.4 Hz, 1H), 6.56 (d, J = 7.7 Hz, 2H), 
6.67 (t, J = 7.4 Hz, 1H), 7.03-7.13 (m, 2H), 7.20-7.28 (m, 1H), 7.29-7.37 (m, 2H), 
7.41-7.49 (m, 4H), 7.52-7.61 (m, 1H), 7.88-7.95 (m, 2H); 13C NMR (75 MHz, CDCl3):  
δ = 198.3, 147.0, 143.0, 136.7, 133.5, 129.1, 128.9, 128.7, 128.5, 128.2, 127.4, 
126.4, 117.8, 113.8, 54.8, 46.3; IR: 3377, 1666, 1601, 1509, 1448, 1372, 1286, 1174, 
1028, 994, 746, 683, 510 [cm-1]; MS (ESI-MS): m/z (%) = 343 (16), 302 (MH+, 100); 
mp: 135-141°C; HPLC analysis (Chiralcel OD-H, 5% iPrOH/n-heptane, 0.5 mL/min, 
254 nm): tr (major) = 47.10 min, tr (minor) = 51.75 min. 
 
 
 
1-phenyl-3-(phenylamino)-3-(4-(trifluoromethyl)phenyl)propan-1-one (137f): 
According to general procedure GP3 138 mg of chalcone and 91 µL of aniline were 
reacted to obtain the product as a white solid. The column chromatography was 
performed using hexanes/ethyl acetate 90/10. 
1H NMR (300 MHz, CDCl3): δ = 3.45 (dd, J = 6.8, 16.5 Hz, 1H), 3.52 (dd, J = 5.5, 
16.5 Hz, 1H), 4.62 (bs, 1H), 5.06 (dd, J = 5.8, 6.6 Hz, 1H), 6.50-6.57 (m, 2H), 6.65-
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6.73 (m, 1H), 7.06-7.15 (m, 2H), 7.42-7.50 (m, 2H), 7.54-7.62 (m, 5H), 7.87-7.94 (m, 
2H); 13C NMR (75 MHz, CDCl3):  δ =197.7, 147.2, 146.6, 136.5, 11.7, 130.3, 129.8, 
129.4, 129.3, 128.8, 128.2, 126.9, 125.9, 125.9, 125.8, 125.7, 122.3, 118.2, 113.9, 
54.4, 46.0; IR: 3402, 1678,1605, 1515, 1327, 1295, 1163, 1117, 1064, 841, 734, 689, 
623, 508 [cm-1]; MS (ESI-MS): m/z (%) = 411 (44), 370 (MH+, 100); mp: 128-134°C; 
HPLC analysis (Chiralcel OD-H, 10% iPrOH/n-heptane, 0.5 mL/min, 254 nm): tr 
(major) = 37.56 min, tr (minor) = 50.45 min. 
 
 
 
3-(4-chlorophenyl)-1-phenyl-3-(phenylamino)propan-1-one (137e): 
According to general procedure GP3 121 mg of chalcone and 91 µL of aniline were 
reacted to obtain the product as a white solid. The column chromatography was 
performed using hexanes/ethyl acetate 90/10. 
1H NMR (300 MHz, CDCl3): δ = 3.41 (dd, J = 7.1, 16.2 Hz, 1H), 3.48 (dd, J = 5.5, 
16.2 Hz, 1H), 4.57 (bs, 1H), 4.97 (dd, J = 5.6, 7.1 Hz, 1H), 6.50-6.57 (m, 2H), 6.64-
6.72 (m, 1H), 7.05-7.14 (m, 2H), 7.24-7.32 (m, 2H), 7.35-7.50 (m, 4H), 7.53-7.62 (m, 
1H), 7.87-7.96 (m, 2H); 13C NMR (75 MHz, CDCl3):  δ = 197.9, 146.7, 141.6, 136.6, 
133.6, 133.0, 129.6, 129.3, 129.2, 129.0, 128.8, 128.6, 128.2, 127.9, 118.1, 113.9, 
54.1, 46.1; IR: 3378, 1666, 1600, 1511, 1489, 1291, 1218, 1179, 992, 746, 688, 508 
[cm-1]; MS (ESI-MS): m/z (%) = 377 (25), 336 (MH+, 100); mp: 108-112°C; HPLC 
analysis (Chiralcel OD-H, 10% iPrOH/n-heptane, 0.5 mL/min, 254 nm): tr (major) = 
36.23 min, tr (minor) = 46.29 min. 
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3-(4-methoxyphenyl)-1-phenyl-3-(phenylamino)propan-1-one (137d): 
According to general procedure GP3 119 mg of chalcone and 91 µL of aniline were 
reacted to obtain the product as a pale yellow solid. The column chromatography was 
performed using hexanes/ethyl acetate 90/10. 
1H NMR (300 MHz, CDCl3): δ = 3.40 (dd, J = 7.4, 16.2 Hz, 1H), 3.50 (dd, J = 5.5, 
16.2 Hz, 1H), 3.77 (s, 3H), 4.51 (bs, 1H), 4.96 (dd, J = 5.7, 7.2 Hz, 1H), 6.52-6.59 (m, 
2H), 6.62-6.70 (m, 1H), 6.81-6.88 (m, 2H), 7.04-7.14 (m, 2H), 7.31-7.38 (m, 2H), 
7.40-7.49 (m, 2H), 7.52-7.59 (m, 1H), 7.87-7.94 (m, 2H); 13C NMR (75 MHz, CDCl3):  
δ = 198.4, 158.8, 147.1, 136.8, 135.0, 133.4, 129.1, 128.7, 128.2, 127.5, 117.7, 
114.2, 113.8, 55.3, 54.2, 46.4; IR: 3375, 1665, 1602, 1509, 1285, 1247, 1220, 1174, 
1028, 995, 747, 683, 511 [cm-1]; MS (ESI-MS): m/z (%) = 373 (6), 332 (MH+, 100); 
mp: 140-145°C; HPLC analysis (Chiralcel OD-H, 10% iPrOH/n-heptane, 0.5 mL/min, 
254 nm): tr (major) = 43.78 min, tr (minor) = 48.94 min. 
 
 
 
3-(3,5-dimethoxyphenylamino)-1,3-diphenylpropan-1-one (146a): 
According to general procedure GP3 138 mg of chalcone and 91 µL of aniline were 
reacted to obtain the product as a dark brown solid. The column chromatography was 
performed using hexanes/ethyl acetate 90/10 followed by 85/15. 
1H NMR (300 MHz, CDCl3): δ = 3.40 (dd, J = 7.4, 16.2 Hz, 1H), 3.51 (dd, J = 5.2, 
16.2 Hz, 1H), 3.66 (s, 6H), 4.63 (bs, 1H), 4.98 (dd, J = 5.2, 7.4 Hz, 1H), 5.76 (d, J = 
2.2 Hz, 2H), 5.84 (t, J = 2.2 Hz, 1H), 7.19-7.27 (m, 1H), 7.28-7.36 (m, 2H), 7.40-7.48 
(m, 4H), 7.52-7.60 (m, 1H), 7.87-7.94 (m, 2H); 13C NMR (75 MHz, CDCl3):  δ = 198.3, 
161.5, 149.0, 144.9, 142.9, 136.6, 133.5, 132.9, 130.6, 129.0, 128.9, 128.7, 128.6, 
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128.5, 128.5, 128.2, 127.4, 126.3, 122.1, 93.8, 92.6, 90.3, 55.2, 55.1, 54.8, 46.2; IR: 
3397, 2935, 1683, 1594, 1448, 1201, 1148, 1068, 810, 730, 688, 535 [cm-1]; MS 
(ESI-MS): m/z (%) = 362 (MH+, 100); mp: 99-103°C; HPLC analysis (Chiralcel OD-H , 
30% iPrOH/n-heptane, 1.0 mL/min, 215 nm): tr = 11.72 min, tr = 13.28 min. 
 
 
5.4 Kinetic resolution of β-hydroxy amides 
General procedure (GP4) for the asymmetric benzoylation: 
Substrate (0.5 mmol, 1.0 eq.) and ligand•CuCl2-complex (5 mol%) were dissolved in 
3 mL of DCM and stirred at r.t. for some minutes. After addition of DIPEA (85 µL, 0.5 
mmol, 1.0 eq.) benzoylchloride (28 µL, 0.25 mmol, 0.5 eq.) was added and the 
mixture was stirred overnight at r.t. Afterwards, the solvent was removed in vacuum 
and the residue was purified by column chromatography on silica gel. 
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3-ethoxy-3-oxo-1-phenylpropyl benzoate (172): 
According to general procedure GP4 97 mg of substrate were reacted to obtain the 
product as a colorless oil. The column chromatography was performed using 
hexanes/ethyl acetate 85/15. 
1H NMR (300 MHz, CDCl3): δ = 1.18 (t, J = 7.1 Hz, 3H), 2.89 (dd, J = 5.2, 15.6 Hz, 
1H), 3.13 (dd, J = 9.0, 15.6 Hz, 1H), 4.12 (q, J = 7.1 Hz, 2H), 6.42 (dd, J = 4.9, 9.0 
Hz, 1H), 7.27-7.49 (m, 7H), 7.52-7.60 (m, 1H), 8.03-8.09 (m, 2H); 13C NMR (75 MHz, 
CDCl3):  δ = 169.7, 165.4, 139.3, 133.1, 130.1, 129.7, 128.7, 128.4, 128.3, 126.5, 
72.9, 60.9, 41.9, 14.1; MS (CI-MS): m/z (%) = 316 (MNH4+, 100), 299 (MH+, 10), 244 
(12), 194 (25), 177 (6); HPLC analysis (Chiralcel OD-H, 10% iPrOH/n-heptane, 0.5 
mL/min, 254 nm): tr = 14.60 min, tr = 17.01 min. 
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3-tert-butoxy-3-oxo-1-phenylpropyl benzoate (173): 
According to general procedure GP4 111 mg of substrate were reacted to obtain the 
product as a colorless oil. The column chromatography was performed using 
hexanes/ethyl acetate 95/5 followed by 90/10. 
1H NMR (300 MHz, CDCl3): δ = 1.36 (s, 9H), 2.82 (dd, J = 5.2, 15.4 Hz, 1H), 3.04 
(dd, J = 9.1, 15.4 Hz, 1H), 6.37 (dd, J = 5.5, 9.1 Hz, 1H), 7.28-7.48 (m, 7H), 7.52-7.59 
(m, 1H), 8.03-8.09 (m, 2H); 13C NMR (75 MHz, CDCl3):  δ = 168.9, 139.4, 133.1, 
130.1, 129.7, 128.6, 128.4, 126.6, 81.2, 73.1, 43.1, 27.9; MS (EI, 70 eV): m/z (%) = 
270 (M-C4H8+•, 24), 253 (5), 165 (90), 131 (19), 105 (100), 77 (24), 57 (25); HPLC 
analysis (Chiralcel OD-H, 5% iPrOH/n-heptane, 0.5 mL/min, 254 nm): tr = 12.71 min, 
tr = 13.77 min. 
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3-(dimethylamino)-3-oxo-1-phenylpropyl benzoate (175): 
According to general procedure GP4 97 mg of substrate were reacted to obtain the 
product as a colorless oil. The column chromatography was performed using 
hexanes/ethyl acetate 25/75. 
1H NMR (300 MHz, CDCl3): δ = 2.86 (dd, J = 5.6, 15.8 Hz, 1H), 2.89 (s, 3H), 2.98 (s, 
3H), 3.18 (dd, J = 7.7, 15.4 Hz, 1H), 6.49 (dd, J = 6.0, 7.4 Hz, 1H), 7.23-7.59 (m, 8H), 
7.99-8.11 (m, 2H); 13C NMR (75 MHz, CDCl3):  δ = 169.0, 165.4, 140.3, 133.0, 130.3, 
129.7, 128.6, 128.4, 128.2, 126.5, 73.6, 40.4, 37.3, 35.5; IR: 2927, 1707, 1639, 1451, 
1414, 1349, 1272, 1139, 1110, 1067, 994, 761, 701, 602, 562 [cm-1]; MS (CI-MS): 
m/z (%) = 315 (9), 298 (MH+, 100), 192 (4), 176 (32); HRMS (EI-MS, m/z) [M+•]: calc.: 
297.1365, found: 297.1368; HPLC analysis (Chiralcel AS, 15% iPrOH/n-heptane, 0.5 
mL/min, 254 nm): tr = 48.41 min, tr = 62.16 min. 
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3-(diisopropylamino)-3-oxo-1-phenylpropyl benzoate (177a): 
According to general procedure GP4 125 mg of substrate were reacted to obtain the 
product as a colorless oil. The column chromatography was performed using 
hexanes/ethyl acetate 90/10 followed by 80/20. 
1H NMR (300 MHz, CDCl3): δ = 1.15 (dd, J = 6.6, 24.7 Hz, 6H), 1.29 (dd, J = 4.9, 6.6 
Hz, 6H), 2.85 (dd, J = 5.8, 15.1 Hz, 1H), 3.13 (dd, J = 8.2, 14.8 Hz, 1H), 3.40-3.60 
(m, 1H), 3.98 (st, J = 6.7 Hz, 1H), 6.51 (dd, J = 5.8, 8.0 Hz, 1H), 7.21-7.57 (m, 8H), 
8.01-8.08 (m, 2H); 13C NMR (75 MHz, CDCl3):  δ = 167.8, 165.4, 140.3, 132.9, 130.4, 
129.7, 128.5, 128.3, 128.1, 126.5, 73.9, 45.9, 42.1, 21.2, 21.0, 20.5; IR: 2970, 1720, 
1623, 1450, 1316, 1266, 1111, 892, 737, 631, 536 [cm-1]; MS (CI-MS): m/z (%) = 354 
(MH+, 100), 250 (9), 234 (4), 232 (21); HPLC analysis (Chiralcel AS, 5% iPrOH/n-
heptane, 0.5 mL/min, 254 nm): tr = 18.24 min, tr = 22.04 min. 
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3-(diphenylamino)-3-oxo-1-phenylpropyl benzoate (177b): 
According to general procedure GP4 159 mg of substrate were reacted to obtain the 
product as a colorless oil. The column chromatography was performed using 
hexanes/ethyl acetate 70/30. 
1H NMR (300 MHz, CDCl3): δ = 2.90 (dd, J = 6.0, 15.1 Hz, 1H), 3.12 (dd, J = 8.0, 
15.1 Hz, 1H), 6.53 (dd, J = 6.2, 7.9 Hz, 1H), 7.03-7.66 (m, 18H), 8.02-8.14 (m, 2H); 
13C NMR (75 MHz, CDCl3):  δ = 169.1, 165.4, 142.5, 139.8, 133.0, 130.3, 129.7, 
128.6, 128.3, 128.2, 126.6, 73.9, 42.2, 20.8; IR: 3062, 3034, 1715, 1646, 1400, 1273, 
1153, 1112, 713, 631, 536 [cm-1]; MS (CI-MS): m/z (%) = 439 (MNH4+, 10), 422 (MH+, 
100), 319 (10), 300 (74), 170 (24); HPLC analysis (Chiralcel OD-H, 15% iPrOH/n-
heptane, 0.5 mL/min, 254 nm): tr = 27.79 min, tr = 40.46 min. 
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3-oxo-1-phenyl-3-(piperidin-1-yl)propyl benzoate (177c): 
According to general procedure GP4 97 mg of substrate were reacted to obtain the 
product as a colorless oil. The column chromatography was performed using 
hexanes/ethyl acetate 25/75. 
1H NMR (300 MHz, CDCl3): δ = 1.37-1.66 (m, 6H), 2.89 (dd, J = 5.8, 15.4 Hz, 1H), 
3.18 (dd, J = 7.7, 15.1 Hz, 1H), 3.34-3.63 (m, 4H), 6.47 (dd, J = 5.8, 7.7 Hz, 1H), 
7.27-7.59 (m, 8H), 8.02-8.10 (m, 2H); 13C NMR (75 MHz, CDCl3):  δ = 167.2, 165.4, 
140.2, 132.9, 130.3, 129.7, 128.6, 128.3, 128.2, 126.6, 73.7, 46.9, 42.8, 40.3, 26.4, 
25.5, 24.5; IR: 2937, 2856, 1718, 1638, 1451, 1354, 1270, 1110, 1070, 1026, 752, 
713, 632, 535 [cm-1]; MS (CI-MS): m/z (%) = 355 (2), 338 (MH+, 100), 232 (4), 216 
(18); HRMS (EI-MS, m/z) [M+•]: calc.: 337.1678, found: 337.1670; HPLC analysis 
(Chiralcel OD-H, 10% iPrOH/n-heptane, 0.5 mL/min, 254 nm): tr = 38.63 min, tr = 
42.77 min. 
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3-(dimethylamino)-1-(4-methoxyphenyl)-3-oxopropyl benzoate (177d): 
According to general procedure GP4 112 mg of substrate were reacted to obtain the 
product as colorless solid. The column chromatography was performed using 
hexanes/ethyl acetate 25/75. 
1H NMR (300 MHz, CDCl3): δ = 2.87 (dd, J = 9.3, 15.4 Hz, 1H), 2.90 (s, 3H), 3.02 (s, 
3H), 3.19 (dd, J = 7.7, 15.3 Hz, 1H), 3.79 (s, 3H), 6.44 (dd, J = 6.3, 7.4 Hz, 1H), 6.84-
6.92 (m, 2H), 7.37-7.47 (m, 4H), 7.49-7.58 (m, 1H), 8.00-8.06 (m, 2H); 13C NMR (75 
MHz, CDCl3):  δ = 169.1, 165.4, 159.4, 132.9, 132.3, 130.4, 129.7, 128.3, 1208.0, 
113.9, 73.3, 55.3, 40.3, 37.4, 35.4; IR: 3056, 2936, 1706, 1643, 1513, 1397, 1314, 
1276, 1243, 1177, 1141, 1110, 1069, 1028, 1000, 874, 829, 756, 713, 621, 577, 543 
[cm-1]; MS (CI-MS): m/z (%) = 328 (MH+, 3), 223 (60), 206 (100), 191 (5); HPLC 
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analysis (Chiralcel AS, 15% iPrOH/n-heptane, 0.5 mL/min, 254 nm): tr = 71.24 min, tr 
= 92.02 min. 
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1-(4-chlorophenyl)-3-(dimethylamino)-3-oxopropyl benzoate (177e): 
According to general procedure GP4 114 mg of substrate were reacted to obtain the 
product as colorless solid. The column chromatography was performed using 
hexanes/ethyl acetate 25/75. 
1H NMR (300 MHz, CDCl3): δ = 2.86 (dd, J = 6.3, 15.6 Hz, 1H), 2.91 (s, 3H), 3.00 (s, 
3H), 3.17 (dd, J = 7.3, 15.5 Hz, 1H), 6.45 (t, J = 6.7 Hz, 1H), 7.29-7.35 (m, 2H), 7.39-
7.47 (m, 4H), 7.51-7.59 (m, 1H), 7.99-8.06 (m, 2H); 13C NMR (75 MHz, CDCl3):  δ = 
168.7, 165.3, 138.8, 134.0, 133.1, 130.1, 129.7, 128.8, 128.4, 128.1, 72.9, 40.2, 
37.3, 35.5; IR: 2918, 1716, 1647, 1489, 1401, 1352, 1273, 1175, 1119, 1009, 875, 
837, 710, 611, 564 [cm-1]; MS (CI-MS): m/z (%) = 349 (MNH4+, 13), 332 (MH+, 100), 
226 (6), 210 (54); HRMS (EI-MS, m/z) [M+•]: calc.: 331.0975, found: 331.0967; HPLC 
analysis (Chiralcel AS, 15% iPrOH/n-heptane, 0.5 mL/min, 254 nm): tr = 47.12 min, tr 
= 56.41 min. 
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3-(dimethylamino)-1-(4-nitrophenyl)-3-oxopropyl benzoate (177f): 
According to general procedure GP4 119 mg of substrate were reacted to obtain the 
product as pale yellow solid. The column chromatography was performed using 
hexanes/ethyl acetate 25/75. 
1H NMR (300 MHz, CDCl3): δ = 2.91 (dd, J = 6.6, 15.9 Hz, 1H), 2.92 (s, 3H), 3.02 (s, 
3H), 3.21 (dd, J = 6.7, 15.9 Hz, 1H), 6.55 (t, J = 6.7 Hz, 1H), 7.40-7.50 (m, 2H), 7.54-
7.62 (m, 1H), 7.65-7.72 (m, 2H), 8.00-8.07 (m, 2H), 8.18-8.25 (m, 2H); 13C NMR (75 
MHz, CDCl3):  δ = 168.2, 165.2, 147.6, 133.4, 129.7, 129.6, 128.5, 127.6, 123.9, 72.6, 
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40.0, 37.3, 25.5; IR: 2929, 1709, 1651, 1519, 1402, 1348, 1272, 1138, 1106, 1068, 
1009, 848, 781, 754, 712, 609, 555 [cm-1]; MS (CI-MS): m/z (%) = 360 (MNH4+, 21), 
343 (MH+, 100), 238 (5), 221 (15), 191 (79); HRMS (EI-MS, m/z) [M+•]: calc.: 
342.1216, found: 342.1208; HPLC analysis (Chiralcel OD-H, 20% iPrOH/n-heptane, 
0.5 mL/min, 254 nm): tr = 27.79 min, tr = 33.91 min. 
 
 
OBz
NMe2
O
 
1-cyclohexyl-3-(dimethylamino)-3-oxopropyl benzoate (177g): 
According to general procedure GP4 99 mg of substrate were reacted to obtain the 
product as colorless oil. The column chromatography was performed using 
hexanes/ethyl acetate 25/75. For the determination of the ee the product was 
dissolved in MeOH, Mg was added and the mixture was stirred overnight at r.t. 
Afterwards the solvent was removed and the residue was purified by column 
chromatography (hexanes/ethyl acetate 25/75). 
1H NMR (300 MHz, CDCl3): δ = 1.05-1.35 (m, 5H), 1.61-1.90 (m, 6H), 2.66 (dd, J = 
5.9, 15.0 Hz, 1H), 2.79 (dd, J = 7.4, 15.1 Hz, 1H), 2.89 (s, 3H), 3.03 (s, 3H), 5.36-
5.45 (m, 1H), 7.38-7.46 (m, 2H), 7.50-7.58 (m, 1H), 7.99-8.06 (m, 2H); 13C NMR (75 
MHz, CDCl3):  δ = 169.9, 165.9, 132.8, 130.6, 129.6, 128.3, 75.4, 41.2, 37.6, 35.5, 
35.3, 29.4, 27.6, 26.4, 26.1, 26.0; IR: 2922, 2851, 1622, 1498, 1449, 1398, 1262, 
1147, 1045, 892, 606 [cm-1]; MS (CI-MS): m/z (%) = 305 (19), 304 (MH+, 100), 182 
(6); HRMS (EI-MS, m/z) [M+•]: calc.: 303.1834, found: 303.1828; GC analysis (CP-
Chirasil-Dex CB, 130°C(10 min) to 175°C (3°C/min), 1 drop of TMS-imidazole was 
added): tr = 20.26 min, tr = 20.52 min. 
 
 
OBz
NMe2
O
 
1-(dimethylamino)-1-oxohexan-3-yl benzoate (177h): 
According to general procedure GP4 80 mg of substrate were reacted to obtain the 
product as colorless oil. The column chromatography was performed using 
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hexanes/ethyl acetate 25/75. For the determination of the ee the product was 
dissolved in MeOH, Mg was added and the mixture was stirred overnight at r.t. 
Afterwards the solvent was removed and the residue was purified by column 
chromatography (hexanes/ethyl acetate 25/75). 
1H NMR (300 MHz, CDCl3): δ = 0.95(t, J = 7.3 Hz, 3H), 1.35-1.54 (m, 2H), 1.73-1.87 
(m, 2H), 2.59 (dd, J = 7.3, 14.8 Hz, 1H), 2.88 (dd, J = 5.9, 14.9 Hz, 1H), 2.92 (s, 3H), 
3.05 (s, 3H), 5.41-5.53 (m, 1H), 7.38-7.48 (m, 2H), 7.51-7.60 (m, 1H), 7.98-8.08 (m, 
2H); 13C NMR (75 MHz, CDCl3):  δ = 169.6, 166.0, 132.9, 130.5, 129.5, 128.3, 72.0, 
38.3, 37.5, 36.4, 35.4, 18.7, 13.9; IR: 2959, 2936, 1718, 1665, 1595, 1491, 1451, 
1377, 1314, 1266, 1177, 1108, 1070, 1026, 1000, 758, 699, 633, 544 [cm-1]; MS (CI-
MS): m/z (%) = 281 (8), 264 (MH+, 100), 142 (4); HRMS (EI-MS, m/z) [M+•]: calc.: 
263.1521, found: 263.1525; GC analysis (CP-Chirasil-Dex CB, 105°C isothermal): t r 
= 22.57 min, tr = 23.51 min. 
 
 
 
2-oxo-1,4-diphenylazetidin-3-yl benzoate (195): 
According to general procedure GP4 120 mg of substrate were reacted to obtain the 
product as colorless solid. The column chromatography was performed using 
hexanes/ethyl acetate 80/20. 
1H NMR (300 MHz, CDCl3): δ = 5.50 (d, J = 5.0 Hz, 1H), 6.27 (d, J = 5.0 Hz, 1H), 
7.08-7.15 (m, 1H), 7.18-7.42 (m, 12H), 7.44-7.52 (m, 1H), 7.64-7.71 (m, 2H); 13C 
NMR (75 MHz, CDCl3):  δ = 164.9, 162.1, 136.9, 133.5, 132.3, 129.6, 129.3, 128.8, 
128.6, 128.3, 128.2, 127.7, 124.8, 117.6, 76.4, 61.5; IR: 1755, 1722, 1495, 1396, 
1262, 1114, 1057, 753, 546; MS (EI, 70 eV): m/z (%) = 343 (M+•, 9), 224 (9), 221 (8), 
181 (11), 105 (100), 77 (37), 51 (6); HRMS (EI-MS, m/z) [M+•]: calc.: 343.1208, 
found: 343.1207; mp: 180-184°C; HPLC analysis (Chir alcel OD-H, 20% iPrOH/n-
heptane, 1.0 mL/min, 254 nm): tr = 6.97 min, tr = 13.00 min. 
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5.5 Assessment of relative reaction rates 
General Procedure (GP5) for the asymmetric Michael additions: 
Reaction using one ligand (GP5.1): 
To a Schlenk tube ligand (0.05 mmol) and Cu(OTf)2 (18.1 mg, 0.05 mmol) were 
added under air atmosphere. Ethanol (2 mL) was added and the mixture was stirred 
for 1h at room temperature (20-25°C). To the result ing blue-green solution malonate 
(1.0 mmol, 1.0 eq.) in EtOH (2 mL) was added and stirring was continued for 20 min 
before the indole (141 mg, 1.2 mmol, 1.2 eq.) was added. After the stirring for 
overnight at room temperature, the red colored solution was concentrated under 
reduced pressure. The crude product was purified by column chromatography 
(performed with hexanes/DCM 1:1, followed by DCM). 
 
 
Reaction using two ligands (GP5.2): 
To a Schlenk tube both ligands (0.025 mmol of each) and Cu(OTf)2 (18.1 mg, 0.05 
mmol) were added under air atmosphere. Ethanol (2 mL) was added and the mixture 
was stirred for 1h at room temperature (20-25°C). T o the resulting blue-green 
solution malonate (1.0 mmol, 1.0 eq.) in EtOH (2 mL) was added and stirring was 
continued for 20 min before the indole (141 mg, 1.2 mmol, 1.2 eq.) was added. After 
the stirring for overnight at room temperature, the red colored solution was 
concentrated under reduced pressure. The crude product was purified by column 
chromatography (performed with hexanes/DCM 1:1, followed by DCM). 
 
 
N
H
COOEt
COOEt
 
Ethyl 2-ethoxycarbonyl-3-(3-indolyl)-3-phenyl propanoate (198): 
Prepared according to the general procedure GP5.1 or GP5.2 and purified by column 
chromatography (performed with hexanes/DCM 1:1, followed by DCM) to obtain the 
pure product as a white solid.  
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1H NMR (300 MHz, CDCl3): δ = 0.93-1.06 (m, 6 H), 3.93-4.06 (m, 4 H), 4.30 (d, J = 
11.8 Hz, 1 H), 5.09 (d, J = 11.8 Hz, 1 H), 7.00-7.07 (m, 1 H), 7.09-7.31 (m, 6 H), 7.37 
(d, J = 7.4 Hz, 2 H), 7.56 (d, J = 8.0 Hz, 1 H), 8.07 (bs, 1 H); 13C NMR (75 MHz, 
CDCl3):  δ = 168.1, 167.9, 141.4, 136.2, 128.4, 128.2, 126.8, 126.7, 122.3, 120.9, 
119.5, 119.4, 117.0, 111.0, 61.5, 61.4, 58.4, 42.9, 13.8, 13.8; MS (CI): m/z (%) = 383 
(MNH4+, 89), 366 (MH+, 3), 206 (100), 178 (5); mp 174-176°C; HPLC analys is 
(Chiralcel OJ-H, 30% iPrOH/n-heptane, 1.0 mL/min, 254 nm; tr (S) = 19.46 min, tr (R) 
= 25.95 min). 
 
 
N
H
COOEt
COOEt
Cl
 
Ethyl 2-ethoxycarbonyl-3-(3-indolyl)-3-(p-chlorophenyl) propanoate (208):  
Prepared according to the general procedure GP5.1 or GP5.2 and purified by column 
chromatography (performed with hexanes/DCM 1:1, followed by DCM) to obtain the 
pure product as a white solid.  
1H NMR (300 MHz, CDCl3): δ = 1.00 (t, J = 7.1 Hz, 3 H), 1.05 (t, J = 7.1 Hz, 3 H), 
3.96-4.06 (m, 4 H), 4.24 (d, J = 11.8 Hz, 1 H), 5.06 (d, J = 11.8 Hz, 1 H), 7.00-7.07 
(m, 1 H), 7.10-7.23 (m, 4 H), 7.27-7.34 (m, 3 H), 7.49 (d, J = 8.2 Hz, 1 H), 8.05 (bs, 1 
H); 13C NMR (75 MHz, CDCl3):  δ = 167.9, 167.8, 140.1, 136.3, 132.5, 129.6, 128.5, 
126.5, 122.4, 121.0, 119.7, 119.2, 116.4, 111.1, 61.6, 58.2, 42.3, 13.9, 13.8; MS (CI): 
m/z (%) = 417 (MNH4+, 100), 399 (3), 242 (30), 240 (67), 206 (2), 178 (8); mp 157-
158°C; HPLC analysis (Chiralcel OJ-H, 20% iPrOH/n-heptane, 1.0 mL/min, 254 nm; tr 
(R) = 15.22 min, tr (S) = 19.03 min). 
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N
H
COOEt
COOEt
Me
 
Ethyl 2-ethoxycarbonyl-3-(3-indolyl)-3-(p-methylphenyl) propanoate (207):  
Prepared according to the general procedure GP5.1 or GP5.2 and purified by column 
chromatography (performed with hexanes/DCM 1:1, followed by DCM) to obtain the 
pure product as a white solid.  
1H NMR (300 MHz, CDCl3): δ = 0.98 (t, J = 7.1 Hz, 3 H), 1.04 (t, J = 7.1 Hz, 3 H), 
2.24 (s, 3 H), 3.94-4.05 (m, 4 H), 4.27 (d, J = 11.8 Hz, 1 H), 5.04 (d, J = 11.8 Hz, 1 
H), 6.99-7.06 (m, 3 H), 7.08-7.18 (m, 2 H), 7.22-7.31 (m, 3 H), 7.55 (d, J = 8.0 Hz, 1 
H), 7.99 (bs, 1 H); 13C NMR (75 MHz, CDCl3):  δ = 168.1, 167.9, 138.4, 136.2, 136.2, 
129.0, 128.0, 126.7, 122.2, 120.8, 119.5, 119.5, 117.3, 110.9, 61.4, 61.4, 58.4, 42.4, 
21.0, 13.8, 13.8; MS (CI): m/z (%) = 397 (MNH4+, 73), 379 (2), 220 (100), 178 (7); mp 
140-142°C;  HPLC analysis (Chiralcel OJ-H, 30% iPrOH/n-heptane, 1.0 mL/min, 254 
nm; tr (R) = 12.23 min, tr (S) = 24.87 min). 
 
 
N
H
COOEt
COOEt
MeO
 
Diethyl 2-((1H-indol-3-yl)(4-methoxyphenyl)methyl)malonate (213):  
Prepared according to the general procedure GP5.1 or GP5.2, but the reaction was 
only stirred for ca. 5h and then purified by column chromatography (performed with 
hexanes/DCM 1:1, followed by DCM) to obtain the pure product as a white solid.  
1H NMR (300 MHz, CDCl3): δ = 0.97-1.07 (m, 6H), 3.73 (s, 3H), 3.95-4.04 (m, 4H), 
4.23 (d, J = 11.7 Hz, 1H), 5.03 (d, J = 11.8 Hz, 1H), 6.73-6.78 (m, 2H), 6.98-7.31 (m, 
6H), 7.52 (d, J = 7.8 Hz, 1H), 8.01 (bs, 1H); 13C NMR (75 MHz, CDCl3):  δ = 167.9, 
158.3, 136.3, 133.5, 129.2, 126.7, 122.3, 120.7, 119.5, 117.4, 113.7, 110.9, 61.4, 
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58.6, 55.3, 42.1, 13.8; MS (CI): m/z (%) = 413 (MNH4+, 71), 396 (MH+, 3), 236 (100), 
178 (13); mp 146-148°C ; HPLC analysis (Phenomenex Lux Cellulose-1, 10% 
iPrOH/n-heptane, 1.0 mL/min, 254 nm; tr (R) = 19.34 min, tr (S) = 21.70 min).  
 
 
General Procedure (GP6) for the asymmetric cyclopropanation: 
Reaction using one ligand (GP6.1): 
To a Schlenk tube ligand (0.05 mmol) and Cu(OTf)2 (18.1 mg, 0.05 mmol) were 
added under N2-atmosphere. DCM (2 mL) was added and the mixture was stirred for 
at least 1h at room temperature (20-25°C). Then one  drop of phenyl hydrazine was 
added, the mixture was stirred for another 10 min before the alkene (1 mmol, 1 eq.) 
was added. The diazo ester was then added via syringe pump (~0.5 mL/h) as a 
solution in DCM (~10%, m/v, 2.0 g, 2.0 eq.). The mixture was stirred overnight at r.t., 
afterwards the solvent was removed under reduced pressure and the residue was 
purified by column chromatography.   
 
 
Reaction using two ligands (GP6.2): 
To a Schlenk tube both ligands (0.025 mmol of each) and Cu(OTf)2 (18.1 mg, 0.05 
mmol) were added under N2-atmosphere. DCM (2 mL) was added and the mixture 
was stirred for at least 1h at room temperature (20-25°C). Then one drop of phenyl 
hydrazine was added, the mixture was stirred for another 10 min before the alkene 
(1.0 mmol, 1 eq.) was added. The diazo ester was then added via syringe pump 
(~0.5 mL/h) as a solution in DCM (~10%, m/v, 2.0 g, 2 eq.). The mixture was stirred 
overnight at r.t., afterwards the solvent was removed under reduced pressure and the 
residue was purified by column chromatography. 
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O
OMe
 
Methyl 2,2-diphenylcyclopropanecarboxylate (219):  
Prepared according to the general procedure GP6.1 or GP6.2 and purified by column 
chromatography (performed with hexanes, followed by hexanes/ethyl acetate 95:5) to 
obtain the pure product as a colourless oil. 1H NMR (300 MHz, CDCl3): δ = 1.62 (dd, J 
= 4.8, 8.1 Hz, 1H), 2.17 (dd, J = 4.9, 5.8 Hz, 1H), 2.56 (dd, J = 5.9, 8.1 Hz, 1H), 3.48 
(s, 3H), 7.13-7.37 (m, 10H); 13C NMR (75 MHz, CDCl3):  δ = 171.2, 144.8, 140.2, 
129.6, 128.5, 128.4, 127.6, 127.0, 126.6, 51.7, 40.0, 28.8, 20.2; MS (EI): m/z (%) = 
252 (M+•, 3), 193 (59), 192 (100), 191 (31), 178 (21), 165 (21), 115 (47), 91 (14); 
HPLC analysis (Chiralcel OJ-H, 30% iPrOH/n-heptane, 1.0 mL/min, 254 nm; tr (R) = 
15.31 min, tr (S) = 23.71 min). 
 
 
General Procedure (GP7) for the asymmetric dihydroxylation: 
Reaction using AD-α-Mix or AD-β-Mix (GP7.1): 
To a 10mL round bottom flask was added AD-Mix (700 mg, 3.0 mmol, 3.0 eq.), 
alkene (1.0 mmol, 1.0 eq.), 1 mL H2O and 1 mL tBuOH. The mixture was vigorously 
stirred for the indicated period of time, then a sat. Na2SO3 solution was added for 
quenching. The mixture was extracted thrice with DCM, the combined organic layers 
were dried over MgSO4, and the solvent was removed under reduced pressure. The 
residue was purified by column chromatography.  
 
 
Reaction using AD-α-Mix and AD-β-Mix (GP7.2): 
To a 10mL round bottom flask was added AD-α-Mix (350 mg, 1.5 mmol, 1.5 eq.),  
AD-β-Mix (350 mg, 1.5 mmol, 1.5 eq.), alkene (1.0 mmol, 1.0 eq.), 1 mL H2O and 1 
mL tBuOH. The mixture was vigorously stirred for the indicated period of time, then a 
sat. Na2SO3 solution was added for quenching. The mixture was extracted thrice with 
DCM, the combined organic layers were dried over MgSO4, and the solvent was 
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removed under reduced pressure. The residue was purified by column 
chromatography.  
 
 
OH
OH
 
1-phenylethane-1,2-diol (223): 
Prepared according to the general procedure GP7.1 or 7.2, the reaction mixture was 
stirred for 2 days. The column chromatography was done using hexanes/ethyl 
acetate (50:50), to obtain the product as a colorless solid. 1H NMR (300 MHz, 
CDCl3): δ = 3.43 (bs, 1H), 3.53-3.74 (m, 2H), 3.80 (bs, 1H), 4.75 (dd, J = 3.3, 8.2 Hz, 
1H), 7.24-7.37 (m, 5H); 13C NMR (75 MHz, CDCl3): δ = 140.5, 128.5, 128.0, 126.1, 
74.8, 68.0; MS (CI): m/z (%) = 173 (MNH4++NH3, 3), 157 (8), 156 (MNH4+, 100), 138 
(4); HPLC analysis (Chiralcel OD-H, 5% iPrOH/n-heptane, 1.0 mL/min, 254 nm; tr (R) 
= 17.44 min, tr (S) = 19.13 min). 
 
 
OH
OH
 
1,2-diphenylethane-1,2-diol (224): 
Prepared according to the general procedure GP7.1 or 7.2, the reaction mixture was 
stirred for 4 days. The column chromatography was done using hexanes/ethyl 
acetate (80:20) followed by hexanes/ethyl acetate (50:50), to obtain the product as a 
colourless solid. 1H NMR (300 MHz, CDCl3): δ = 2.85 (s, 2H), 4.71 (s, 2H), 7.08-7.17 
(m, 4H), 7.20-7.27 (m, 6H); 13C NMR (75 MHz, CDCl3):  δ = 139.8, 128.2, 128.0, 
127.0, 79.1; MS (CI): m/z (%) = 233 (14), 232 (MNH4+, 100), 214 (12); HPLC analysis 
(Chiralcel OJ-H, 10% iPrOH/n-heptane, 1.0 mL/min, 254 nm; tr (R,R) = 13.24 min, tr 
(S,S) = 14.78 min). 
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5.6 Mathematic derivation of the formula: 
The selectivity of two catalysts is constituted by their ee-values 	 and . 
Furthermore, the resulting ee-value of the mixture of both catalysts is denoted by . 
In the following the rate ratio      of the two catalysts will be derivated by 
means of the aforementioned values. 
According to the definition of the ee-value it is deemed to be: 	       (1) 
       (2) 
            (3) 
 
By variables substitution one can simplify the problem.   	   	  (4) 
 ̂  	 
  	  (5) 
       (6) 
    
   (7) 
 
From the last formulas ensues: 	     (8) 
     (9) 
     (10) 
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With the variable order (̂; ; ; ) we get the following homogeneous system of 
equations (row order (10,9,8)): 
̂   !
""#
	 
  
  
 	  	 
  
 	1 %
&&' 
  
  	   	        · 1 · 	 
  
  
 
 	 
  
The sought formula is:     
 	 
  
     
For the utilization of this formula one has to convert all values to either the (R) or (S) 
enantiomer:  )  
); + ,  -1,2, 01 
Hence, the final formula for a 1:1 ratio of the 2 catalysts is: 
 
    	 
  
 
For the general formula: 
  	  		    
X1 and X2 are the ratios of Catalyst 1 and Catalyst 2 respectively. 
As stated above: 
 
  	   		      · 	 ·    ·  · 1	 ·  · 	 
  
  
 
 		 
  
)  
); + ,  -1,2, 01 
 
    		 
  
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E. Appendix 
1. NMR Spectra 
1H-NMR (300 MHz):    upper image 
 
13C-NMR (75 MHz):     lower image 
 
Solvent (if not stated otherwise):   CDCl3 
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(ppm)
0.01.02.03.04.05.06.07.08.09.0
(3aR,8aS)-8,8a-dihydro-3aH-indeno[1,2-d]oxazol-2-amine (43)  
 
 
(ppm)
0102030405060708090100110120130140150160170180190
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(ppm)
0.01.02.03.04.05.06.07.08.09.0
(3aR,8aS)-3,3a,8,8a-tetrahydro-2H-indeno[1,2-d]oxazol-2-one (42e) 
 
 
(ppm)
0102030405060708090100110120130140150160170180190
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(ppm)
0.01.02.03.04.05.06.07.08.09.0
(3aR,8aS)-2-ethoxy-8,8a-dihydro-3aH-indeno[1,2-d]oxazole (44)  
 
 
(ppm)
0102030405060708090100110120130140150160170180190
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(3aR,8aS)-bis((3aR,8aS)-8,8a-dihydro-3aH-indeno[1,2-d]oxazol-2-yl)amine (45) 
 
 
(ppm)
0102030405060708090100110120130140150160170180190
(ppm)
0.01.02.03.04.05.06.07.08.09.0
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(3aR,8aS)-N-((3aR,8aS)-8,8a-dihydro-3aH-indeno[1,2-d]oxazol-2-yl)-N-methyl-
8,8a-dihydro-3aH-indeno[1,2-d]oxazol-2-amine (46) 
 
(ppm)
0102030405060708090100110120130140150160170180190
(ppm)
0.01.02.03.04.05.06.07.08.09.0
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(ppm)
0.01.02.03.04.05.06.07.08.09.0
Cyclohex-2-enyl benzoate (83)  
 
 
(ppm)
0102030405060708090100110120130140150160170180190
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(ppm)
0.01.02.03.04.05.06.07.08.09.0
(1R,3S,5R)-6,6-dimethyl-2-methylenebicyclo[3.1.1]heptan-3-yl benzoate (93) 
 
 
(ppm)
0102030405060708090100110120130140150160170180190
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(ppm)
0.01.02.03.04.05.06.07.08.09.0
1-phenylethanol (103) 
 
 
(ppm)
0102030405060708090100110120130140150160170180190
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(ppm)
0.01.02.03.04.05.06.07.08.09.0
2-(1-hydroxyethyl)phenol (105b) 
 
 
(ppm)
0102030405060708090100110120130140150160170180190
E. Appendix 
 
157 
 
(ppm)
0.01.02.03.04.05.06.07.08.09.0
1-(2-bromophenyl)ethanol (106b) 
 
 
(ppm)
0102030405060708090100110120130140150160170180190
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(ppm)
0.01.02.03.04.05.06.07.08.09.0
1-(2-methoxyphenyl)ethanol (107b) 
 
 
(ppm)
0102030405060708090100110120130140150160170180190
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(ppm)
0.01.02.03.04.05.06.07.08.09.0
Phenyl(p-tolyl)methanol (108b) 
 
 
(ppm)
0102030405060708090100110120130140150160170180190
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(ppm)
0.01.02.03.04.05.06.07.08.09.0
1,2,3,4-tetrahydronaphthalen-1-ol (109b) 
 
 
(ppm)
0102030405060708090100110120130140150160170180190
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(ppm)
0.01.02.03.04.05.06.07.08.09.0
1-(naphthalen-2-yl)ethanol (110b) 
 
 
(ppm)
0102030405060708090100110120130140150160170180190
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(ppm)
0.01.02.03.04.05.06.07.08.09.0
1-phenylpropan-2-ol (111b) 
 
 
(ppm)
0102030405060708090100110120130140150160170180190
E. Appendix 
 
163 
 
(ppm)
0.01.02.03.04.05.06.07.08.09.0
1-phenyl-2-(pyridin-2-yl)ethanol (112b) 
 
 
(ppm)
0102030405060708090100110120130140150160170180190
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(ppm)
0.01.02.03.04.05.06.07.08.09.0
Ethyl 2-hydroxypropanoate (113b) 
 
 
(ppm)
0102030405060708090100110120130140150160170180190
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(ppm)
0.01.02.03.04.05.06.07.08.09.0
N-benzyl-1-phenylethanamine (114b) 
 
 
(ppm)
0102030405060708090100110120130140150160170180190
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(ppm)
0.01.02.03.04.05.06.07.08.09.0
1,3-diphenyl-3-(phenylamino)propan-1-one (137a) 
 
 
(ppm)
0102030405060708090100110120130140150160170180190
NH O
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(ppm)
0.01.02.03.04.05.06.07.08.09.0
1-phenyl-3-(phenylamino)-3-(4-(trifluoromethyl)phenyl)propan-1-one (137f) 
 
 
(ppm)
0102030405060708090100110120130140150160170180190
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(ppm)
0.01.02.03.04.05.06.07.08.09.0
3-(4-chlorophenyl)-1-phenyl-3-(phenylamino)propan-1-one (137e) 
 
 
(ppm)
0102030405060708090100110120130140150160170180190
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(ppm)
0.01.02.03.04.05.06.07.08.09.0
3-(4-methoxyphenyl)-1-phenyl-3-(phenylamino)propan-1-one (137d) 
 
 
(ppm)
0102030405060708090100110120130140150160170180190
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(ppm)
0.01.02.03.04.05.06.07.08.09.0
3-(3,5-dimethoxyphenylamino)-1,3-diphenylpropan-1-one (146a) 
 
 
(ppm)
0102030405060708090100110120130140150160170180190
NH O
OMe
MeO
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(ppm)
0.01.02.03.04.05.06.07.08.09.0
3-ethoxy-3-oxo-1-phenylpropyl benzoate (172) 
 
 
(ppm)
0102030405060708090100110120130140150160170180190
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172 
 
(ppm)
0.01.02.03.04.05.06.07.08.09.0
3-tert-butoxy-3-oxo-1-phenylpropyl benzoate (173) 
 
 
(ppm)
0102030405060708090100110120130140150160170180190
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(ppm)
0.01.02.03.04.05.06.07.08.09.0
3-(dimethylamino)-3-oxo-1-phenylpropyl benzoate (175) 
 
 
(ppm)
0102030405060708090100110120130140150160170180190
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174 
 
(ppm)
0.01.02.03.04.05.06.07.08.09.0
3-(diisopropylamino)-3-oxo-1-phenylpropyl benzoate (176a) 
 
 
(ppm)
0102030405060708090100110120130140150160170180190
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175 
 
(ppm)
0.01.02.03.04.05.06.07.08.09.0
3-(diphenylamino)-3-oxo-1-phenylpropyl benzoate (176b) 
 
 
(ppm)
0102030405060708090100110120130140150160170180190
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176 
 
(ppm)
0.01.02.03.04.05.06.07.08.09.0
3-oxo-1-phenyl-3-(piperidin-1-yl)propyl benzoate (176c) 
 
 
(ppm)
0102030405060708090100110120130140150160170180190
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177 
 
(ppm)
0.01.02.03.04.05.06.07.08.09.010.0
3-(dimethylamino)-1-(4-methoxyphenyl)-3-oxopropyl benzoate (176d) 
 
 
(ppm)
0102030405060708090100110120130140150160170180190
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178 
 
(ppm)
0.01.02.03.04.05.06.07.08.09.0
1-(4-chlorophenyl)-3-(dimethylamino)-3-oxopropyl benzoate (176e) 
 
 
(ppm)
0102030405060708090100110120130140150160170180190
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179 
 
(ppm)
0.01.02.03.04.05.06.07.08.09.0
3-(dimethylamino)-1-(4-nitrophenyl)-3-oxopropyl benzoate (176f) 
 
 
(ppm)
0102030405060708090100110120130140150160170180190
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180 
 
(ppm)
0.01.02.03.04.05.06.07.08.09.0
1-cyclohexyl-3-(dimethylamino)-3-oxopropyl benzoate (176g) 
 
 
(ppm)
0102030405060708090100110120130140150160170180190
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181 
 
(ppm)
0.01.02.03.04.05.06.07.08.09.0
1-(dimethylamino)-1-oxohexan-3-yl benzoate (176h) 
 
 
(ppm)
0102030405060708090100110120130140150160170180190
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182 
 
(ppm)
0.01.02.03.04.05.06.07.08.09.0
2-oxo-1,4-diphenylazetidin-3-yl benzoate (195) 
 
 
(ppm)
0102030405060708090100110120130140150160170180190
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183 
 
(ppm)
0.01.02.03.04.05.06.07.08.09.0
Ethyl 2-ethoxycarbonyl-3-(3-indolyl)-3-phenyl propanoate (198) 
 
 
(ppm)
0102030405060708090100110120130140150160170180190
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184 
 
(ppm)
0.01.02.03.04.05.06.07.08.09.0
Ethyl 2-ethoxycarbonyl-3-(3-indolyl)-3-(p-chlorophenyl) propanoate (208) 
 
 
(ppm)
0102030405060708090100110120130140150160170180190
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185 
 
(ppm)
0.01.02.03.04.05.06.07.08.09.0
Ethyl 2-ethoxycarbonyl-3-(3-indolyl)-3-(p-methylphenyl) propanoate (207) 
 
 
(ppm)
0102030405060708090100110120130140150160170180190
N
H
COOEt
COOEt
Me
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186 
 
(ppm)
0102030405060708090100110120130140150160170180190
Diethyl 2-((1H-indol-3-yl)(4-methoxyphenyl)methyl)malonate (213) 
 
  
(ppm)
0.01.02.03.04.05.06.07.08.09.0
N
H
COOEt
COOEt
MeO
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Methyl 2,2-diphenylcyclopropanecarboxylate (219) 
 
 
(ppm)
0102030405060708090100110120130140150160170180190
(ppm)
0.01.02.03.04.05.06.07.08.09.0
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188 
 
(ppm)
0.01.02.03.04.05.06.07.08.09.0
1-phenylethane-1,2-diol (223) 
 
 
(ppm)
0102030405060708090100110120130140150160170180190
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(ppm)
0.01.02.03.04.05.06.07.08.09.0
1,2-diphenylethane-1,2-diol (224) 
 
 
 
 
 
 
 
 
 
 
 
 
 
(ppm)
0102030405060708090100110120130140150160170180190
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2. X-ray crystallographic data 
(3aR,8aS)-bis((3aR,8aS)-8,8a-dihydro-3aH-indeno[1,2-d]oxazol-2-yl)amine (45) 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1: Crystal data and structure refinement for 45. 
      Crystal Data  
  
Empirical formula  C20 H17 N3 O2  
Formula weight  331.37  
Crystal size  0.190 x 0.120 x 0.050 mm  
Crystal description  rod  
Crystal colour  colourless  
Crystal system Orthorhombic  
Space group  P 21 21 21  
Unit cell dimensions               a = 5.07650(10) A   alpha = 90 deg.  
                                         b = 11.0849(3) A    beta = 90 deg.  
                                         c = 27.5100(7) A   gamma = 90 deg.  
Volume  1548.06(7) A^3  
Z, Calculated density  4,  1.422 Mg/m^3  
Absorption coefficient  0.759 mm^-1  
F(000)  696 
   
      Data Collection  
  
Measurement device type  Oxford Diffraction Gemini Ultra  
Measuremnet method  omega-scan  
Temperature  123 K  
Wavelength  1.54184 A  
Monochromator   graphite  
Theta range for data collection  3.21 to 66.66 deg.  
Index ranges   =-4<=h<=5 -12<=k<=12 -28<=l<=32 
Reflections collected / unique  5227 / 2657 [R(int) = 0.0168]  
Reflections greater I>2\s(I) 2466 
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Absorption correction  Semi-empirical from equivalents  
Max. and min. transmission  1.00000 and 0.82211  
   
      Refinement  
  
Refinement method  Full-matrix least-squares on F^2  
Hydrogen treatment  :  
Data / restraints / parameters  2657 / 1 / 229  
Goodness-of-fit on F^2  1.057 
Final R indices [I>2sigma(I)]      R1 = 0.0346, wR2 = 0.0937  
R indices (all data)               R1 = 0.0377, wR2 = 0.0957  
Absolute structure parameter  -0.2(2)  
Largest diff. peak and hole  0.393 and -0.454 e.A^-3  
 
 
Table 2: Atomic coordinates ( x 104) and equivalent isotropic displacement 
parameters (Å2 x 103) for 45. U(eq) is defined as one third of the trace of the 
orthogonalized Uij tensor. 
   Atom x    y     z  U(eq)  
O(1) -6930(2) -1955(1) -2018(1) 24(1)  
O(2) -13434(2) -2002(1) -3157(1) 24(1)  
N(1) -10122(3) -1986(1) -2596(1) 22(1)  
N(2) -8217(3) -3773(1) -2251(1) 24(1)  
N(3) -11763(3) -3820(1) -2942(1) 23(1)  
C(1) -8533(3) -2584(1) -2313(1) 20(1)  
C(2) -5127(3) -2793(1) -1776(1) 24(1)  
C(3) -6499(3) -4019(1) -1838(1) 23(1)  
C(4) -7949(3) -4172(1) -1358(1) 21(1)  
C(5) -7105(3) -3316(1) -1021(1) 22(1)  
C(6) -5007(3) -2516(2) -1233(1) 23(1)  
C(7) -8191(4) -3292(1) -556(1) 24(1)  
C(8) -10098(4) -4130(1) -433(1) 25(1)  
C(9) -10935(4) -4984(2) -772(1) 27(1)  
C(10) -9874(3) -5014(1) -1237(1) 23(1)  
C(11) -11721(3) -2671(1) -2886(1) 21(1)  
C(12) -15025(3) -2848(1) -3434(1) 23(1)  
C(13) -13601(3) -4065(1) -3343(1) 22(1)  
C(14) -12132(3) -4289(1) -3815(1) 21(1)  
C(15) -12804(3) -3439(1) -4165(1) 21(1)  
C(16) -14859(4) -2573(1) -3978(1) 24(1)  
C(17) -11610(4) -3461(1) -4622(1) 24(1)  
C(18) -9749(4) -4344(2) -4721(1) 25(1)  
C(19) -9084(3) -5194(2) -4367(1) 25(1)  
C(20) -10262(3) -5169(2) -3912(1) 23(1)  
 
Table 3: Bond lengths [Å] and angles [deg] for 45. 
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O(1)-C(1) 1.3441(18) C(4)-C(5)-C(7) 120.15(15) 
O(1)-C(2) 1.4643(19) C(6)-C(5)-C(7) 128.72(15) 
O(2)-C(11) 1.3636(18) C(4)-C(5)-C(6) 111.13(14) 
O(2)-C(12) 1.4538(19) C(2)-C(6)-C(5) 103.50(13) 
N(1)-C(1) 1.303(2) C(5)-C(7)-C(8) 119.14(15) 
N(1)-C(11) 1.368(2) C(7)-C(8)-C(9) 120.47(16) 
N(2)-C(1) 1.339(2) C(8)-C(9)-C(10) 120.87(17) 
N(2)-C(3) 1.457(2) C(4)-C(10)-C(9) 118.46(15) 
N(3)-C(11) 1.283(2) O(2)-C(11)-N(3) 117.64(13) 
N(3)-C(13) 1.471(2) O(2)-C(11)-N(1) 113.29(13) 
N(1)-H(1N) 0.955(16) N(1)-C(11)-N(3) 129.04(15) 
C(2)-C(3) 1.537(2) O(2)-C(12)-C(16) 110.72(13) 
C(2)-C(6) 1.526(2) O(2)-C(12)-C(13) 102.61(12) 
C(3)-C(4) 1.523(2) C(13)-C(12)-C(16) 107.74(13) 
C(4)-C(5) 1.394(2) C(12)-C(13)-C(14) 103.55(13) 
C(4)-C(10) 1.391(2) N(3)-C(13)-C(14) 111.15(13) 
C(5)-C(7) 1.394(2) N(3)-C(13)-C(12) 104.80(12) 
C(5)-C(6) 1.505(2) C(13)-C(14)-C(15) 111.17(13) 
C(7)-C(8) 1.384(3) C(13)-C(14)-C(20) 128.01(14) 
C(8)-C(9) 1.394(2) C(15)-C(14)-C(20) 120.78(14) 
C(9)-C(10) 1.389(2) C(14)-C(15)-C(16) 111.43(14) 
C(12)-C(16) 1.531(2) C(16)-C(15)-C(17) 128.22(15) 
C(12)-C(13) 1.550(2) C(14)-C(15)-C(17) 120.35(14) 
C(13)-C(14) 1.518(2) C(12)-C(16)-C(15) 104.16(13) 
C(14)-C(20) 1.387(2) C(15)-C(17)-C(18) 119.04(15) 
C(14)-C(15) 1.389(2) C(17)-C(18)-C(19) 120.17(16) 
C(15)-C(16) 1.508(2) C(18)-C(19)-C(20) 120.79(15) 
C(15)-C(17) 1.395(2) C(14)-C(20)-C(19) 118.86(15) 
C(17)-C(18) 1.388(3) O(1)-C(2)-H(2) 112.00 
C(18)-C(19) 1.397(2) C(3)-C(2)-H(2) 112.00 
C(19)-C(20) 1.387(2) C(6)-C(2)-H(2) 112.00 
C(2)-H(2) 10.000 N(2)-C(3)-H(3) 113.00 
C(3)-H(3) 10.000 C(2)-C(3)-H(3) 113.00 
C(6)-H(6A) 0.9900 C(4)-C(3)-H(3) 113.00 
C(6)-H(6B) 0.9900 C(2)-C(6)-H(6A) 111.00 
C(7)-H(7) 0.9500 C(2)-C(6)-H(6B) 111.00 
C(8)-H(8) 0.9500 C(5)-C(6)-H(6A) 111.00 
C(9)-H(9) 0.9500 C(5)-C(6)-H(6B) 111.00 
C(10)-H(10) 0.9500 H(6A)-C(6)-H(6B) 109.00 
C(12)-H(12) 10.000 C(5)-C(7)-H(7) 120.00 
C(13)-H(13) 10.000 C(8)-C(7)-H(7) 120.00 
C(16)-H(16A) 0.9900 C(7)-C(8)-H(8) 120.00 
C(16)-H(16B) 0.9900 C(9)-C(8)-H(8) 120.00 
C(17)-H(17) 0.9500 C(8)-C(9)-H(9) 120.00 
C(18)-H(18) 0.9500 C(10)-C(9)-H(9) 120.00 
C(19)-H(19) 0.9500 C(4)-C(10)-H(10) 121.00 
C(20)-H(20) 0.9500 C(9)-C(10)-H(10) 121.00 
C(1)-O(1)-C(2) 108.84(12) O(2)-C(12)-H(12) 112.00 
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C(11)-O(2)-C(12) 106.83(11) C(13)-C(12)-H(12) 112.00 
C(1)-N(1)-C(11) 115.77(14) C(16)-C(12)-H(12) 112.00 
C(1)-N(2)-C(3) 110.81(13) N(3)-C(13)-H(13) 112.00 
C(11)-N(3)-C(13) 106.48(13) C(12)-C(13)-H(13) 112.00 
C(11)-N(1)-H(1N) 91.0(10) C(14)-C(13)-H(13) 112.00 
C(1)-N(1)-H(1N) 123.5(10) C(12)-C(16)-H(16A) 111.00 
O(1)-C(1)-N(2) 111.21(13) C(12)-C(16)-H(16B) 111.00 
O(1)-C(1)-N(1) 118.16(14) C(15)-C(16)-H(16A) 111.00 
N(1)-C(1)-N(2) 130.62(15) C(15)-C(16)-H(16B) 111.00 
O(1)-C(2)-C(6) 109.96(12) H(16A)-C(16)-H(16B) 109.00 
C(3)-C(2)-C(6) 107.76(13) C(15)-C(17)-H(17) 120.00 
O(1)-C(2)-C(3) 103.17(12) C(18)-C(17)-H(17) 121.00 
C(2)-C(3)-C(4) 102.79(13) C(17)-C(18)-H(18) 120.00 
N(2)-C(3)-C(2) 101.08(12) C(19)-C(18)-H(18) 120.00 
N(2)-C(3)-C(4) 114.07(13) C(18)-C(19)-H(19) 120.00 
C(5)-C(4)-C(10) 120.91(15) C(20)-C(19)-H(19) 120.00 
C(3)-C(4)-C(10) 128.43(14) C(14)-C(20)-H(20) 121.00 
C(3)-C(4)-C(5) 110.66(13) C(19)-C(20)-H(20) 121.00 
 
Table 4: Anisotropic displacement parameters (A2 x 103) for h262. The anisotropic 
displacement factor exponent takes the form: -2 pi2 [ h2 a*2 U11 + .. + 2 h k a*b*U12] 
Atom    U11   U22   U33    U23    U13  U12  
O(1) 23(1) 25(1) 24(1) 1(1) -4(1) -4(1)  
O(2) 25(1) 23(1) 25(1) -2(1) -4(1) 2(1)  
N(1) 20(1) 25(1) 21(1) -1(1) 3(1) 1(1)  
N(2) 25(1) 26(1) 21(1) -1(1) 0(1) 2(1)  
N(3) 25(1) 23(1) 21(1) 2(1) -1(1) -2(1)  
C(1) 18(1) 26(1) 17(1) -2(1) 3(1) -2(1)  
C(2) 17(1) 29(1) 24(1) 1(1) -1(1) 0(1)  
C(3) 21(1) 25(1) 23(1) -1(1) -1(1) 1(1)  
C(4) 19(1) 23(1) 20(1) 0(1) -3(1) 4(1)  
C(5) 19(1) 21(1) 24(1) 2(1) -2(1) 1(1)  
C(6) 18(1) 26(1) 25(1) 1(1) -3(1) -2(1)  
C(7) 26(1) 25(1) 22(1) -2(1) -5(1) 1(1)  
C(8) 25(1) 27(1) 22(1) 3(1) 2(1) 3(1)  
C(9) 24(1) 25(1) 31(1) 3(1) -1(1) -1(1)  
C(10) 21(1) 22(1) 26(1) -2(1) -2(1) 1(1)  
C(11) 17(1) 28(1) 17(1) 0(1) 3(1) 0(1)  
C(12) 17(1) 28(1) 24(1) -2(1) 0(1) -3(1)  
C(13) 19(1) 23(1) 23(1) -1(1) 0(1) -2(1)  
C(14) 18(1) 23(1) 21(1) -3(1) -2(1) -4(1)  
C(15) 16(1) 23(1) 24(1) -2(1) -3(1) -1(1)  
C(16) 21(1) 25(1) 25(1) -1(1) -4(1) 3(1)  
C(17) 24(1) 28(1) 20(1) 2(1) -4(1) -2(1)  
C(18) 24(1) 30(1) 22(1) -3(1) 1(1) -3(1)  
C(19) 23(1) 26(1) 28(1) -3(1) 0(1) 2(1)  
C(20) 21(1) 23(1) 25(1) 1(1) -4(1) -1(1)  
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Table 5. Hydrogen coordinates ( x 104) and isotropic displacement parameters (A2 x 
103) for 45. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 6: Torsion angles [deg] for 45. 
C(2)-O(1)-C(1)-N(1) -173.62(13)  C(5)-C(4)-C(10)-C(9) -0.2(2)  
C(2)-O(1)-C(1)-N(2) 7.60(16)  C(10)-C(4)-C(5)-C(7) -0.1(2)  
C(1)-O(1)-C(2)-C(3) -18.49(15)  C(3)-C(4)-C(10)-C(9) -179.96(15)  
C(1)-O(1)-C(2)-C(6) -133.21(13)  C(4)-C(5)-C(7)-C(8) 0.4(3)  
C(12)-O(2)-C(11)-N(1) -178.61(12)  C(4)-C(5)-C(6)-C(2) 12.83(17)  
C(11)-O(2)-C(12)-C(13) -9.58(15)  C(7)-C(5)-C(6)-C(2) -167.53(16)  
C(12)-O(2)-C(11)-N(3) 2.95(18)  C(6)-C(5)-C(7)-C(8) -179.23(16)  
C(11)-O(2)-C(12)-C(16) -124.31(13)  C(5)-C(7)-C(8)-C(9) -0.4(3)  
C(1)-N(1)-C(11)-O(2) 176.86(13)  C(7)-C(8)-C(9)-C(10) 0.1(3)  
C(1)-N(1)-C(11)-N(3) -4.9(2)  C(8)-C(9)-C(10)-C(4) 0.2(3)  
C(11)-N(1)-C(1)-O(1) -179.63(13)  O(2)-C(12)-C(13)-C(14) -104.03(13)  
C(11)-N(1)-C(1)-N(2) -1.1(2)  C(16)-C(12)-C(13)-N(3) 129.43(14)  
C(3)-N(2)-C(1)-O(1) 7.70(18)  O(2)-C(12)-C(16)-C(15) 97.52(14)  
C(1)-N(2)-C(3)-C(2) -18.37(16)  C(13)-C(12)-C(16)-C(15) -13.95(17)  
C(1)-N(2)-C(3)-C(4) 91.17(16)  C(16)-C(12)-C(13)-C(14) 12.85(16)  
C(3)-N(2)-C(1)-N(1) -170.88(16)  O(2)-C(12)-C(13)-N(3) 12.55(15)  
C(11)-N(3)-C(13)-C(14) 99.92(15)  N(3)-C(13)-C(14)-C(15) -118.89(14)  
C(11)-N(3)-C(13)-C(12) -11.30(16)  N(3)-C(13)-C(14)-C(20) 58.7(2)  
C(13)-N(3)-C(11)-N(1) -172.42(15)  C(12)-C(13)-C(14)-C(15) -6.88(17)  
C(13)-N(3)-C(11)-O(2) 5.73(18)  C(12)-C(13)-C(14)-C(20) 170.71(15)  
C(6)-C(2)-C(3)-N(2) 137.57(13)  C(13)-C(14)-C(15)-C(16) -1.94(19)  
C(6)-C(2)-C(3)-C(4) 19.50(15)  C(13)-C(14)-C(15)-C(17) 178.03(15)  
O(1)-C(2)-C(6)-C(5) 91.81(14)  C(20)-C(14)-C(15)-C(16) -179.72(15)  
C(3)-C(2)-C(6)-C(5) -19.96(16)  C(20)-C(14)-C(15)-C(17) 0.3(2)  
Atom         x      y     z    U(eq)  
H(1N) -11600(30) -1537(15) -2480(6) 26 
H(2) -3338 -2786 -1928 28 
H(3) -5229 -4690 -1903 27 
H(6A) -3253 -2714 -1098 28 
H(6B) -5395 -1655 -1170 28 
H(7) -7628 -2707 -325 29 
H(8) -10843 -4123 -117 30 
H(9) -12247 -5554 -683 32 
H(10) -10451 -5595 -1467 27 
H(12) -16890 -2868 -3317 28 
H(13) -14859 -4731 -3265 26 
H(16A) -16577 -2713 -4139 28 
H(16B) -14315 -1726 -4035 28 
H(17) -12065 -2879 -4861 29 
H(18) -8925 -4371 -5031 30 
H(19) -7810 -5796 -4438 30 
H(20) -9797 -5745 -3672 28 
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O(1)-C(2)-C(3)-N(2) 21.27(15)  C(13)-C(14)-C(20)-C(19) -177.89(15)  
O(1)-C(2)-C(3)-C(4) -96.80(13)  C(15)-C(14)-C(20)-C(19) -0.5(2)  
C(2)-C(3)-C(4)-C(5) -11.77(17)  C(14)-C(15)-C(16)-C(12) 10.00(18)  
C(2)-C(3)-C(4)-C(10) 168.05(16)  C(17)-C(15)-C(16)-C(12) -169.96(16)  
N(2)-C(3)-C(4)-C(10) 59.6(2)  C(14)-C(15)-C(17)-C(18) 0.1(3)  
N(2)-C(3)-C(4)-C(5) -120.26(15)  C(16)-C(15)-C(17)-C(18) -179.92(16)  
C(10)-C(4)-C(5)-C(6) 179.56(14)  C(15)-C(17)-C(18)-C(19) -0.2(3)  
C(3)-C(4)-C(5)-C(6) -0.61(18)  C(17)-C(18)-C(19)-C(20) -0.1(3)  
C(3)-C(4)-C(5)-C(7) 179.72(15)  C(18)-C(19)-C(20)-C(14) 0.4(2)  
 
 
Table 7: Hydrogen-bonds for 45 [Å and deg.]. 
 D-H...A d(D-H) d(H...A) d(D...A) <(DHA)  
   
    
 C(2)-H(2)...N(1)#1 10.000 26.100  3.513(2)  150.00  
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X-ray structure of complex 47 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1: Crystal data and structure refinement for 47. 
      Crystal Data    
Empirical formula  C42 H38 Cu N6 O4, 2(Cl O4)  
Formula weight  952.99  
Crystal size  0.262 x 0.214 x 0.170 mm  
Crystal description  prism  
Crystal colour  smaragd green  
Crystal system Orthorhombic  
Space group  P 21 21 21  
Unit cell dimensions               a = 11.2373(2) A   alpha = 90 deg.  
                                         b = 14.6525(2) A    beta = 90 deg.  
                                         c = 24.0956(4) A   gamma = 90 deg.  
Volume  3967.45(11) A^3  
Z, Calculated density  4,  1.595 Mg/m^3  
Absorption coefficient  2.665 mm^-1  
F(000)  1963 
    
      Data Collection    
Measurement device type  Goniometer Xcalibur, detector: Ruby (Gemini 
ultra Mo)  
Measuremnet method  \w scans  
E. Appendix 
 
197 
 
Temperature  123 K  
Wavelength  1.54184 A  
Monochromator   graphite  
Theta range for data collection  3.53 to 66.65 deg.  
Index ranges   =-13<=h<=11 -17<=k<=17 -28<=l<=26 
Reflections collected / unique  18468 / 6900 [R(int) = 0.0243]  
Reflections greater I>2\s(I) 6782 
Absorption correction  Semi-empirical from equivalents  
Max. and min. transmission  1.00000 and 0.90883  
    
      Refinement    
Refinement method  Full-matrix least-squares on F^2  
Hydrogen treatment  :  
Data / restraints / parameters  6900 / 12 / 571  
Goodness-of-fit on F^2  1.034 
Final R indices [I>2sigma(I)]      R1 = 0.0338, wR2 = 0.0888  
R indices (all data)               R1 = 0.0344, wR2 = 0.0894  
Absolute structure parameter  -0.011(13)  
Largest diff. peak and hole  0.654 and -0.853 e.A^-3  
 
 
Table 2: Atomic coordinates ( x 104) and equivalent isotropic displacement 
parameters (A2 x 103) for 47. U(eq) is defined as one third of the trace of the 
orthogonalized Uij tensor. 
   Atom x    y     z  
Cu(1) 5361(1) 10102(1) 8818(1) 
O(1) 3226(2) 12217(1) 9340(1) 
O(2) 1882(2) 9884(1) 8298(1) 
O(3) 7656(2) 8109(1) 9371(1) 
O(4) 8861(2) 10552(1) 8378(1) 
N(1) 4666(2) 11233(1) 9100(1) 
N(2) 2683(2) 11063(2) 8766(1) 
N(3) 3785(2) 9709(1) 8569(1) 
N(4) 6127(2) 8982(1) 9080(1) 
N(5) 8148(2) 9368(2) 8884(1) 
N(6) 6894(2) 10550(2) 8556(1) 
C(1) 5274(2) 11891(2) 9479(1) 
C(2) 5777(2) 11455(2) 9997(1) 
C(3) 6803(3) 10933(2) 10052(1) 
C(4) 7098(3) 10595(2) 10571(1) 
C(5) 6382(3) 10786(2) 11027(1) 
C(6) 5369(3) 11309(2) 10974(1) 
C(7) 5064(2) 11640(2) 10456(1) 
C(8) 4014(3) 12243(2) 10300(1) 
C(9) 4232(2) 12487(2) 9691(1) 
C(10) 3570(2) 11479(2) 9067(1) 
C(11) 1486(2) 11498(2) 8744(1) 
C(12) 2845(2) 10213(2) 8553(1) 
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C(13) 2158(3) 8945(2) 8127(1) 
C(14) 1941(3) 8832(3) 7511(1) 
C(15) 3163(3) 8907(2) 7257(1) 
C(16) 3471(4) 8951(2) 6695(1) 
C(17) 4661(4) 8977(2) 6556(1) 
C(18) 5534(3) 8963(2) 6955(1) 
C(19) 5235(3) 8928(2) 7518(1) 
C(20) 4048(3) 8910(2) 7659(1) 
C(21) 3511(2) 8875(2) 8232(1) 
C(31) 5561(2) 8230(2) 9407(1) 
C(32) 5064(2) 8533(2) 9958(1) 
C(33) 4113(2) 9116(2) 10059(1) 
C(34) 3776(3) 9284(2) 10604(1) 
C(35) 4376(3) 8869(2) 11042(1) 
C(36) 5327(3) 8287(2) 10940(1) 
C(37) 5678(3) 8118(2) 10397(1) 
C(38) 6642(3) 7498(2) 10191(1) 
C(39) 6614(2) 7599(2) 9561(1) 
C(40) 7261(2) 8836(2) 9101(1) 
C(41) 9387(2) 8997(2) 8894(2) 
C(42) 7914(2) 10154(2) 8606(1) 
C(43) 8407(3) 11306(2) 8041(1) 
C(44) 8451(3) 11071(3) 7422(1) 
C(45) 7188(3) 11213(2) 7229(1) 
C(46) 6753(3) 11176(2) 6686(1) 
C(47) 5542(3) 11311(2) 6599(1) 
C(48) 4787(3) 11494(2) 7039(1) 
C(49) 5216(3) 11538(2) 7580(1) 
C(50) 6419(2) 11385(2) 7671(1) 
C(51) 7086(2) 11391(2) 8211(1) 
Cl(2) 8273(1) 7846(1) 7619(1) 
O(9) 7787(4) 7642(3) 8157(2) 
O(10) 7441(3) 7471(2) 7209(1) 
O(11) 9353(3) 7529(2) 7556(2) 
O(12) 8226(3) 8847(2) 7559(1) 
O(13) 9755(11) 7645(10) 7885(4) 
O(14) 8706(11) 8259(9) 7152(4) 
O(15) 8299(13) 6825(9) 7512(4) 
O(16) 7797(12) 7996(10) 8112(6) 
Cl(1) 808(1) 10197(1) 10014(1) 
O(5) 565(3) 9505(2) 10418(1) 
O(6) -294(2) 10509(2) 9769(1) 
O(7) 1392(2) 10962(2) 10269(1) 
O(8) 1565(2) 9823(1) 9587(1) 
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Table 3: Bond lengths [Å] and angles [deg] for 47. 
Cu(1)-N(1) 1.954(2)  C(3)-C(2)-C(7) C(3)-C(2)-C(7) 
Cu(1)-N(3) 1.957(2)  C(2)-C(3)-C(4) C(2)-C(3)-C(4) 
Cu(1)-N(4) 1.959(2)  C(3)-C(4)-C(5) C(3)-C(4)-C(5) 
Cu(1)-N(6) 1.949(2)  C(4)-C(5)-C(6) C(4)-C(5)-C(6) 
Cl(2)-O(10) 1.467(3)  C(5)-C(6)-C(7) C(5)-C(6)-C(7) 
Cl(2)-O(11) 1.309(3)  C(6)-C(7)-C(8) C(6)-C(7)-C(8) 
Cl(2)-O(12) 1.475(3)  C(2)-C(7)-C(6) C(2)-C(7)-C(6) 
Cl(2)-O(13) 1.809(12)  C(2)-C(7)-C(8) C(2)-C(7)-C(8) 
Cl(2)-O(14) 1.367(11)  C(7)-C(8)-C(9) C(7)-C(8)-C(9) 
Cl(2)-O(15) 1.519(13)  C(1)-C(9)-C(8) C(1)-C(9)-C(8) 
Cl(2)-O(9) 1.438(4)  O(1)-C(9)-C(1) O(1)-C(9)-C(1) 
Cl(2)-O(16) 1.322(14)  O(1)-C(9)-C(8) O(1)-C(9)-C(8) 
Cl(1)-O(7) 1.437(3)  N(1)-C(10)-N(2) N(1)-C(10)-N(2) 
Cl(1)-O(8) 1.444(2)  O(1)-C(10)-N(1) O(1)-C(10)-N(1) 
Cl(1)-O(6) 1.445(2)  O(1)-C(10)-N(2) O(1)-C(10)-N(2) 
Cl(1)-O(5) 1.432(3)  N(2)-C(12)-N(3) N(2)-C(12)-N(3) 
O(1)-C(9) 1.467(3)  O(2)-C(12)-N(2) O(2)-C(12)-N(2) 
O(1)-C(10) 1.323(3)  O(2)-C(12)-N(3) O(2)-C(12)-N(3) 
O(2)-C(12) 1.334(3)  C(14)-C(13)-C(21) C(14)-C(13)-C(21) 
O(2)-C(13) 1.469(4)  O(2)-C(13)-C(14) O(2)-C(13)-C(14) 
O(3)-C(40) 1.325(3)  O(2)-C(13)-C(21) O(2)-C(13)-C(21) 
O(3)-C(39) 1.463(3)  C(13)-C(14)-C(15) C(13)-C(14)-C(15) 
O(4)-C(42) 1.332(3)  C(14)-C(15)-C(16) C(14)-C(15)-C(16) 
O(4)-C(43) 1.463(4)  C(14)-C(15)-C(20) C(14)-C(15)-C(20) 
N(1)-C(10) 1.286(3)  C(16)-C(15)-C(20) C(16)-C(15)-C(20) 
N(1)-C(1) 1.493(3)  C(15)-C(16)-C(17) C(15)-C(16)-C(17) 
N(2)-C(10) 1.374(3)  C(16)-C(17)-C(18) C(16)-C(17)-C(18) 
N(2)-C(11) 1.490(3)  C(17)-C(18)-C(19) C(17)-C(18)-C(19) 
N(2)-C(12) 1.361(3)  C(18)-C(19)-C(20) C(18)-C(19)-C(20) 
N(3)-C(12) 1.289(3)  C(15)-C(20)-C(19) C(15)-C(20)-C(19) 
N(3)-C(21) 1.498(3)  C(15)-C(20)-C(21) C(15)-C(20)-C(21) 
N(4)-C(40) 1.293(3)  C(19)-C(20)-C(21) C(19)-C(20)-C(21) 
N(4)-C(31) 1.496(3)  N(3)-C(21)-C(13) N(3)-C(21)-C(13) 
N(5)-C(42) 1.359(3)  N(3)-C(21)-C(20) N(3)-C(21)-C(20) 
N(5)-C(40) 1.368(3)  C(13)-C(21)-C(20) C(13)-C(21)-C(20) 
N(5)-C(41) 1.495(3)  N(4)-C(31)-C(32) N(4)-C(31)-C(32) 
N(6)-C(51) 1.502(3)  N(4)-C(31)-C(39) N(4)-C(31)-C(39) 
N(6)-C(42) 1.290(3)  C(32)-C(31)-C(39) C(32)-C(31)-C(39) 
C(1)-C(2) 1.513(4)  C(31)-C(32)-C(33) C(31)-C(32)-C(33) 
C(1)-C(9) 1.548(3)  C(33)-C(32)-C(37) C(33)-C(32)-C(37) 
C(2)-C(3) 1.390(4)  C(31)-C(32)-C(37) C(31)-C(32)-C(37) 
C(2)-C(7) 1.391(4)  C(32)-C(33)-C(34) C(32)-C(33)-C(34) 
C(3)-C(4) 1.385(4)  C(33)-C(34)-C(35) C(33)-C(34)-C(35) 
C(4)-C(5) 1.389(5)  C(34)-C(35)-C(36) C(34)-C(35)-C(36) 
C(5)-C(6) 1.378(5)  C(35)-C(36)-C(37) C(35)-C(36)-C(37) 
C(6)-C(7) 1.384(4)  C(32)-C(37)-C(36) C(32)-C(37)-C(36) 
C(7)-C(8) 1.521(4)  C(36)-C(37)-C(38) C(36)-C(37)-C(38) 
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C(8)-C(9) 1.530(4)  C(32)-C(37)-C(38) C(32)-C(37)-C(38) 
C(13)-C(21) 1.545(4)  C(37)-C(38)-C(39) C(37)-C(38)-C(39) 
C(13)-C(14) 1.515(5)  O(3)-C(39)-C(31) O(3)-C(39)-C(31) 
C(14)-C(15) 1.507(5)  O(3)-C(39)-C(38) O(3)-C(39)-C(38) 
C(15)-C(20) 1.389(5)  C(31)-C(39)-C(38) C(31)-C(39)-C(38) 
C(15)-C(16) 1.399(5)  O(3)-C(40)-N(5) O(3)-C(40)-N(5) 
C(16)-C(17) 1.379(6)  O(3)-C(40)-N(4) O(3)-C(40)-N(4) 
C(17)-C(18) 1.373(5)  N(4)-C(40)-N(5) N(4)-C(40)-N(5) 
C(18)-C(19) 1.399(4)  O(4)-C(42)-N(5) O(4)-C(42)-N(5) 
C(19)-C(20) 1.377(5)  O(4)-C(42)-N(6) O(4)-C(42)-N(6) 
C(20)-C(21) 1.509(4)  N(5)-C(42)-N(6) N(5)-C(42)-N(6) 
C(31)-C(39) 1.547(3)  O(4)-C(43)-C(44) O(4)-C(43)-C(44) 
C(31)-C(32) 1.507(4)  O(4)-C(43)-C(51) O(4)-C(43)-C(51) 
C(32)-C(37) 1.402(4)  C(44)-C(43)-C(51) C(44)-C(43)-C(51) 
C(32)-C(33) 1.389(3)  C(43)-C(44)-C(45) C(43)-C(44)-C(45) 
C(33)-C(34) 1.388(4)  C(44)-C(45)-C(46) C(44)-C(45)-C(46) 
C(34)-C(35) 1.392(4)  C(44)-C(45)-C(50) C(44)-C(45)-C(50) 
C(35)-C(36) 1.389(4)  C(46)-C(45)-C(50) C(46)-C(45)-C(50) 
C(36)-C(37) 1.390(4)  C(45)-C(46)-C(47) C(45)-C(46)-C(47) 
C(37)-C(38) 1.498(4)  C(46)-C(47)-C(48) C(46)-C(47)-C(48) 
C(38)-C(39) 1.524(4)  C(47)-C(48)-C(49) C(47)-C(48)-C(49) 
C(43)-C(51) 1.545(4)  C(48)-C(49)-C(50) C(48)-C(49)-C(50) 
C(43)-C(44) 1.532(4)  C(49)-C(50)-C(51) C(49)-C(50)-C(51) 
C(44)-C(45) 1.508(5)  C(45)-C(50)-C(49) C(45)-C(50)-C(49) 
C(45)-C(46) 1.396(4)  C(45)-C(50)-C(51) C(45)-C(50)-C(51) 
C(45)-C(50) 1.395(4)  C(43)-C(51)-C(50) C(43)-C(51)-C(50) 
C(46)-C(47) 1.391(5)  N(6)-C(51)-C(43) N(6)-C(51)-C(43) 
C(47)-C(48) 1.383(5)  N(6)-C(51)-C(50) N(6)-C(51)-C(50) 
C(48)-C(49) 1.391(5)  N(1)-C(1)-H(1) N(1)-C(1)-H(1) 
C(49)-C(50) 1.388(4)  C(2)-C(1)-H(1) C(2)-C(1)-H(1) 
C(50)-C(51) 1.503(4)  C(9)-C(1)-H(1) C(9)-C(1)-H(1) 
C(1)-H(1) 10.000 C(2)-C(3)-H(3) C(2)-C(3)-H(3) 
C(3)-H(3) 0.9500  C(4)-C(3)-H(3) C(4)-C(3)-H(3) 
C(4)-H(4) 0.9500  C(5)-C(4)-H(4) C(5)-C(4)-H(4) 
C(5)-H(5) 0.9500  C(3)-C(4)-H(4) C(3)-C(4)-H(4) 
C(6)-H(6) 0.9500  C(6)-C(5)-H(5) C(6)-C(5)-H(5) 
C(8)-H(8B) 0.9900  C(4)-C(5)-H(5) C(4)-C(5)-H(5) 
C(8)-H(8A) 0.9900  C(5)-C(6)-H(6) C(5)-C(6)-H(6) 
C(9)-H(9) 10.000 C(7)-C(6)-H(6) C(7)-C(6)-H(6) 
C(11)-H(11C) 0.9800  C(7)-C(8)-H(8A) C(7)-C(8)-H(8A) 
C(11)-H(11A) 0.9800  C(7)-C(8)-H(8B) C(7)-C(8)-H(8B) 
C(11)-H(11B) 0.9800  C(9)-C(8)-H(8A) C(9)-C(8)-H(8A) 
C(13)-H(13) 10.000 C(9)-C(8)-H(8B) C(9)-C(8)-H(8B) 
C(14)-H(14A) 0.9900  H(8A)-C(8)-H(8B) H(8A)-C(8)-H(8B) 
C(14)-H(14B) 0.9900  O(1)-C(9)-H(9) O(1)-C(9)-H(9) 
C(16)-H(16) 0.9500  C(1)-C(9)-H(9) C(1)-C(9)-H(9) 
C(17)-H(17) 0.9500  C(8)-C(9)-H(9) C(8)-C(9)-H(9) 
C(18)-H(18) 0.9500  N(2)-C(11)-H(11A) N(2)-C(11)-H(11A) 
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C(19)-H(19) 0.9500  N(2)-C(11)-H(11B) N(2)-C(11)-H(11B) 
C(21)-H(21) 10.000 N(2)-C(11)-H(11C) N(2)-C(11)-H(11C) 
C(31)-H(31) 10.000 H(11A)-C(11)-H(11B) H(11A)-C(11)-H(11B) 
C(33)-H(33) 0.9500  H(11A)-C(11)-H(11C) H(11A)-C(11)-H(11C) 
C(34)-H(34) 0.9500  H(11B)-C(11)-H(11C) H(11B)-C(11)-H(11C) 
C(35)-H(35) 0.9500  C(14)-C(13)-H(13) C(14)-C(13)-H(13) 
C(36)-H(36) 0.9500  C(21)-C(13)-H(13) C(21)-C(13)-H(13) 
C(38)-H(38A) 0.9900  O(2)-C(13)-H(13) O(2)-C(13)-H(13) 
C(38)-H(38B) 0.9900  C(15)-C(14)-H(14A) C(15)-C(14)-H(14A) 
C(39)-H(39) 10.000 C(15)-C(14)-H(14B) C(15)-C(14)-H(14B) 
C(41)-H(41B) 0.9800  C(13)-C(14)-H(14A) C(13)-C(14)-H(14A) 
C(41)-H(41C) 0.9800  C(13)-C(14)-H(14B) C(13)-C(14)-H(14B) 
C(41)-H(41A) 0.9800  H(14A)-C(14)-H(14B) H(14A)-C(14)-H(14B) 
C(43)-H(43) 10.000 C(15)-C(16)-H(16) C(15)-C(16)-H(16) 
C(44)-H(44A) 0.9900  C(17)-C(16)-H(16) C(17)-C(16)-H(16) 
C(44)-H(44B) 0.9900  C(18)-C(17)-H(17) C(18)-C(17)-H(17) 
C(46)-H(46) 0.9500  C(16)-C(17)-H(17) C(16)-C(17)-H(17) 
C(47)-H(47) 0.9500  C(17)-C(18)-H(18) C(17)-C(18)-H(18) 
C(48)-H(48) 0.9500  C(19)-C(18)-H(18) C(19)-C(18)-H(18) 
C(49)-H(49) 0.9500  C(18)-C(19)-H(19) C(18)-C(19)-H(19) 
C(51)-H(51) 10.000 C(20)-C(19)-H(19) C(20)-C(19)-H(19) 
N(1)-Cu(1)-N(3) 89.73(9)  N(3)-C(21)-H(21) N(3)-C(21)-H(21) 
N(1)-Cu(1)-N(4) 140.72(9)  C(13)-C(21)-H(21) C(13)-C(21)-H(21) 
N(1)-Cu(1)-N(6) 100.38(9)  C(20)-C(21)-H(21) C(20)-C(21)-H(21) 
N(3)-Cu(1)-N(4) 104.49(9)  N(4)-C(31)-H(31) N(4)-C(31)-H(31) 
N(3)-Cu(1)-N(6) 143.10(9)  C(32)-C(31)-H(31) C(32)-C(31)-H(31) 
N(4)-Cu(1)-N(6) 89.89(9)  C(39)-C(31)-H(31) C(39)-C(31)-H(31) 
O(9)-Cl(2)-O(10) 106.7(2)  C(32)-C(33)-H(33) C(32)-C(33)-H(33) 
O(9)-Cl(2)-O(11) 112.6(2)  C(34)-C(33)-H(33) C(34)-C(33)-H(33) 
O(9)-Cl(2)-O(12) 106.4(2)  C(33)-C(34)-H(34) C(33)-C(34)-H(34) 
O(10)-Cl(2)-O(11) 112.3(2)  C(35)-C(34)-H(34) C(35)-C(34)-H(34) 
O(10)-Cl(2)-O(12) 106.49(19)  C(34)-C(35)-H(35) C(34)-C(35)-H(35) 
O(11)-Cl(2)-O(12) 112.0(2)  C(36)-C(35)-H(35) C(36)-C(35)-H(35) 
O(14)-Cl(2)-O(15) 106.8(7)  C(35)-C(36)-H(36) C(35)-C(36)-H(36) 
O(14)-Cl(2)-O(16) 144.2(8)  C(37)-C(36)-H(36) C(37)-C(36)-H(36) 
O(15)-Cl(2)-O(16) 108.9(8)  C(37)-C(38)-H(38A) C(37)-C(38)-H(38A) 
O(5)-Cl(1)-O(6) 109.75(17)  C(37)-C(38)-H(38B) C(37)-C(38)-H(38B) 
O(5)-Cl(1)-O(7) 110.37(15)  H(38A)-C(38)-H(38B) H(38A)-C(38)-H(38B) 
O(5)-Cl(1)-O(8) 109.16(14)  C(39)-C(38)-H(38A) C(39)-C(38)-H(38A) 
O(6)-Cl(1)-O(7) 108.68(13)  C(39)-C(38)-H(38B) C(39)-C(38)-H(38B) 
O(6)-Cl(1)-O(8) 109.50(13)  C(38)-C(39)-H(39) C(38)-C(39)-H(39) 
O(7)-Cl(1)-O(8) 109.38(13)  O(3)-C(39)-H(39) O(3)-C(39)-H(39) 
C(9)-O(1)-C(10) 106.43(19)  C(31)-C(39)-H(39) C(31)-C(39)-H(39) 
C(12)-O(2)-C(13) 107.2(2)  N(5)-C(41)-H(41A) N(5)-C(41)-H(41A) 
C(39)-O(3)-C(40) 107.29(19)  H(41A)-C(41)-H(41B) H(41A)-C(41)-H(41B) 
C(42)-O(4)-C(43) 106.4(2)  N(5)-C(41)-H(41B) N(5)-C(41)-H(41B) 
Cu(1)-N(1)-C(10) 126.76(18)  N(5)-C(41)-H(41C) N(5)-C(41)-H(41C) 
C(1)-N(1)-C(10) 107.2(2)  H(41A)-C(41)-H(41C) H(41A)-C(41)-H(41C) 
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Cu(1)-N(1)-C(1) 125.28(16)  H(41B)-C(41)-H(41C) H(41B)-C(41)-H(41C) 
C(10)-N(2)-C(12) 120.6(2)  C(51)-C(43)-H(43) C(51)-C(43)-H(43) 
C(11)-N(2)-C(12) 119.9(2)  O(4)-C(43)-H(43) O(4)-C(43)-H(43) 
C(10)-N(2)-C(11) 119.0(2)  C(44)-C(43)-H(43) C(44)-C(43)-H(43) 
C(12)-N(3)-C(21) 106.4(2)  C(43)-C(44)-H(44A) C(43)-C(44)-H(44A) 
Cu(1)-N(3)-C(12) 125.57(18)  C(43)-C(44)-H(44B) C(43)-C(44)-H(44B) 
Cu(1)-N(3)-C(21) 126.31(15)  C(45)-C(44)-H(44A) C(45)-C(44)-H(44A) 
Cu(1)-N(4)-C(40) 125.72(18)  C(45)-C(44)-H(44B) C(45)-C(44)-H(44B) 
C(31)-N(4)-C(40) 106.1(2)  H(44A)-C(44)-H(44B) H(44A)-C(44)-H(44B) 
Cu(1)-N(4)-C(31) 126.89(16)  C(45)-C(46)-H(46) C(45)-C(46)-H(46) 
C(40)-N(5)-C(41) 117.8(2)  C(47)-C(46)-H(46) C(47)-C(46)-H(46) 
C(40)-N(5)-C(42) 122.0(2)  C(46)-C(47)-H(47) C(46)-C(47)-H(47) 
C(41)-N(5)-C(42) 119.7(2)  C(48)-C(47)-H(47) C(48)-C(47)-H(47) 
Cu(1)-N(6)-C(42) 127.11(19)  C(47)-C(48)-H(48) C(47)-C(48)-H(48) 
Cu(1)-N(6)-C(51) 125.64(16)  C(49)-C(48)-H(48) C(49)-C(48)-H(48) 
C(42)-N(6)-C(51) 107.1(2)  C(48)-C(49)-H(49) C(48)-C(49)-H(49) 
N(1)-C(1)-C(2) 113.8(2)  C(50)-C(49)-H(49) C(50)-C(49)-H(49) 
N(1)-C(1)-C(9) 102.72(18)  N(6)-C(51)-H(51) N(6)-C(51)-H(51) 
C(2)-C(1)-C(9) 104.4(2)  C(43)-C(51)-H(51) C(43)-C(51)-H(51) 
C(1)-C(2)-C(3) 128.4(3)  C(50)-C(51)-H(51) C(50)-C(51)-H(51) 
C(1)-C(2)-C(7) C(1)-C(2)-C(7)   
 
 
Table 4: Anisotropic displacement parameters (A2 x 103) for 47. The anisotropic 
displacement factor exponent takes the form: -2 pi^2 [ h^2 a*^2 U11 + ... + 2 h k a* b* 
U12 ] 
              U11   U22   U33    U23    U13  U12  
Cu(1) 15(1) 15(1) 26(1) -1(1) 1(1) 0(1)  
O(1) 25(1) 18(1) 35(1) -4(1) 2(1) 5(1)  
O(2) 16(1) 27(1) 31(1) -2(1) -3(1) -2(1)  
O(3) 24(1) 22(1) 38(1) 4(1) -3(1) 4(1)  
O(4) 16(1) 30(1) 35(1) 2(1) 2(1) -4(1)  
N(1) 19(1) 17(1) 29(1) -1(1) 2(1) 2(1)  
N(2) 17(1) 21(1) 28(1) 1(1) 0(1) 3(1)  
N(3) 19(1) 18(1) 23(1) -1(1) 0(1) -2(1)  
N(4) 19(1) 17(1) 28(1) 0(1) -1(1) 1(1)  
N(5) 16(1) 20(1) 38(1) -1(1) 1(1) 2(1)  
N(6) 22(1) 20(1) 23(1) 0(1) 2(1) -4(1)  
C(1) 23(1) 16(1) 31(1) -3(1) 2(1) -3(1)  
C(2) 27(1) 17(1) 34(1) -3(1) -2(1) -7(1)  
C(3) 24(1) 26(1) 38(2) -6(1) -1(1) -3(1)  
C(4) 33(2) 23(1) 44(2) -1(1) -9(1) -1(1)  
C(5) 40(2) 27(1) 37(2) 3(1) -8(1) -11(1)  
C(6) 39(2) 27(1) 33(2) -2(1) 4(1) -10(1)  
C(7) 29(2) 19(1) 35(2) -5(1) 2(1) -7(1)  
C(8) 28(2) 29(1) 35(2) -7(1) 4(1) -1(1)  
C(9) 22(1) 19(1) 34(1) -4(1) 3(1) -1(1)  
C(10) 21(1) 16(1) 27(1) 3(1) 5(1) 0(1)  
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C(11) 18(1) 31(2) 41(2) 9(1) 3(1) 9(1)  
C(12) 19(1) 21(1) 22(1) 4(1) 2(1) -1(1)  
C(13) 24(1) 26(1) 40(2) -6(1) 0(1) -5(1)  
C(14) 32(2) 50(2) 49(2) -20(2) -13(1) 6(2)  
C(15) 41(2) 26(1) 33(2) -7(1) -7(1) -1(1)  
C(16) 64(2) 30(2) 32(2) -4(1) -9(2) 7(2)  
C(17) 77(3) 31(2) 25(2) -3(1) 7(2) -1(2)  
C(18) 52(2) 33(2) 37(2) -5(1) 18(2) -7(2)  
C(19) 30(2) 23(1) 33(2) -4(1) 4(1) -5(1)  
C(20) 32(2) 16(1) 28(1) -2(1) 2(1) -1(1)  
C(21) 19(1) 18(1) 30(1) -1(1) 0(1) -4(1)  
C(31) 23(1) 15(1) 32(1) 2(1) -3(1) -5(1)  
C(32) 26(1) 19(1) 29(1) 2(1) 0(1) -8(1)  
C(33) 22(1) 25(1) 33(1) 5(1) -2(1) -2(1)  
C(34) 31(2) 27(1) 38(2) 2(1) 7(1) -5(1)  
C(35) 45(2) 30(2) 31(2) -2(1) 3(1) -11(1)  
C(36) 38(2) 25(1) 29(1) 5(1) -6(1) -9(1)  
C(37) 31(2) 17(1) 36(2) 3(1) -4(1) -8(1)  
C(38) 36(2) 24(1) 37(2) 10(1) -6(1) 3(1)  
C(39) 24(1) 16(1) 38(2) 2(1) -3(1) -2(1)  
C(40) 23(1) 18(1) 28(1) -2(1) -2(1) 2(1)  
C(41) 12(1) 31(2) 64(2) -5(2) -3(1) 5(1)  
C(42) 17(1) 23(1) 25(1) -4(1) 1(1) -1(1)  
C(43) 25(1) 31(1) 28(1) 1(1) 2(1) -6(1)  
C(44) 26(2) 58(2) 30(2) 1(1) 6(1) -8(1)  
C(45) 30(2) 25(1) 29(1) -2(1) 2(1) -3(1)  
C(46) 47(2) 25(2) 29(2) -2(1) -4(1) -5(1)  
C(47) 48(2) 22(1) 33(2) 1(1) -14(1) -2(1)  
C(48) 34(2) 26(2) 51(2) 6(1) -14(2) 5(1)  
C(49) 32(2) 23(1) 35(2) 2(1) -1(1) 4(1)  
C(50) 25(1) 17(1) 31(1) 1(1) 0(1) -3(1)  
C(51) 24(1) 20(1) 25(1) 1(1) 1(1) -3(1)  
Cl(2) 55(1) 46(1) 41(1) -12(1) 6(1) -12(1)  
O(9) 51(1) 52(1) 55(1) -11(1) -9(1) -9(1)  
O(10) 51(1) 52(1) 55(1) -11(1) -9(1) -9(1)  
O(11) 51(1) 52(1) 55(1) -11(1) -9(1) -9(1)  
O(12) 51(1) 52(1) 55(1) -11(1) -9(1) -9(1)  
O(13) 68(4) 86(5) 39(3) -14(3) 2(3) -9(4)  
O(14) 68(4) 86(5) 39(3) -14(3) 2(3) -9(4)  
O(15) 68(4) 86(5) 39(3) -14(3) 2(3) -9(4)  
O(16) 68(4) 86(5) 39(3) -14(3) 2(3) -9(4)  
Cl(1) 29(1) 25(1) 29(1) 1(1) 6(1) 2(1)  
O(5) 75(2) 36(1) 46(1) 14(1) 28(1) 4(1)  
O(6) 25(1) 38(1) 53(1) -10(1) 3(1) 8(1)  
O(7) 42(1) 39(1) 51(1) -10(1) -3(1) -6(1)  
O(8) 26(1) 35(1) 31(1) 3(1) 6(1) 8(1)  
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Table 5: Hydrogen coordinates ( x 104) and isotropic displacement parameters (A2 x 
103) for 47. 
                         x      y     z    U(eq)  
H(1) 5885 12263 9279 28 
H(3) 7292 10810 9740 35 
H(4) 7791 10231 10616 40 
H(5) 6596 10553 11381 41 
H(6) 4888 11439 11289 40 
H(8A) 3994 12799 10533 36 
H(8B) 3254 11910 10344 36 
H(9) 4413 13152 9648 30 
H(11A) 987 11251 9041 45 
H(11B) 1116 11370 8384 45 
H(11C) 1569 12159 8792 45 
H(13) 1703 8487 8350 36 
H(14A) 1580 8231 7429 52 
H(14B) 1409 9318 7369 52 
H(16) 2874 8964 6415 51 
H(17) 4883 9005 6176 53 
H(18) 6347 8977 6848 49 
H(19) 5834 8917 7796 34 
H(21) 3727 8301 8433 27 
H(31) 4950 7898 9182 28 
H(33) 3700 9395 9760 32 
H(34) 3131 9685 10678 38 
H(35) 4133 8985 11413 42 
H(36) 5735 8007 11240 37 
H(38A) 6484 6858 10301 39 
H(38B) 7426 7684 10341 39 
H(39) 6552 6993 9373 31 
H(41A) 9459 8506 8620 54 
H(41B) 9565 8758 9264 54 
H(41C) 9950 9486 8803 54 
H(43) 8850 11883 8120 33 
H(44A) 9005 11481 7222 46 
H(44B) 8704 10431 7364 46 
H(46) 7272 11061 6383 40 
H(47) 5229 11276 6234 41 
H(48) 3964 11591 6970 44 
H(49) 4696 11670 7880 36 
H(51) 6932 11961 8428 27 
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Table 6: Torsion angles [deg] for 47. 
N(3)-Cu(1)-N(1)-C(1) 166.8(2)  N(1)-C(1)-C(9)-O(1) -9.9(2)  
N(4)-Cu(1)-N(1)-C(1) 53.9(3)  N(1)-C(1)-C(9)-C(8) 108.5(2)  
N(6)-Cu(1)-N(1)-C(1) -48.9(2)  C(9)-C(1)-C(2)-C(3) -172.4(3)  
N(3)-Cu(1)-N(1)-C(10) -1.9(2)  C(2)-C(1)-C(9)-C(8) -10.5(3)  
N(4)-Cu(1)-N(1)-C(10) -114.8(2)  C(2)-C(1)-C(9)-O(1) -128.9(2)  
N(6)-Cu(1)-N(1)-C(10) 142.4(2)  N(1)-C(1)-C(2)-C(7) -103.8(2)  
N(1)-Cu(1)-N(3)-C(12) 10.5(2)  C(3)-C(2)-C(7)-C(6) 0.3(4)  
N(4)-Cu(1)-N(3)-C(12) 153.4(2)  C(1)-C(2)-C(7)-C(8) -1.4(3)  
N(6)-Cu(1)-N(3)-C(12) -96.6(2)  C(7)-C(2)-C(3)-C(4) 0.4(4)  
N(1)-Cu(1)-N(3)-C(21) 173.6(2)  C(3)-C(2)-C(7)-C(8) 178.4(2)  
N(4)-Cu(1)-N(3)-C(21) -43.4(2)  C(1)-C(2)-C(7)-C(6) -179.5(2)  
N(6)-Cu(1)-N(3)-C(21) 66.5(3)  C(1)-C(2)-C(3)-C(4) -179.8(3)  
N(1)-Cu(1)-N(4)-C(31) 67.7(3)  C(2)-C(3)-C(4)-C(5) -0.6(4)  
N(3)-Cu(1)-N(4)-C(31) -40.3(2)  C(3)-C(4)-C(5)-C(6) 0.2(5)  
N(6)-Cu(1)-N(4)-C(31) 174.1(2)  C(4)-C(5)-C(6)-C(7) 0.5(5)  
N(1)-Cu(1)-N(4)-C(40) -97.6(2)  C(5)-C(6)-C(7)-C(8) -178.5(3)  
N(3)-Cu(1)-N(4)-C(40) 154.4(2)  C(5)-C(6)-C(7)-C(2) -0.7(4)  
N(6)-Cu(1)-N(4)-C(40) 8.8(2)  C(2)-C(7)-C(8)-C(9) -5.3(3)  
N(1)-Cu(1)-N(6)-C(42) 139.2(2)  C(6)-C(7)-C(8)-C(9) 172.7(3)  
N(3)-Cu(1)-N(6)-C(42) -117.1(2)  C(7)-C(8)-C(9)-C(1) 9.7(3)  
N(4)-Cu(1)-N(6)-C(42) -2.6(2)  C(7)-C(8)-C(9)-O(1) 123.1(2)  
N(1)-Cu(1)-N(6)-C(51) -46.4(2)  C(21)-C(13)-C(14)-C(15) -12.0(4)  
N(3)-Cu(1)-N(6)-C(51) 57.3(3)  C(14)-C(13)-C(21)-C(20) 10.9(3)  
N(4)-Cu(1)-N(6)-C(51) 171.8(2)  O(2)-C(13)-C(14)-C(15) 99.7(3)  
C(9)-O(1)-C(10)-N(2) 172.4(2)  C(14)-C(13)-C(21)-N(3) 128.9(3)  
C(9)-O(1)-C(10)-N(1) -8.5(3)  O(2)-C(13)-C(21)-N(3) 12.4(3)  
C(10)-O(1)-C(9)-C(1) 11.0(3)  O(2)-C(13)-C(21)-C(20) -105.6(2)  
C(10)-O(1)-C(9)-C(8) -104.9(2)  C(13)-C(14)-C(15)-C(16) -172.4(3)  
C(13)-O(2)-C(12)-N(2) -175.9(2)  C(13)-C(14)-C(15)-C(20) 9.0(4)  
C(13)-O(2)-C(12)-N(3) 4.1(3)  C(14)-C(15)-C(20)-C(21) -2.3(4)  
C(12)-O(2)-C(13)-C(14) -125.4(3)  C(16)-C(15)-C(20)-C(21) 179.0(3)  
C(12)-O(2)-C(13)-C(21) -10.3(3)  C(14)-C(15)-C(20)-C(19) 176.8(3)  
C(39)-O(3)-C(40)-N(5) -178.3(2)  C(14)-C(15)-C(16)-C(17) -177.1(3)  
C(40)-O(3)-C(39)-C(38) -121.7(2)  C(20)-C(15)-C(16)-C(17) 1.4(4)  
C(40)-O(3)-C(39)-C(31) -6.2(3)  C(16)-C(15)-C(20)-C(19) -2.0(4)  
C(39)-O(3)-C(40)-N(4) 3.4(3)  C(15)-C(16)-C(17)-C(18) -0.2(4)  
C(43)-O(4)-C(42)-N(5) 172.6(2)  C(16)-C(17)-C(18)-C(19) -0.5(4)  
C(42)-O(4)-C(43)-C(51) 11.2(3)  C(17)-C(18)-C(19)-C(20) -0.1(4)  
C(43)-O(4)-C(42)-N(6) -8.9(3)  C(18)-C(19)-C(20)-C(15) 1.3(4)  
C(42)-O(4)-C(43)-C(44) -104.8(3)  C(18)-C(19)-C(20)-C(21) -179.8(3)  
C(10)-N(1)-C(1)-C(2) 117.9(2)  C(15)-C(20)-C(21)-N(3) -116.9(2)  
C(1)-N(1)-C(10)-O(1) 1.5(3)  C(15)-C(20)-C(21)-C(13) -5.3(3)  
C(10)-N(1)-C(1)-C(9) 5.7(3)  C(19)-C(20)-C(21)-N(3) 64.1(3)  
Cu(1)-N(1)-C(1)-C(9) -164.84(16)  C(19)-C(20)-C(21)-C(13) 175.7(3)  
Cu(1)-N(1)-C(1)-C(2) -52.7(3)  N(4)-C(31)-C(39)-C(38) 123.6(2)  
C(1)-N(1)-C(10)-N(2) -179.5(2)  C(32)-C(31)-C(39)-O(3) -112.8(2)  
Cu(1)-N(1)-C(10)-O(1) 171.84(17)  N(4)-C(31)-C(32)-C(33) 66.7(3)  
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Cu(1)-N(1)-C(10)-N(2) -9.2(4)  N(4)-C(31)-C(32)-C(37) -115.2(2)  
C(12)-N(2)-C(10)-N(1) 13.5(4)  C(39)-C(31)-C(32)-C(33) 179.3(2)  
C(10)-N(2)-C(12)-O(2) 176.6(2)  C(39)-C(31)-C(32)-C(37) -2.6(3)  
C(11)-N(2)-C(10)-O(1) 4.1(3)  N(4)-C(31)-C(39)-O(3) 6.7(3)  
C(11)-N(2)-C(10)-N(1) -175.0(3)  C(32)-C(31)-C(39)-C(38) 4.1(3)  
C(12)-N(2)-C(10)-O(1) -167.5(2)  C(33)-C(32)-C(37)-C(36) 0.4(4)  
C(11)-N(2)-C(12)-O(2) 5.2(3)  C(33)-C(32)-C(37)-C(38) 178.3(2)  
C(11)-N(2)-C(12)-N(3) -174.8(3)  C(31)-C(32)-C(37)-C(38) 0.0(3)  
C(10)-N(2)-C(12)-N(3) -3.3(4)  C(31)-C(32)-C(33)-C(34) 178.0(3)  
Cu(1)-N(3)-C(12)-O(2) 170.45(16)  C(37)-C(32)-C(33)-C(34) 0.1(4)  
C(12)-N(3)-C(21)-C(20) 101.2(2)  C(31)-C(32)-C(37)-C(36) -177.9(2)  
C(21)-N(3)-C(12)-N(2) -175.5(2)  C(32)-C(33)-C(34)-C(35) -0.5(4)  
Cu(1)-N(3)-C(21)-C(13) -176.33(17)  C(33)-C(34)-C(35)-C(36) 0.6(5)  
Cu(1)-N(3)-C(21)-C(20) -64.6(3)  C(34)-C(35)-C(36)-C(37) -0.2(5)  
Cu(1)-N(3)-C(12)-N(2) -9.6(4)  C(35)-C(36)-C(37)-C(38) -177.8(3)  
C(21)-N(3)-C(12)-O(2) 4.6(3)  C(35)-C(36)-C(37)-C(32) -0.3(4)  
C(12)-N(3)-C(21)-C(13) -10.6(3)  C(32)-C(37)-C(38)-C(39) 2.6(3)  
C(40)-N(4)-C(31)-C(32) 107.8(2)  C(36)-C(37)-C(38)-C(39) -179.7(3)  
Cu(1)-N(4)-C(31)-C(39) -172.70(17)  C(37)-C(38)-C(39)-O(3) 108.3(2)  
Cu(1)-N(4)-C(40)-N(5) -8.9(4)  C(37)-C(38)-C(39)-C(31) -4.1(3)  
C(40)-N(4)-C(31)-C(39) -5.1(3)  O(4)-C(43)-C(44)-C(45) 124.8(3)  
C(31)-N(4)-C(40)-O(3) 1.3(3)  C(44)-C(43)-C(51)-C(50) -10.6(3)  
C(31)-N(4)-C(40)-N(5) -176.7(3)  O(4)-C(43)-C(51)-N(6) -9.9(3)  
Cu(1)-N(4)-C(40)-O(3) 169.10(18)  O(4)-C(43)-C(51)-C(50) -128.8(2)  
Cu(1)-N(4)-C(31)-C(32) -59.9(3)  C(51)-C(43)-C(44)-C(45) 11.0(3)  
C(41)-N(5)-C(42)-O(4) -2.5(4)  C(44)-C(43)-C(51)-N(6) 108.3(3)  
C(40)-N(5)-C(42)-O(4) -174.2(2)  C(43)-C(44)-C(45)-C(46) 173.6(3)  
C(42)-N(5)-C(40)-N(4) -0.1(4)  C(43)-C(44)-C(45)-C(50) -7.5(4)  
C(40)-N(5)-C(42)-N(6) 7.4(4)  C(46)-C(45)-C(50)-C(49) -1.2(4)  
C(42)-N(5)-C(40)-O(3) -178.3(2)  C(46)-C(45)-C(50)-C(51) 179.9(2)  
C(41)-N(5)-C(42)-N(6) 179.1(3)  C(50)-C(45)-C(46)-C(47) -0.2(4)  
C(41)-N(5)-C(40)-O(3) 9.9(4)  C(44)-C(45)-C(50)-C(49) 179.8(3)  
C(41)-N(5)-C(40)-N(4) -172.0(3)  C(44)-C(45)-C(46)-C(47) 178.7(3)  
Cu(1)-N(6)-C(51)-C(43) -169.93(17)  C(44)-C(45)-C(50)-C(51) 0.9(3)  
Cu(1)-N(6)-C(42)-O(4) 177.18(17)  C(45)-C(46)-C(47)-C(48) 1.1(4)  
C(42)-N(6)-C(51)-C(43) 5.4(3)  C(46)-C(47)-C(48)-C(49) -0.7(4)  
C(51)-N(6)-C(42)-O(4) 1.9(3)  C(47)-C(48)-C(49)-C(50) -0.7(4)  
Cu(1)-N(6)-C(42)-N(5) -4.5(4)  C(48)-C(49)-C(50)-C(45) 1.6(4)  
Cu(1)-N(6)-C(51)-C(50) -57.8(3)  C(48)-C(49)-C(50)-C(51) -179.7(3)  
C(51)-N(6)-C(42)-N(5) -179.7(2)  C(45)-C(50)-C(51)-C(43) 6.1(3)  
C(42)-N(6)-C(51)-C(50) 117.5(2)  C(49)-C(50)-C(51)-N(6) 76.3(3)  
C(9)-C(1)-C(2)-C(7) 7.4(3)  C(49)-C(50)-C(51)-C(43) -172.7(3)  
N(1)-C(1)-C(2)-C(3) 76.5(3)  C(45)-C(50)-C(51)-N(6) -104.9(3)  
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Table 7: Hydrogen-bonds for 47 [Å and deg.]. 
 D-H...A d(D-H) d(H...A) d(D...A) <(DHA)  
 C(8)-H(8B)...O(7)  0.9900 25.200  3.494(4)  169.00  
 C(9)-H(9)...O(6)#1 10.000 24.400  3.255(3)  139.00  
 C(9)-H(9)...O(7)#1 10.000 25.800  3.326(3)  131.00  
 C(11)-H(11A)...O(6)  0.9800 25.200  3.494(4)  176.00  
 C(11)-H(11A)...O(8)  0.9800 25.600  3.187(4)  122.00  
 C(11)-H(11C)...O(1)  0.9800 22.800  2.645(3)  101.00  
 C(33)-H(33)...O(8)  0.9500 25.100  3.251(3)  134.00  
 C(38)-H(38A)...O(8)#2  0.9900 24.800  3.444(4)  164.00  
 C(39)-H(39)...O(5)#2 10.000 25.100  3.301(4)  136.00  
 C(41)-H(41A)...O(9)  0.9800 25.300  3.214(5)  127.00  
 C(41)-H(41C)...O(2)#3  0.9800 25.600  3.408(3)  145.00  
 C(41)-H(41C)...O(4)  0.9800 22.300  2.662(4)  105.00  
 C(44)-H(44A)...O(11)#4  0.9900 24.600  3.264(5)  138.00  
 C(44)-H(44B)...O(12)  0.9900 24.300  3.285(5)  145.00  
 C(47)-H(47)...O(5)#5  0.9500 24.400  3.328(4)  155.00  
 C(48)-H(48)...O(9)#6  0.9500 25.200  3.379(6)  151.00  
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